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iABSTRACT 
GLYCOSYLATION PATTERNS AND RECOGNITION BY LECTINS
INTRODUCTION
The space on the cell surface is fairly limited and has to harbour a multitude of signals, 
making high-density coding compulsory. Satisfying this requirement, the glycocalyx, a 
fuzz-like carbohydrate coat, is present on the external surface of cell membranes of both 
eukaryotes and prokaryotes, as well as of cell-derived vesicles. In addition to offering 
chemical resistance and backbone support, their extended presence on cellular surfaces 
plays an important functional role, frequently mediating recognition processes. Lectins, 
a ubiquitous family of effector proteins, are capable of reversibly binding carbohydrate 
sequences with extraordinary selectivity, thus acting as translators of sugar-encoded 
signals.
Their existence and action as fine-tuned binders argues for their probable co-evolution 
with saccharides in the frame of the high organisational diversity of the latter. Through 
recognition of sugar structures by endogenous lectins, the discrimination between self-
and non-self-glycosylation patterns lies behind the innate immunity response. In this 
perspective, the eventual presentation of aberrant glycosylation profiles by host cells at 
both structural and expression levels is commonly associated to pathogenesis, cancer 
being the most relevant example.
Even though these altered self-patterns do not typically elicit immune responses, they 
constitute attractive targets for diagnosis and therapeutic intervention. During the last 
decade, the findings supporting that extracellular vesicles (EV) could transfer molecular 
patterns, metabolites or effectors in a horizontal manner, revolutionised the biomarker 
field. These membrane vesicles are assembled in an orchestrated process, then liberated 
by almost all cells, including tumour cells, and are thought to share glycosylation 
profiles with them. Although the use of lectins as tools for glycotypification of tissues in 
physiology, or of bacterial strains in microbiology, was long established, lectin-based 
high-scale analytical methodologies for classification of EV are still missing.
In contrast, nonself pathogens´ glycosignatures, with definite structure, accessibility and 
density, are key targets for recognition by host lectins and/or soluble molecules for 
triggering defence responses.  Nonetheless, bacteria are highly dynamic organisms and 
effortlessly adapt to changing environments under selection pressure. In order to evade 
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host immunity strategies, they normally disguise their tell-tale glycostructures or even 
integrate host mimicry motifs. Along with pathogen glycotypification using lectins of 
known specificity as decoding tools, it is expected that the exploration of docking sites 
for endogenous lectins directly at the bacterial surface will pave the way for the 
establishment of virulence correlations. Up until recently, these studies were commonly 
performed following isolation and purification of selected surface components.
However, in these ligand-targeted approaches, the natural presentation and accessibility 
of glycans along with any possible contribution to the binding of neighbour molecules 
are not taken into account, an aspect of particular relevance in the case of weak binders.
OBJECTIVES
The core objective of this PhD Thesis is the design and development of novel high-
throughput platforms for the study of protein-carbohydrate interactions directly at the 
surface of the probes. Specific objectives are the following: 
• Design and application of novel microarray and Quartz Crystal Microgravimetry 
strategies for the analysis of surface glycosylation of bacteria and the exploration of 
their recognition by lectins of the innate immune system. Nontypeable Haemophilus 
influenzae (NTHi) was selected as model of non-encapsulated opportunistic pathogen of 
relevance in upper respiratory tract infections. 
• Development of microarray and QCM chips based on the incorporation of entire 
extracellular vesicles, as powerful tools for the analysis of glycosylation patterns of 
exosomes and microvesicles of diverse cellular origin and determination of the kinetic 
parameters of vesicle-lectin interactions.  
• Development of a microarray platform for the evaluation of adhesin 
functionality in live bacteria and the screening of glycosylated nano-scaffolds as 
possible anti-adhesive agents.  
FUNDAMENTAL INPUTS OF THE PHD THESIS 
In this Thesis, novel microarray and quartz crystal microbalance (QCM) strategies were 
applied to the analysis of carbohydrate-mediated interactions directly at the bacterial or 
extracellular vesicle surface, thus preserving the native environment, distribution and 
vicinity of glycan targets.  
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First, a novel bacteria-based microarray set-up was developed and the glycosylation 
patterns of different strains of the opportunistic respiratory pathogen nontypeable 
Haemophilus influenzae (NTHi) were examined as a case-study. To this aim, a panel of 
lectins with diverse binding preferences was employed. The results revealed the 
availability of carbohydrate structures that could be targeted by endogenous lectins with 
the appropriate carbohydrate-binding specificity. The recognition of clinical isolates of 
different origin by innate immunity-associated lectins was also explored, yielding semi-
quantitative data on binding avidity. In addition, to enable determination of binding 
affinity and kinetics for representative NTHi-lectin pairs, Quartz Crystal Microbalance 
(QCM) bacteria-based biosensors were designed, developed and used. Aiming towards 
ligand dissection among the various glycoconjugates present on the bacterial surface, 
the lipooligosaccharide (LOS), a major virulence factor, was isolated, quantified and 
structurally characterised by a combination of homo- and heteronuclear NMR 
techniques. Using designer microarrays, the LOS was found to be a target for some 
lectins, and in two selected cases the recognised epitopes were defined at atomic level 
using NMR-STD experiments. Finally, a pilot study of the influence of selected 
endogenous lectins on bacterial viability in vitro and on the potential for adhesion and 
invasion in cell culture was carried out.
Second, different extracellular vesicle populations were isolated and characterised by 
determination of their total protein cargo, particle concentration and morphology. The 
development of a widely applicable analytical tool enabling the glycoprofiling of 
distinct vesicular populations was a key objective. To this end, novel vesicle-based 
microarrays were set-up and validated by the use of selected known vesicle-binding 
molecules. Vesicle recognition by a panel of lectins of well-defined specificities was 
examined, revealing specific binding motifs. Based on lectin preferences for distinct 
populations, QCM chips were developed aimed at direct “fishing” and detection of 
vesicles in flow. In addition, the binding kinetics for representative vesicle-lectin pairs 
was investigated using vesicle-based QCM chips, here described for the first time. 
Finally, a novel microarray application for the search of anti-adhesive compounds was 
developed. FimH, a carbohydrate-binding adhesin of Escherichia coli involved in 
urothelium colonisation and infection, was selected as target. A microarray set-up was 
designed for assessing FimH functionality on the surface of fixed and live bacteria at 
different growth phases. Furthermore, a competitive binding assay was established 
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using the same microarray platform and concanavalin A for set-up validation. Model 
multivalent ligands were tested as inhibitors of the binding to the arrays, and SPR and 
ITC analyses of the interaction served to confirm the microarray-derived results. The 
validated microarray set-up was finally used for evaluation of glycofullerenes as 
inhibitors of E. coli bacterial adhesion to array-printed ligands. 
MAIN CONCLUSIONS 
 Bacteria-based microarrays have proved to be efficient for lectin typing of bacterial 
glycosignatures, also providing semi-quantitative data on binding avidity. The 
results evidenced the availability of Man/Glc, sialic acid, and Gal residues on the 
surface of NTHi for lectin recognition. Consistent with this observation, the binding 
of lectins of the innate immune system with the appropriate carbohydrate-binding 
specificity, including Siglec-14 and several members of the galectin family, has 
been detected. In addition, the first experimental evidence for direct binding of SP-
D to NTHi has been obtained. Comparison of the behaviour of selected galectins 
belonging to the three structural subgroups of this family unveiled striking 
differences in NTHi binding, which was found to be driven by carbohydrate 
recognition in the case of galectins 3 and 8, and by ionic interactions for galectin-4 
and its C-terminal carbohydrate-recognition domain. LOS microarrays and NMR-
based characterisation and mapping revealed lectin- and oligosaccharide-specific 
epitopes, detecting even slight divergences in the behaviour of lectins with similar 
nominal binding specificities, as the Gal-recognizing Ricinus communis and Viscum 
album agglutinins . 
 Lectin screening of distinct EV populations immobilised into microarrays pointed 
to EV-specific glycosylation profiles that could be exploited for designing new 
isolation protocols based on lectin affinity chromatography.
 Pioneer QCM sensor chips incorporating entire bacteria or EV have been developed 
and used for label-free kinetic analysis of probe−lectin interactions directly at the 
surface, yielding quantitative data on binding affinity and kinetic parameters. In 
addition, a straight-forward QCM approach for in-flow selective capture of vesicles 
of interest has been set up, paving the way for non-invasive, high-throughput 
screening of aberrant glycosignatures transported by EV through biological fluids.
v Finally, a microarray set-up for assessment of the functionality of E. coli FimH 
adhesin has been successfully established and found to be efficient for 
discriminating between fimbriate (FimH-expressing) and afimbriate states in live 
bacteria. In addition, its potential for evaluation of dodecafullerenes as inhibitors of 
FimH binding has been demonstrated. Parallel microarray, SPR and ITC analyses 
using ConA as model lectinhave served to validate the microarray-derived results.  
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RESUMEN 
PATRONES DE GLICOSILACIÓN Y RECONOCIMIENTO POR LECTINAS 
INTRODUCCIÓN 
La mayoría de los procesos de señalización biológica que tienen lugar en los 
organismos vivos involucran cuatro categorías de biomoléculas: ácidos nucleicos, 
proteínas, carbohidratos y/o lípidos. Los ácidos nucleicos y las proteínas, cuya 
secuencia y estructura fue objeto de estudio exhaustivo durante el siglo pasado, fueron 
identificados como biomoléculas responsables de la transmisión de información 
genética y como moléculas efectoras, respectivamente. No obstante, no parecía posible 
explicar integralmente procesos dinámicos a nivel intra- e intercelular, como por 
ejemplo la adhesión celular, la infección microbiana o la quimiotaxis de linfocitos, en 
un contexto de sólo dos dimensiones, i.e. ácidos nucleicos y proteínas. La existencia de 
un sistema encriptado adicional parecía esencial para cumplir estas funciones y los 
carbohidratos, ubicuos y diversos, se revelaron como biomoléculas idóneas para ejercer 
este papel. 
La extraordinaria capacidad de biocodificación de la que disponen deriva de su 
versatilidad estructural. Para una determinada secuencia de azúcares existen multitud de 
posibles isoformas: basta con variar la configuración anomérica del enlace glicosídico 
(α- o β-), la forma de cada anillo, la posición de los enlaces, la presencia o no de 
sustituciones específicas (fosforilación, sulfatación, etc.) y/o la disposición lineal o 
ramificada de las unidades que componen dicha secuencia. Es evidente que las 
glicoformas constituyen un sistema muy flexible y además editable de manera dinámica, 
que goza al mismo tiempo de cierta independencia del genoma. Una colección de 
enzimas se encarga de su modificación, confiriendo a las células la capacidad de 
adaptarse constantemente a su entorno. A pesar de este proceso de adaptación, existen 
ciertos patrones de glicosilación, que constituyen una “huella dactilar”, identificativa de 
su portador. 
La capacidad de los carbohidratos para actuar como señales de reconocimiento hace 
necesaria la existencia de una precisa maquinaria que permita hacer este código 
operativo: las lectinas. Esta familia universal de proteínas une carbohidratos selectiva y 
reversiblemente. Aunque la afinidad de las lectinas por mono- y disacáridos es 
intrínsecamente baja (KD = 10-4 a 10-3 M), ésta se regula a diferentes niveles dando paso 
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a una notable selectividad hacia sus dianas. Por lo que se refiere a la  lectina, la afinidad 
aumenta cuando ésta presenta sitios de unión extendidos, que ofrecen un área mayor de 
contacto, o múltiples sitios que operan simultánea y cooperativamente. Por otro lado, la 
presentación multivalente de ligandos, ya sea dentro de una misma molécula (por 
ejemplo, en oligosacáridos ramificados) o por agrupación de moléculas adyacentes, 
resulta en un aumento geométrico de la afinidad (efecto cluster).  
En un contexto fisiológico, la matriz extracelular y el glicocálix, que se localiza en el 
exterior de la membrana de células eucariotas, patógenos o incluso derivados celulares 
(cuerpos apoptóticos, exosomas y demás vesículas) se caracterizan precisamente por 
presentar una alta densidad tridimensional de glicanos. En consecuencia, estas 
estructuras están enriquecidas en sitios de unión para lectinas endógenas, como son las 
lectinas del sistema inmune innato. Asimismo, los patrones de glicosilación específicos 
de cada una de ellas permiten su tipificación. En el caso de las bacterias, sus 
“glicofirmas” pueden contener carbohidratos que no se encuentran en el glicocálix de 
las células eucariotas, o también pueden imitar a los carbohidratos del huésped con el 
fin de evitar el reconocimiento por lectinas endógenas y así evadir la respuesta inmune. 
En las bacterias Gram-negativas, en particular, los lipopolisacáridos y los polisacáridos 
capsulares constituyen factores de virulencia importantes. Ciertas especies bacterianas 
(e.g. Haemophilus, Neisseria, etc.) presentan en la cara externa de su envoltura celular 
estructuras de lipooligosacárido (LOS), anclado a la membrana mediante el lípido A, y 
consistente en un núcleo interno y ramificaciones de unas pocas unidades sacarídicas en 
modo no repetitivo. La extensión de estas ramificaciones está sujeta a control de 
variación de fase, un proceso de activación genética selectiva que puede dar lugar a 
evasión inmune. Por tanto, el glico-fenotipado de patógenos junto a la identificación de 
los epítopos reconocidos por lectinas endógenas podría permitir el establecimiento de 
correlaciones de virulencia.  
Para la identificación de los ligandos de lectinas endógenas se han utilizado técnicas de 
alto rendimiento (high-throughput), como por ejemplo plataformas de microarrays de 
carbohidratos. Éstos, sin embargo, presentan una serie de limitaciones, como es estar 
compuestos por librerías relativamente limitadas de oligosacáridos, generalmente de 
origen eucariota, cuya presentación en el array difiere sustancialmente con respecto a su 
entorno natural. Como consecuencia, estas plataformas no permiten evaluar la 
accesibilidad y densidad de cada oligosacárido en la superficie diana. Asimismo, ya que 
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sólo se examina la unión a ligandos individuales, tampoco puede detectarse  una posible 
unión derivada del reconocimiento simultáneo de diferentes moléculas vecinas. 
En el caso de las células eucariotas, los patrones de glicosilación se caracterizan por ser 
más estables y presentar escasos cambios fenotípicos individuales. No obstante, sí 
pueden verse alterados en casos de enfermedad, siendo el cáncer el ejemplo más 
prominente. Las células tumorales pueden presentar un perfil de glicosilación aberrante, 
tanto a nivel estructural como de expresión, en comparación con sus homólogos no 
transformados. La detección mediante procedimientos no invasivos de glicoproteínas 
asociadas a malignidad que pudieran ser de aplicación en diagnóstico temprano sigue 
siendo un reto difícil de conseguir, ya que estas glicoproteínas en muchos casos también 
se expresan en enfermedades benignas. Durante la última década, el descubrimiento de 
que las vesículas extracelulares pueden trasferir de manera horizontal (i.e. de una célula 
a otra) patrones moleculares, metabolitos o efectores, ha catalizado su uso como 
biomarcadores. Estas vesículas membranales son secretadas por casi todo tipo de células 
y se cree que comparten patrones de glicosilación con su célula de origen. Sin embargo, 
la glicofenotipificación de poblaciones individuales de vesículas extracelulares está 
dificultada en gran medida por la falta de metodología específica apropiada.  
De todo lo anterior se desprende que la caracterización de los patrones de glicosilación 
de diferentes tipos de sondas, como bacterias o vesículas extracelulares, puede ayudar al 
establecimiento de correlaciones funcionales. Para ello es necesario el desarrollo de 
nuevas metodologías analíticas de alto rendimiento que integren el uso de lectinas como 
herramientas únicas de descodificación. 
OBJETIVOS
El objetivo central de esta Tesis doctoral es el diseño y desarrollo de nuevas plataformas 
de alto rendimiento, destinadas al estudio de interacciones proteína-carbohidrato 
directamente en la superficie de bacterias y vesículas extracelulares, preservando el 
entorno y densidad natural de los epítopos. Los objetivos específicos son los siguientes: 
• Desarrollo de microarrays de diseño y nuevas aplicaciones de la 
microgravimetría basada en cristales de cuarzo (Quartz Crystal Microgravimetry, QCM) 
para el análisis de la glicosilación de superficie de bacterias, y la exploración de su 
reconocimiento por lectinas del sistema inmune innato. Como bacteria modelo, se ha 
xutilizado Haemophilus influenzae no tipificable (NTHi), la cual es un ejemplo relevante 
de patógeno oportunista no encapsulado. 
• Desarrollo de microarrays de vesículas extracelulares y chips de QCM como 
herramienta para el análisis de los patrones de glicosilación de exosomas y 
microvesículas de diferente origen y el estudio de los parámetros cinéticos de 
interacciones vesícula-lectina.  
• Desarrollo de un método de microarrays que permita la evaluación de la 
funcionalidad de adhesinas bacterianas en bacterias vivas y el escrutinio de 
nanosistemas glicosilados como posibles agentes anti-adhesivos. 
RESULTADOS Y APORTACIONES FUNDAMENTALES 
En esta memoria se describe el diseño, validación y aplicación de nuevas estrategias 
para el glicofenotipado de bacterias y vesículas extracelulares, y para la evaluación de 
compuestos anti-adhesivos, empleando las tecnologías de microarrays y QCM.  
En la sección 4.1, se describen los patrones de glicosilación obtenidos para distintas 
cepas de NTHi mediante ensayos de unión a microarrays de NTHi de un panel de 
lectinas con diferentes especificidades de unión a carbohidratos. Asimismo, se detallan 
los parámetros cinéticos obtenidos para la interacción de pares NTHi-lectina 
representativos, usando novedosos chips de QCM que incorporan la bacteria entera. La 
identificación del LOS de NTHi como ligando de ciertas lectinas ha dado paso a su 
análisis estructural por Resonancia Magnética Nuclear y a la elucidación a nivel 
atómico de los epítopos reconocidos mediante Diferencia de Trasferencia de Saturación 
(STD-NMR). Por otra parte, el estudio de la unión de lectinas del sistema inmune innato 
a diferentes aislados clínicos de NTHi ha demostrado un reconocimiento selectivo que 
depende tanto de la lectina como del aislado. Finalmente, se ha efectuado un estudio 
piloto de la influencia de lectinas endógenas seleccionadas sobre la viabilidad 
bacteriana in vitro y su capacidad de adhesión e invasión del epitelio pulmonar, no 
observándose efectos significativos. 
En la sección 4.2, se describe el desarrollo de una aplicación de la tecnología de los 
microarrays que permite el glicotipado de poblaciones distintas de vesículas 
extracelulares. Las diferentes preparaciones de vesículas se han caracterizado mediante 
determinación del cargo total de proteína, medida de la concentración de las partículas y 
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observación morfológica por microscopía electrónica de trasmisión. Después de 
incorporar las vesículas en microarrays, sus patrones de glicosilación se han explorado 
mediante ensayos de unión del panel de lectinas de especificidad conocida. Al igual que 
se hiciera para las bacterias, se han desarrollado chips de QCM derivatizados con 
lectinas para la captura directa y detección selectiva de vesículas en flujo. Igualmente, 
se han realizado estudios cinéticos de la interacción de pares vesícula-lectina 
representativos, directamente sobre la superficie de las vesículas, empleando chips de 
QCM con vesículas enteras incorporadas. 
Por último, en la sección 4.3, se describe una novedosa aplicación de los microarrays 
para la búsqueda de compuestos anti-adhesivos. En concreto, los microarrays
desarrollados han permitido evaluar la funcionalidad en su entorno natural de FimH, 
una adhesina de Escherichia coli que reconoce carbohidratos e interviene en la 
infección de epitelios humanos, empleando para ello células de E. coli vivas.  Se ha 
establecido un ensayo competitivo que permite la valoración de compuestos inhibidores 
de la adhesión, incluyendo glicoestructuras supramoleculares (fulerenos) o 
gliconanopartículas de silicio. La plataforma se ha validado empleando concanavalina A 
como lectina modelo, y los resultados obtenidos se han confirmado mediante resonancia 
de plasmón de superficie (SPR) y calorimetría de valoración isoterma (ITC). 
CONCLUSIONES PRINCIPALES 
 Se han desarrollado microarrays basados en la incorporación de bacterias 
completas que permiten su glicofenotipado, proporcionando datos semi-
cuantitativos sobre la avidez de la unión de diferentes lectinas a su superficie. Los 
resultados han revelado la presencia de residuos de Man/Glc, ácido siálico y Gal en 
la superficie de NTHi, los cuales actúan como señales de reconocimiento para 
lectinas del sistema inmune innato, incluyendo Siglec-14 y diferentes galectinas. 
Además, se ha obtenido la primera evidencia experimental del reconocimiento 
directo de NTHi por SP-D. El estudio comparativo del comportamiento de 
galectinas seleccionadas, pertenecientes a los tres subgrupos estructurales de esta 
familia de lectinas, ha revelado claras divergencias. En el caso de las galectinas 3 y 
8, la unión a NTHi está mediada por el reconocimiento de carbohidratos. Sin 
embargo, la unión de la galectina-4 depende fundamentalmente de interacciones 
iónicas. Utilizando microarrays de LOS y diferentes  técnicas de RMN, se han 
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identificado los epítopos reconocidos por determinadas lectinas, detectándose 
interesantes diferencias en el comportamiento de lectinas homólogas, como es el 
caso de las aglutininas específicas de Gal procedentes de Ricinus communis y 
Viscum album. 
 El estudio del reconocimiento de distintas subpoblaciones de vesículas 
extracelulares por un panel de lectinas con distintas especificidades de unión ha 
demostrado la existencia de perfiles de glicosilación característicos para cada 
subpoblación, los cuales podrían ser aprovechados para diseñar nuevos 
procedimientos para su fraccionamiento.  
 Se han desarrollado nuevos chips de QCM que incorporan bacterias o vesículas 
extracelulares enteras, y permiten el análisis de las interacciones sonda-lectina, 
directamente en su superficie, proporcionando datos cuantitativos sobre la afinidad 
de unión y parámetros cinéticos. Por otro lado, se ha establecido una nueva y 
sencilla aproximación que permite la captura selectiva en flujo continuo de 
vesículas de interés, abriendo así el camino para la detección y escrutinio no 
invasivo y de alto rendimiento de glicofirmas aberrantes transportadas por vesículas 
extracelulares en fluidos biológicos.  
 Por último, se han desarrollado nuevos microarrays de diseño para la evaluación de 
la funcionalidad de la adhesina FimH de E. coli (específica de mannosa), los cuales 
permiten discriminar entre bacterias fimbriadas y no fimbriadas. Adicionalmente, 
se ha demostrado su utilidad para la evaluación de glicofulerenos como inhibidores 
de la adhesión bacteriana. La validación de la plataforma utilizando concanavalina 
A como lectina modelo ha incluido el análisis de las interacciones lectina-inhibidor 
mediante resonancia de plasmón de superficie y calorimetría de valoración 
isoterma, confirmando los resultados obtenidos. 
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31.1 The Codes of Life 
During the second half of the 20th century, the leading lines of research focused on 
unravelling the chemical basis of heredity. Proteins were the first cell components to be 
considered the genetic information carrier, because of being both abundant and complex, 
made up of twenty main building blocks (amino acids). Up until O. Avery et al. discovered 
that DNA is the essential molecule able to induce bacterial transformation (Avery et al., 
1944), it had been considered a rather monotonous substance, not intricate enough to 
convey a huge amount of information, as it is only constituted by four alphabet characters: 
adenine, thymine, guanine and cytosine. A few years later, Watson and Crick observed that 
complementarity of the hydrogen-bonding patterns of the four bases is critical not only for 
DNA stability but also for its replicability (Watson and Crick, 1953). Both properties serve 
the necessity of rigidity and optimal fidelity in the inherited genetic information. 
From one aspect, adding letters to this alphabet would bring about more sequence 
combinations of nucleotides and thus increase the informational content of oligomers. 
Nevertheless, summing up manifold chemical, thermodynamic and computational studies, 
four still seems to be the optimal size for the genetic alphabet, “as a compromise between 
stability and evolvability, fidelity and enzymatic/catalytic efficiency as well as information 
density and error resistance” (Szathmary, 2003). 
The genetic code, relating two sequence types (i.e. nucleic acids into proteins) in a linear 
manner via the transcription and translation processes, triggers the conversion of triplet 
coding to peptides arranged in bioactive shapes (Barbieri, 2008). As opposed to DNA’s 
rigid structure, the higher degree of limberness of peptides can endow proteins with the 
capacity to adopt distinct functional conformations or even to behave as conformational 
switches. Moreover, proteins are built up by twenty main different “letters” and, as a 
consequence, they constitute an information carrier of higher intricacy.  
Furthermore, the ubiquitous presence of co- and post-translational modifications, such as 
phosphorylation or glycosylation, suggests that a protein’s activity profile is determined at 
different levels, beyond its sequence. Of course, the covalent attachment of glycans can 
directly influence the macromolecule´s intrinsic properties, such as solubility, molecular 
mass or electric charge. It may also have a significant impact on the minimisation of 
misfolding by offering assistance, thus playing an important role in the protein quality 
control, a fundamental cellular activity (Roth et al., 2010).
4What is more, glycosylation produces an abundant, highly regulated inventory of 
conjugates containing protein or lipidic cores, which can be localised intracellularly, on the 
cell membrane or in the extracellular matrix (see below). Using glycan-binding tools and 
high-throughput multiplex analysis techniques, glycophenotyping of cells and tissues can 
nowadays be conveniently accomplished. Glycomes have been proved to be highly cell 
specific, hinting at their utility as unique cellular descriptors (Fujitani et al., 2013) or 
molecular fingerprints, the glycosignatures. 
To realize all the potential of carbohydrates for variability, a refined toolbox of enzymes is 
dedicated to glycan biosynthesis and modification, and biomolecule glycosylation, 
following an actively regulated pathway. Factors including the in situ concentration of 
substrates as well as the presence and localisation of distinct glycosidases and 
glycosyltransferases confer to the process a decidedly dynamic character and add up to 
determine the glycophenotype. An intriguing sensitivity to epigenetic influences as well as 
infections characterizes the latter and attests that the “Sugar Code” is not directly encoded 
by the genome, hereby conferring to living cells adaptability and capacity of response to 
environmental stimuli. 
1.2 The Sugar Code: the “sweet” side of molecular recognition
For a long time, carbohydrates, the most abundant type of biomolecules in nature, were 
almost entirely side-lined with respect to biological information transfer, and had been 
assigned the role of building blocks of protective cell-wall constituents (e.g. cellulose 
and chitin) or metabolism fuel (e.g. glycogen). However, this aspect was questioned 
occasionally over the years and, in the ‘70s, the landscape started to change, when the 
oligosaccharides of mammalian tissues and serum glycoproteins were assigned 
functional roles (Laurence et al., 1972).  
At the same time, attempts to comprehensively understand intra- and intercellular 
recognition processes, such as lymphocyte routing and cell adhesion, seemed unviable 
in the framework of only two dimensions (nucleic acids and proteins), Fig. 1.1. The 
consideration of another encrypted system was therefore essential to bridge this gap, 
and sugars, with their unique versatility and dense bio-coding capacity, had already 
started to reveal themselves as very “shapely” molecules (Rees, 1972). 
5 Essentially, five are the structural characteristics of sugars that confer them an 
outstanding aptitude for intricate coding: their potential for variability in (i) the 
anomeric configuration of the glycosidic linkage (α or β), ii) the position of this bond (1 
→ 1, 2, 3, 4, 6 for hexopyranoses), iii) the ring size (five-membered, furanose, or six-
membered, pyranose rings), iv) site-speci¿c substitutions (phosphorylation, acetylation 
or sulphation), and v) the linear or branched arrangement of oligomers (Gabius et al., 
2004). 
For a trisaccharide composed of 3 random sugars out of more than 20 commonly found 
in mammals (i.e. glucose, mannose, galactose, fucose, N-acetyl-glucosamine, etc.), the 
number of occurring trimers by sequence permutation alone reaches 203 (8000). 
However, as more factors should be considered in a trisaccharidic structure, the number 
of possible occurring molecules should be calculated as [Permutations  anomerics 
ring sizes  linkages] what results in more than 6 million structures. Hence, oligomers 
of more than 8 constituent parts, which also have the potential of generating numerous 
branched isomers, would sum up to astronomical numbers, superior to the Avogadro's 
number (Laine, 2008). 
Furthermore, the described carbohydrate structures, either linear or branched, 
encompass only the first and second dimensions of the Sugar Code. The conformational 
behaviour of oligosaccharides, also determined by stereo-electronic effects and steric 
interactions across the glycosidic bond (Solís et al., 2015), constitutes the third 
dimension. The twist angles around the glycosidic linkage can vary, so that a 
carbohydrate structure of well-defined sequence can adopt several conformations in 
solution in which the relative orientation of the monomers is different. Questions on 
low-energy conformations of oligosaccharides, flexibility and dynamics can be 
answered experimentally, using e.g. high-field nuclear magnetic resonance, while 
.
Fig. 1.1 From genomics to glycomics passing through proteomics: each step brings us closer to a clearer 
view of molecular and cellular physiology.
6several in silico tools and methods have been developed in order to assist in the 
interpretation of experimental results (Lütteke and Frank, 2009).  
In an evolutionary frame, how could organisms take advantage of such a convoluted 
coding system? In order to answer this question, we have to consider that without the 
constraint of having to achieve optimal fidelity, a bio-code is expected to reach a high 
information density. Conformational flexibility plus the potential for rapid and reversible 
structural modulations by e.g. phosphorylation/sulphation are another two strategic 
elements of a powerful coding tool (Gabius, 2000). All the above requisites are met in the 
Sugar Code, together with the gain of relative genome independence. 
More to the point, the space on the cell surface is fairly limited and has to harbour a 
multitude of signals, making high-density coding necessary. Indeed, most cells have a 
fuzz-like carbohydrate coat on the external surface of their plasma membranes named 
glycocalyx (Bennett, 1963), meaning “sugar coat” (from greek γλυκύς = sweet and κάλυξ 
= husk). Tissue cells are also surrounded by a dynamic and complex-nature resilient 
meshwork. The extracellular matrix provides mechanical and structural support, but also 
the spatial context for signalling events to take place, with direct implications in 
developmental patterning, maintenance of stem cell niches and cancer progression (Hay, 
1991; Kim et al., 2011). Sugars constitute an important part of both the calyx and the 
extracellular matrix and are linked to distinct aglycon parts to form a variety of 
glycoconjugates. Glycolipids, glycoproteins and proteoglycans are the most 
representative families (please see Fig. 1.2). In detail: 
 Glycolipids are ubiquitous lipid–glycan conjugates usually found in the plasmatic 
membrane clustered in microdomains, the “lipid rafts”, with their glycosidic part 
protruding towards the extracellular space, freely accessible for intermolecular 
interactions. They contain one or more monosaccharides bound to a hydrophobic  
membrane-anchoring compound such as an acylglycerol, a sphingoid, a ceramide (N-
acyl-sphingoid) or a prenylphosphate. Most mammalian glycolipids belong to the class of  
glycosphingolipids (GSLs) and contain a lipid backbone composed of sphingosine and a 
fatty acid. Glucosylceramide is the glycolipid core most frequently found in mammals, 
and is the starting point for the biosynthesis of GSLs of higher glycan complexity by 
Golgi-localised glycosyltransferases. GSLs are divided into two categories – neutral or
7acidic – depending on whether they carry or not a negative charge due to sulphation or 
sialylation (Kopitz, 2009). 
 Glycoproteins contain oligosaccharide chains, which can be either N-linked or O-linked. 
N-glycan biosynthesis in mammals starts with the transfer of the preassembled lipid-
linked oligosaccharide Glc3Man9GlcNAc2 to an asparagine residue. Then, the 
oligosaccharide undergoes a step-wise size reduction, in some cases reaching a 
pentasaccharide stage (Man3GlcNAc2) followed by a subsequent neo-synthesis, thereby 
contributing to glycan remodelling and opening the way to the complexity of the cellular 
N-glycome.  Besides mannose, N-acetyl-glucosamine and galactose, N-glycan chains may 
also contain L-fucose and N-acetyl-neuraminic (sialic) acid, or get substituted by sulphate 
or phosphate groups (Zuber and Roth, 2009). In addition, the hydroxyl groups of 
serine/threonine also serve as potential targets for glycan attachment, with O-glycan sites 
often appearing as clusters. O-glycans are synthesised by transfer of one monosaccharide 
(GalNAc, GlcNAc, Man, Fuc or Glc) to the site and sequential addition of others, 
forming a core unit that can be later extended (Patsos and Corfield, 2009). 
 Proteoglycans (PGs) make up a family of complex macromolecules consisting of a 
protein core to which different high-molecular-weight polyanionic glycosaminoglycan 
(GAG) chains are linked covalently. GAGs are linear polymers of 50-150 repeating 
disaccharides built up by a hexosamine and a uronic acid, usually D-Glucuronic (D-
GlcA) or L-Iduronic acid (L-IdoA), or galactose (Esko et al., 2009). GAG chains are 
attached to the protein core via a carbohydrate‒protein linkage region which is either a 
tetrasaccharide (GlcA-Gal-Gal-Xyl) glycosidically linked to a serine residue or has a 
Fig. 1.2 Schematic depiction of the various classes of mammalian glycans. From left to right: OM, oligomannose; 
GM and GD, mono- and disialylated glycosphingolipids; HS, heparan sulphate; CS, chondroitin sulphate; KS I, 
keratan sulphate; HA, hyaluronan. Monosaccharide abbreviations are as follows: SA, sialic acid; Gal, galactose; 
Man, mannose; GlcNAc, N-acetyl-glucosamine; GlcA, glucuronic acid; Fuc, fucose; GalNAc, N-acetyl-
galactosamine; Xyl, xylose; Glc, glucose; GlcN, glucosamine. Adapted from (Dalziel et al., 2014).
8glycoprotein-like structure. Sulphate groups are usually present on carbon atoms 4´ or 6´ 
of the hexosamine entity, but could also be present on C2 of L-IdoA. GAG saccharide 
chains usually correspond to a molecular weight greater than 20 kDa (Buddecke, 2009). 
These simple definitions encompass an exceptionally large range of structures involving 
different core proteins (molecular  weight ranges 20-250 kDa) as well as diverse classes 
or numbers and lengths of individual GAG chains (chondroitin/heparan/keratan sulphate, 
etc.) (Wight et al., 1991), depending on selective enzyme expression and localisation 
(Esko et al., 2009). 
In addition to offering chemical resistance and backbone support, this extended presence 
of saccharides on the cellular surface plays an important functional role, frequently 
mediating cell recognition and adhesion processes, such as tissue organization, 
fertilization (Töpfer-Petersen et al., 1998), growth regulation (Iozzo, 2005; Villalobo and 
Gabius, 1998), immune response (Rabinovich and Toscano, 2009), inflammation (Jack et 
al., 2001; Schwartz-Albiez, 2009) or cancer (Hakomori, 1985; Ohtsubo and Marth, 
2006). This is why specific alterations of the glycolipid/glycoprotein glycosylation 
patterns or up-regulation of their synthesis have recently been associated to pathogenesis, 
suggesting certain structures as disease markers or potential targets for therapeutic 
intervention (Dalziel et al., 2014; Dube and Bertozzi, 2005; Peracaula et al., 2008). 
Besides, carbohydrates also constitute markers for antibodies (Calarese et al., 2005), 
hormones (Villalobo and Gabius, 1998), plant (Jiménez et al., 2008; Kabat et al., 1947; 
Olsnes et al., 1978) or bacterial toxins (Haan and Hirst, 2004), and viral (Childs et al., 
2009) or bacterial receptors (adhesins) (Karlsson, 1995; Krogfelt et al., 1990).  
In particular, aiming at actively inducing their entry into target cells for replication and/or 
immune disguise, both Gram-positive and -negative bacteria have evolved sophisticated 
molecular strategies and machinery, frequently involving specific recognition of 
extracellular matrix components (Kline et al., 2009). Direct engagement of these 
elements by bacterial adhesins (Remaut and Waksman, 2004) or translocation of bacterial 
effector molecules into the target-cell cytosol was shown to promote rearrangements of 
the plasma membrane architecture and to facilitate pathogen engulfment (Mulvey, 2002; 
Pizarro-Cerdá and Cossart, 2006). Adhesins are anchored on the bacterial cell-wall, as the 
SdrG protein of Staphylococcus epidermidis, which binds to the Bβ chain of human 
fibrinogen (Ponnuraj et al., 2003), or constitute components of supramolecular fibres 
9called fimbriae or pili, as FimH of uropathogenic Escherichia coli, UPEC (Bouckaert et 
al., 2005; Choudhury et al., 1999).  
Of the various UPEC adhesins, type-1 pili FimH adhesins are by far the most prevalent 
(Bahrani-Mougeot et al., 2002), being expressed by a wide range of pathogenic, 
commensal and laboratory strains (Fukiya et al., 2004). FimH is exposed at the their tip, 
its carbohydrate-binding pocket being localised at the distal end of the protein N-terminal 
domain (Bouckaert et al., 2005). It selectively binds a variety of mannose-presenting 
glycoproteins expressed by diverse host cell types (Ofek et al., 1977), including bladder 
epithelial cells (Fig. 1.3). Uroplakin Ia, bearing oligomannose structures and abundantly 
present on differentiated urothelial cells, has been identified as target (Xie et al., 2006; 
Zhou et al., 2001). Although FimH binds to uroplakin Ia with moderate strength, the 
interaction of multiple fimbriae of an individual bacterium and the array of polymerised 
uroplakin on the cell surface lead to high avidity and ensure stable bacterial adhesion 
(Zhou et al., 2001). The increasing incidence of bacterial resistance to antibiotics has 
stimulated the interest in the synthesis of anti-adhesive, sugar-bearing multivalent 
scaffolds to be used as alternative or complementary therapy, willing to overcome these 
intrinsic avidity issues (Reichardt et al., 2013).
Fig. 1.3 Uropathogenic E.coli (UPEC) bears fibrous pili, frequently exposing adhesins at their tip. FimH 
recognises high-mannose structures on uroplakin Ia, a bladder epithelium glycoprotein. Bacteria strongly 
adhere on target cells by establishing multivalent interactions.
Apart from eukaryotic cells, pathogens are also coated with a variety of carbohydrate-rich 
structures that usually serve to typify strains (Peterson and Quie, 1981) and are 
specifically recognised by host receptors for triggering defence responses (Davicino et 
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al., 2011; Kumar et al., 2011; Sahly et al., 2008). In the case of bacteria (Fig. 1.4), 
lipopolysaccharides (LPSs) and capsular polysaccharides are important virulence factors 
often including unusual carbohydrate monomers with respect to mammals (Herget et al., 
2008; Schirm et al., 2005). LPSs constitute one of the major outer-membrane components 
of Gram-negative bacteria, anchored to the outer leaflet of the bacterial cell envelope. 
Fig. 1.4 Structural features of the bacterial cell walls, including peptidoglycan found in both Gram-
positive and -negative bacteria, LPS and capsular polysaccharide. O-antigen and capsular polysaccharides 
are named in parenthesis, not being ubiquitous in Gram-negative species. Adapted from Midlands 
Technical College online courses, (©Pearson Education).
They are composed of a highly conserved lipid A molecule – serving as hydrophobic 
anchor – and a variable polysaccharide, the O-antigen/chain, built up by repeating 
saccharide units on a small inner core oligosaccharide (Freudenberg and Galanos, 1990). 
The core saccharide is connected to the lipid A moiety through one or more acidic sugars 
identified as 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo), and might be further subjected 
to assorted non-stoichiometric substitutions, such as addition of phosphate, 
phosphoethanolamine (PEtn), or pyrophosphoethanolamine (PPEtn) moieties (Gibson et 
al., 1993). Some bacteria synthetize lipooligosaccharide (LOS) molecules characterised 
by the presence of an extended branched core region prominently composed of hexoses 
(Hex) and heptoses (Hep), but lacking repetitive O-chains (Phillips et al., 1992).  
Extensive structural studies of the LOS of Haemophilus spp. have led to the identification 
of the conserved inner-core moiety l-α-D-Hepp-(1→2)-[PEtn→6]-l-α-D-Hepp-(1→3)-[β-
D-Glcp-(1→4)]-l-α-DHepp, linked to one Kdo 4-phosphate unit (Schweda et al., 2007). 
Each backbone Hep can be a point for the addition of a Hex or further chain extensions, 
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which constitute the outer core. It is likely that this heterogeneity, including structural 
intermediates as well as products of alternative biosynthetic pathways, enables 
pathogenic bacteria to adapt to changing and potentially hostile environments, through 
rapid phase variation of their LPS structures (Morey et al., 2013; Raetz et al., 2007). 
Glycosylation alterations are frequent in bacteria as well, and directly affect the virulence 
capacity of microorganisms either by promoting resistance to antimicrobial peptides and 
getting involved in self-aggregation and biofilm formation (Morey et al., 2013), or by 
interfering with the ability of the host receptors to recognize LPSs as non-self elements 
(Raetz et al., 2007). 
Recently, bacteria have also been found to carry heavily glycosylated proteins, which 
may impede host inflammatory and immune responses (Schmidt et al., 2003) or play 
specific roles in adhesion and colonisation (Mell et al., 2016). Major O- and N-
glycosylation pathways involve the synthesis of a lipid-linked oligosaccharide and its 
transfer en bloc to the protein acceptor by an oligosaccharyltransferase (Iwashkiw et al., 
2013; Nothaft and Szymanski, 2010). In an alternative pathway, glycosyltransferases 
sequentially transfer monosaccharides to the protein acceptor from their nucleotide-
activated forms. This pathway, found to be operative for N-glycosylation only in a few γ-
proteobacteria species (Naegeli et al., 2014a; Naegeli et al., 2014b), was first described in 
nontypeable H, influenzae (NTHi): NTHi HMWC is an inverting N-glycosyltransferase 
that adds Glc and Gal monosaccharides at Asn residues and is also able to form di-
hexoses at the sites with Glc modification (Grass et al., 2010; Gross et al., 2008). 
Whereas the HMW1C-like glycosyltransferase from Actinobacillus pleuropneumoniae, 
the best studied member of this family at biochemical level, is able to modify different 
polypeptide structures in vitro (Schwarz and Aebi, 2011), the only endogenous substrate 
proteins described so far for NTHi HMWC are the high-molecular adhesins HMW1A and 
HMW2A (Gawthorne et al., 2014; Naegeli et al., 2014a). 
In summary, carbohydrates have exceptional properties for storing biological information 
and potentially establishing intermolecular interactions, thereby contributing to multiple 
biological events. Yet, their in-principle advantageous complexity poses the new 
requirement of a multifaceted machinery specialised in making this coding operative. In 
fact, the mechanism that permits organisms to exploit all three dimensions of the 
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carbohydrates’ potential is their recognition by protein receptors. The proteins capable to 
specifically recognise sugars and hence decipher the glycocode are the lectins. 
1.3 Lectins, the translators of the Sugar Code
The first documented observation of lectin activity was made in 1861, when S.W. Mitchell 
reported blood “clotting” by the rattlesnake venom (Mitchell, 1861). Experiments were 
repeated with washed erythrocytes, in order to exclude interaction with other plasma 
components. The development of the classical haemagglutination assay addressed this 
necessity. This assay has proved to be instrumental to detect the cell cross-linking capacity 
of proteins from plant extracts. In fact, the first study on such an activity dates back to 
1888, when Hermman Stillmark described the haemagglutination phenomenon induced by 
a protein factor present in Ricinus communis seeds, denominated ricin (Stillmark, 1888). 
Stillmark’s study also revealed a certain degree of selectivity in agglutination of red blood-
cells from different animal species. Meanwhile, the further discovery that plant extracts are 
rich sources of agglutinins made possible the first purification of such a protein 
(concanavalin A, ConA) by crystallisation (Sumner, 1919) and the demonstration of its 
specific interaction with carbohydrate groups by the precipitation of starch, glycogen and 
mucin (Sumner and Howell, 1936).
 A few years later, the ability of ricin and other haemagglutinins to distinguish among ABH 
blood groups was evidenced and, since this behaviour resembled that of serum antibodies, 
these proteins were called antibody-like substances, due to their exquisite binding 
specificity. However, as Boyd explained in his classical paper in 1954 (Boyd and 
Shapleigh, 1954), “it would appear to be a matter of semantics as to whether a substance 
not produced in response to an antigen should be called an antibody, even though it is a 
protein and combines specifically with a certain antigen only”. Although sugar-binding 
proteins are known to be up- or down-regulated in a variety of inflammatory processes, 
their biosynthesis does not require a previous immune stimulation. Moreover, they don´t 
present any structural resemblance to antibodies – with the exception of animal I-type 
lectins (Crocker et al., 2007) – and they cannot chemically modify the carbohydrates they 
bind to, making their distinction from carbohydrate-active enzymes clear. Thus, Boyd 
introduced a new term and called those proteins lectins (from latin lectus, the past principle 
of legere meaning to pick, choose or select), due to their extraordinary capacity to select 
their ligand and specifically bind to it (Boyd, 1954). Still, in order to reach the present 
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version of the term lectin, its definition underwent several refinements. The experimental 
focus put initially on agglutination required at least bivalency for the cross-linking of two 
cell surfaces, thus excluding monovalent proteins. Subsequently, three criteria have been 
established that must be simultaneously met by a protein in order to qualify as a member of 
the lectin family: (i) confirmed carbohydrate-binding activity, (ii) clear distinction from 
immunoglobulins, and (iii) clear distinction from enzymes tailoring free saccharides and 
from sensor/carrier proteins for the same molecules.
Another significant discussion started with the realisation that a name for a protein does 
not often cover all its structural facets, as many proteins are known to be composed of 
several domains (modules). Such a modular design underlies operativity in multiple 
aspects and enables that a lectin domain can be linked to other functional modules, even 
including catalytic ones. Class I plant chitinases, for instance, are built by a chitin-binding 
hevein domain and a catalytic domain, separated by a hinge region (Collinge et al., 1993). 
The protein modules´ association is physiologically relevant in terms of inter-domain 
cooperation, as found in numerous cases of endogenous receptors. As significant example 
relevant to the present work, chimera-type galectin-3 or pulmonary surfactant protein-D  
(SP-D) (Crouch, 1998) are instructive cases of proteins with one carbohydrate-recognition 
domain (CRD) linked to other types of bioactive regions (Fig. 1.5). These two proteins 
possess collagen-like tails 
available for auto-association 
and multimer formation, 
leading to suited CRD spatial 
vicinity and high-affinity 
ligand binding, pertinent to 
their physiological role 
(Brewer et al., 2002; Dam and 
Brewer, 2008). 
Following the concept of the Sugar Code, the frequency with which domains or protein 
folds are adapted to accommodate glycan epitopes as ligands should be fairly high in order 
to match the evident glycome complexity (Solís et al., 2015). The past decades have 
witnessed the emergence of an insight into the structural and functional diversity of animal 
lectins. The establishment of several techniques to detect them and characterise their
Fig. 1.5 Structure of SP-D monomers, trimers and multimers.
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Table 1.1  Principal families of animal lectins
Family Overall fold Specificity Examples Localisation Functions
C-type Diverse Collectins
(MBL: 1AFB,
SP-D: 2GGU*)
Asialoglycoprotein 
receptor: 1DV8
P-selectin: 1G1Q
Extracellularly
Cell membrane
Recognition of
foreign/aberrant 
glycosignatures on cells 
(endocytosis or 
opsonisation) and of 
apoptotic/necrotic cells 
(glycans & peptide 
motifs).
I-type Sialic acids Siglecs
Sialoadhesin: 
1QFO*)
Neural Cell 
Adhesion Molecule 
(NCAM): 1EPF
Cell membrane Cell adhesion and 
growth, cell-cell 
interactions, recognition
of microbial and host-
like epitopes, 
induction/suppression of
effector release and 
inflammatory cascades.
P-type Man-6-PO4 OS-9 MRH
domain: 3AIH*
Mannose-6P-
receptor: 1M6P
Intracellularly
(endosomes,
Golgi)
Intracellular routing
of glycoproteins and 
vesicles, apical delivery.
S-type
(galectins)
β-Gal Animal, fungal,
human galectins
(hGal-1: 1GZW*
hGal-3: 1A3K
hGal-8: 3AP4)
Extracellularly
Intracellularly
(cytoplasm,
nucleus)
Extracellular matrix 
network assembly, cell
migration and routing,
cell-cell interactions, 
ligand-receptor bridging 
and endocytosis via 
lattice formation.
Pentraxins Diverse Serum amyloid
P-component:
1GYK*
C-reactive protein:
1GNH
Extracellularly First-line of defence, 
recognition of 
foreign/aberrant 
glycosignatures 
(endocytosis or 
opsonisation).
Adapted from (Solís et al., 2015). 
* Protein Data Bank (PDB) ¿les selected for graphical representation.
C-type
Ig-like
P-type
β-sandwich
β-sandwich
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specificity and interactions with saccharides has paved the way for the dynamic 
development of the field of functional glycomics. Up to the present, 14 different folds have 
been identified in human/animal lectins (Gupta, 2012), many of which resemble folds of 
plant (Solís et al., 2015), bacterial or viral lectin modules (Holgersson et al., 2009), 
attesting their ubiquitous presence. For example, the β-sandwich fold was first observed
in the crystal structure of ConA, the first to be solved for a leguminous lectin (Hardman 
and Ainsworth, 1972), although it is very common among animal lectins. This fold also 
proved out to be versatile enough to let several lectin groups arise, including galectins, 
pentraxins, calnexins, etc. Taken together the fairly large number of folds with the high 
level of intra-family diversification clearly argues in favour of the extraordinary potential 
of sugar receptors to be physiologically significant in a multitude of manners. Common 
folds and structure-based classification of the main animal lectin families are shown in 
Table 1.1, along with a brief description of their biological functions. The presence of at 
least one noncatalytic, carbohydrate-recognition domain reversibly binding to a specific 
carbohydrate is the denominator in the whole lectin family in all kingdoms, regardless of 
the presence or not of other cooperating modules (Peumans and Van Damme, 1995). What 
is more, all modes of spatial ligand accommodation that can be envisioned have co-
evolved, so that the translation of the sugar-encrypted message into a
physiological response is resolutely connected to the recognition capacity of the lectins. 
This selectivity is defined by different degrees of sugar engagement in the corresponding 
sites, following a theme of contact complementarity: starting from flat surfaces and 
shallow grooves it progresses to a firm grip of higher degrees of H-bonding to reach high 
affinity for di- or oligosaccharides (Gabius et al., 2011).
1.4 Atomic features and thermodynamics of lectin-carbohydrate interactions 
As described before, when directly compared to oligonucleotides and peptides in terms of 
coding capacity, oligosaccharides constitute an intricate lexicon characterised by the 
exceptional structural diversity of sugars. A wide panel of ligands (sugar-code words), both 
charged and neutral, is recognised by the endogenous lectins. A detailed insight into the 
atomic features of protein-sugar interactions is fundamental to understand how this 
complexity and high coding potential is turned into an operative sugar code.
In the first place, the abundant presence of freely rotatable hydroxyl groups makes 
carbohydrates appropriate for bidirectional acceptor/donor hydrogen (H)-bonds, which 
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often include coordination of metal ions or water-mediated bridging. The sp3-hybridised 
oxygen atom can participate as an acceptor in two H-bonds, while the proton can act as 
donor. Carbohydrate-binding sites profusely contain polar residues with planar side-chains 
(Asn, Asp, Gln, Glu, Arg, His and Lys), also able to rotate and participate in hydrogen-
bonding (Solís et al., 2009). Usually, complex formation involves a few (key) hydroxyl 
groups of the sugar directly engaged in strong hydrogen bonds, while others participate in 
weaker hydrogen bonds or remain exposed to the solvent and do not interact with the 
protein (Solís et al., 2009). The contribution of each group to the binding can be estimated 
through chemical mapping studies in solution by the use of engineered ligands (Solís and 
Díaz-Mauriño, 1997). 
As significant example, ConA specificity for mannose/glucose-containing oligosaccharides 
involves reliable sensing through topologically fixed bidentate H-bonding. To this end, the 
equatorial position of the 4-hydroxyl group in mannose/glucose is critical by contributing 
to the establishment of appropriate H-bonds. Worth mentioning, the organisation of the 
binding site is assisted by a structural Ca2+ ion, required for ConA activity, which stabilises 
a cis-peptide bond between Ala207-Asp208 (Bouckaert et al., 2000) and makes the epimer 
distinction possible (Gabius, 2009; Gabius et al., 2011), as depicted in Fig. 1.6 (a). 
In addition to H-bonding, other types of interactions contribute to the affinity for an 
epitope in solution. For instance, positively charged Lys and Arg residues are prominently 
involved in the binding of negatively charged sugars (containing carboxylate, sulphate or 
phosphate groups), evidencing that electrostatic interactions dominate recognition (Lasky, 
1995; Solı́s et al., 1998).
Fig. 1.6 Epimer selection by two types of lectins. (a) Basic atomic features of α-D-mannose recognition 
by ConA: Importance of the equatorial 4’ OH and 6’ OH in fixed bidentate H-bond formation. (b) Basic 
atomic features of β-D-galactose recognition by hGal-1: CH-π interaction established between the sugar 
CH-patch and the delocalised π-electron cloud of tryptophane-68. Adapted from (Gabius et al., 2011).
(b) (a)
Trp68
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Also, the set of C-H bonds permits hydrophobic interactions, while other non-polar groups 
such as the methyl moiety of acetamido groups may be involved in van der Waals contacts. 
Furthermore, sugar-binding sites often contain a suitably positioned aromatic residue (Trp, 
Tyr and, less commonly, Phe) whose delocalised π-electron cloud helps in the 
establishment of stacking interactions with the C-H patches of positively polarised 
character, as depicted in Fig. 1.6 (b) for human galectin-1 (hGal-1) (López-Lucendo et al., 
2004). The orientation of the aromatic side-chain is frequently a significant determinant of 
specificity, by impeding the binding of incorrect epimers (Lemieux, 1989). Finally, 
solvophobic effects might also be significant, since sugars perturb solvent structure in their 
vicinity, with diverse enthalpic/entropic consequences. In addition, complementarity of 
shapes and different degrees of sugar engagement in lectins’ shallow grooves or deep 
pockets is definitely a strategic feature (Gabius et al., 2011).
In any disaccharide, the relative orientation of the two pyranose rings can be easily 
characterised by two or three (in the case of the 1-6 bond) torsion angles of the glycosidic 
bond, Φ, Ψ and Ω, as depicted in Fig. 1.7. In analogy to Ramachandran’s two-dimensional 
Φ and Ψ conformational maps for dipeptides, similar diagrams can be established for 
disaccharides, featuring a simplified projection of the potential energy as a function of the 
given coordinates Φ, Ψ or/and Ω (Kožár et al., 2009). In fact, some torsion angles would 
give conformations that are sterically hindered, while others would maximise hydrogen 
bonding with a given receptor. Unlike peptides, only a few conformers are energetically 
privileged in glycans, defining the minima in 
conformational energy maps. Besides, there are 
demonstrated cases of selection of a minor 
conformer of the ligand from an equilibrium 
mixture in solution, such as the recognition of C-
lactose by bovine galectin-1 (Asensio et al., 
1999). Thus, the lectin presents a kind of 
molecular “lock” into which a certain “key” – or 
group of “keys” – can fit by fulfilling certain 
requirements as for spatial coordination and 
thermodynamic selectivity. It is thus clear that 
besides the specific protein‒carbohydrate 
contacts other factors govern the lectin‒sugar interaction. 
Fig. 1.7 Schematic representation of 
isomaltose (D-Glc-α(1-6)D-Glc) along 
with the torsion angles that define the 
conformations at the glycosidic linkage 
between the two contiguous residues:
Φ = O5-C1-O1-C4', Ψ = C1-O1-C4' -C5' ,
Ω = O1-C6' -C5' -O5' .
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The binding affinity (or the Gibbs free energy of binding, ΔGo) is the outcome of the 
enthalpy/entropy gains and penalties derived from the different events associated with the 
recognition process (lectin, sugar, solvent). In detail, the net enthalpy change encompasses 
the favourable contribution of protein‒sugar contacts and of the new water‒water H-bonds 
formed upon desolvation of lectin and sugar, as well as the unfavourable contribution of 
the rupture of protein‒water and sugar‒water interactions. The net entropy change includes 
the entropy gain of water molecules ordered over non-polar regions or directly bound to 
the protein (or sugar groups) when they return to the bulk, along with an entropy reduction 
of distressed water molecules that surrounded protein polar surfaces or ligands (Solís et al., 
2009). Besides, other events imposing entropic penalties should be considered, such as 
restrictions in rotation of the ligands or the loss of conformational freedom upon complex 
formation. In fact, even if the sugar-binding site might be pre-shaped and not undergo 
significant conformational changes, any alteration of the flexibility and internal mobility of 
the whole macromolecule could affect the binding thermodynamics (López-Lucendo et al., 
2004; Nesmelova et al., 2010).  
All things considered, the thermodynamic analysis of protein-carbohydrate interactions 
typically reveals enthalpy-entropy compensation, binding events being mostly 
enthalpically driven. Even though changes may be substantial, the net Gibbs energy (ΔGo) 
is relatively small for mono- or disaccharides, with affinities in the millimolar range (Solís
et al., 2009). Given this relatively low affinity, extended binding sites have been 
established as another mechanism of affinity modulation (Rini, 1995), efficiently operating 
at the level of small lectin domains and increasing the affinity to the micromolar range. The 
43-amino acid lectin hevein, for instance, reversibly binds to chitin, a β(1→4)-linked
N-acetyl-glucosamine (GlcNAc) polysaccharide. When testing oligomers of GlcNAc with 
increasing chain length, the ΔGo values determined by isothermal titration calorimetry 
increase from -3.8 kcal/mol for the dimer up to -7.8 kcal/mol for the pentamer (Asensio et 
al., 2000). The contact (sub)site for the activity inhibitory hapten (mono- or disaccharide) 
is embedded into a more complex sugar contact region – even able to accommodate 
oligomers. Plant defence proteins, class I chitinases (Collinge et al., 1993), and chitinase-
like proteins, such as the human cartilage glycoprotein-39 (Fusetti et al., 2003), possess a 
series of up to six subsites that ensure tight binding of chitin fragments and contribute to 
the overall defence function. Thermodynamically, the process is driven by a favourable 
enthalpy through the establishment of additional contacts that are associated with a smaller 
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entropic penalty, as the overall motion and conformational freedom of the oligosaccharide 
as already been restricted, at least in part, upon binding to the primary subsite (Solís et al., 
2009). 
Apart from one-chain oligosaccharide accommodation, glycan branching may also have an 
important effect on affinity, as remarkably seen in the glycoside cluster effect – a  valency 
increase in ligands translates into a geometrical increase in affinity (André et al., 2006; Lee 
and Lee, 2000). The signalling and regulatory potential of natural cluster formation of such 
lectin-reactive epitopes is now starting to be unveiled. High local epitope density may be 
attributable to branches of the same glycan chain, but also to the vicinity of neighbouring 
glycan chains (Gabius et al., 2011). Overall, a high glycan density in three dimensions, as 
happens in the glycocalyx or the extracellular matrix, increases the propensity of lectin 
association (Dam and Brewer, 2010).
On the other hand, evolutionary diversification has generated divergences in the topology 
and/or spatial arrangement of the CRDs in different lectins, what is termed subunit 
multivalency (Rini, 1995). Clusters of binding sites can be created by either interchain 
disulphide bond association – as in the illustrative case of the trimeric, endogenous C-type 
lectin SP-D (Fig. 1.5) (Crouch et al., 1994), or by tandem-repeat display in the same 
peptidic chain – as in the case of galectins-4, -8 and -9 (Cooper, 2002). Besides spatial 
vicinity, a lower entropy cost for binding to the second binding site, due to low flexibility 
and restricted mobility of the ligand, favours a stronger complex formation (Solís et al., 
2009). The spatially favoured binding steps towards saturation may exhibit particularly 
high affinities, down to the nanomolar range. This feature is relevant for understanding 
binding preferences on the cellular or pathogen surface, in terms of multivalency of both 
ligands and CRDs (Dam and Brewer, 2010).
1.5 Glycosylation patterns as markers for self and non-self recognition 
Since the term glycobiology was introduced (Rademacher et al., 1988), the role of glycan 
recognition by endogenous lectins in intercellular communication and within the cell itself 
has become increasingly considered. As described in section 1.2, a toolbox of sequentially 
and competitively acting factors allows both temporal and developmental regulation of the 
glycosylation patterns. Almost 2% of the mammalian genome, evolutionarily conserved, is 
dedicated to the codification for a portfolio of enzymes and transporters involved in 
glycosylation, of relevance to sustaining normal physiology (Ohtsubo and Marth, 2006). 
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Product of the coordinated action of the glycosylation machinery, the cell surface glycans 
constitute a hallmark for immune cell activation, differentiation and homeostasis (Marth 
and Grewal, 2008). Alterations and aberrant forms of the involved enzymes may cause 
disruptions in developmental signal-transduction pathways (Fortini, 2001) or even 
compromise the viability of embryonic stem cells and mammalian ontogeny (Shafi et al., 
2000).
The level of specialisation and regulation is high, often making glycans functionally 
redundant outside particular biological contexts (Lowe and Marth, 2003). For example, 
deletion of the ST6Gal-I locus (α2,6-sialyltransferase) results in a profound 
immunosuppression, having little effect elsewhere (Hennet et al., 1998). On the other hand, 
ablation of the Golgi α-mannosidase II chronically activates the innate immune system 
inducing in mice an autoimmune disease similar to human systemic lupus erythematosus 
(Chui et al., 2001; Green et al., 2007). N-glycans produced under this enzyme deficiency 
bear mannose structures, ligands for innate immunity lectins, and provoke a disturbance of 
a fundamental defence mechanism. It should be acknowledged that mammalian N-glycan 
processing safeguards against the generation of an endogenous immunological signal of 
non-self. Thus, glycan regulation draws the narrow line between tolerance and immune 
activation.
Despite their ubiquitous extracellular presence and claimed pivotal role in immunity, 
sugars were described as T-cell-independent antigens up until recently. In particular, pure 
carbohydrates had previously shown relatively poor immunogenicity when used for 
immunisation against bacterial pathogens (Beuvery et al., 1982). The development of a 
new generation of vaccines was consequently pursued, involving carbohydrate conjugation 
to a carrier protein and forcing the adaptive immune system to generate a thymus-
dependent response against the carbohydrate moiety (Kasper et al., 1996). This strategy 
effectively led to the production of protective antibodies against the bacteria from which 
the carbohydrates originated, as in the commercially available vaccines against 
Haemophilus influenzae type B (Kelly et al., 2004) and Streptococcus pneumoniae (Darkes 
and Plosker, 2002). Simultaneously, pathogen-associated and naturally occurring 
carbohydrate structures, even including protein-free polysaccharides, were found to be 
presented by antigen-presenting cells (Tzianabos et al., 2000; Zeng et al., 1997) and 
capable of activating T-helper cells via T-cell receptor recognition (Cobb and Kasper, 
2005). These advances illustrated the indisputable relevance of the recognition of non-self 
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glycopatterns in the induction of immunologic memory and immunoglobulin class-
switching. 
In contrast to the vast repertoire of antigen-specific immunoglobulins that the adaptive 
immune system holds, the innate immune system recognizes microorganisms via a limited 
number of germline-encoded pattern-recognition receptors (PRRs), which are 
constitutively expressed. PRRs target essential molecules associated to microbial survival 
or virulence, evolutionarily conserved (Akira et al., 2006), unique to microbes, and 
invariant among microorganisms of a given class (Medzhitov and Janeway, 2002), such as 
endotoxin (lipid A) for Gram-negative bacteria or lipoteichoic acids for Gram-positive. A 
subset of PRRs, including Toll-like receptors and endogenous lectins, bridges innate with 
adaptive immunity by detecting explicit non-self glycosylation patterns and, subsequently, 
activating signalling pathways or interfering in inflammation (Barton and Medzhitov, 
2003). At least three classes of lectins, C-type lectins, siglecs and galectins (see section 1.3 
for classification) have been long described as PRRs in the literature (van Kooyk and 
Rabinovich, 2008). Some of their essential functions in innate immunity are given through 
examples in Table 1.2.
Table 1.2  Examples of endogenous lectins involved in innate immunity as PRRs
Lectin Type Specificity Functions
Mannose-
binding lectin C
Terminal Man
/GlcNAc Activation of the complement lectin-pathway
Surfactant 
proteins
(-A, -D)
C Man,maltose
Increase bacterial membrane permeability, 
opsonise pathogens, regulate production of 
inflammatory mediators
DC-SIGN C Internal/terminal Man
Pathogen recognition, antigen presentation or 
internalisation, interaction with T-cells
Dectin-1 C β1,3 and 1,6glucans
Anti-fungal defence by induction of TNF-α, 
regulation of T-cell proliferation
Ficolins (L-, H-) Fibrinogen-like GlcNAc/GalNAc Activation of the complement lectin-pathway
Galectins (1-15) S β-Gal
Increase bacterial membrane permeability 
and modulate immune activation and 
inflammation
Serum amyloid P 
component Pentraxin
Gal (4,6-
pyruvate 
acetal)
Opsonises pathogens, promotes their 
complement-mediated clearance
Siglecs I Sialic acids
Increase pathogen uptake by macrophages 
and modulate immunogenic or tolerogenic 
programs of antigen-presenting cells
References: (Bottazzi et al., 2016; Crocker et al., 2007; Crouch et al., 2000; Fujita, 2002; McGreal et al., 
2004; Rabinovich et al., 2012; Stowell et al., 2014; Wright). 
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The accessibility and density of glycans on the pathogen surface strongly contributes to 
their recognition by lectins (Reid et al., 2010). Interestingly, molecular mimicry is 
exploited by pathogens that disguise by masking their patterns with host-self antigens 
(Moran et al., 1996). Most nasopharyngeal pathogens, including nontypeable H. influenzae
present on their surfaces sialic acid or digalactose units that function as anti-recognition 
molecules, allowing the microbe to masquerade as “self” (Vimr and Lichtensteiger, 2002) 
and to avoid complement-mediated bacteriolysis (Fujita, 2002; Hood et al., 1999; Weiser 
and Pan, 1998).
On the other hand, in addition to acting as self-recognition signals, mammalian glycans, 
densely coating every cell, also serve as docking sites for pathogen receptors, as described 
above (Karlsson, 1995; Sharon, 1996). Pathogens could thus act as an exogenous selection 
pressure upon their long-lived hosts obliging them to shift their glycopatterns in order to 
evade infection, without compromising their own survival (Gagneux and Varki, 1999). In 
this setting, glycosylation patterns seem to be trapped in never-ending cycles of 
evolutionary “Red Queen” effects. The name of this evolutionary concept derives from the 
Red Queen’s comment to Alice in Through the Looking Glass that “it takes all the running
you can do, to stay in the same place” (Van Valen, 1974). Hence, the remarkably well 
conserved mammalian glycans are prone to undergo rapid, even constant, evolutionary 
change to guarantee the organism survival (Gagneux and Varki, 1999), causing inter-
individual deviations and also leading to the emergence of distinct susceptibility traits 
towards infectious agents (Varki, 2006).
The glycosylation patterns can also be altered in disease, cancer being the most prominent 
example. Tumour cells may display an aberrant glycosylation profile, at both structural and 
expression levels, compared with their non-transformed counterparts (Pinho and Reis, 
2015). Two principal mechanisms underlying the tumour-associated alterations of 
carbohydrate structures were postulated in the so-called incomplete synthesis of truncated 
structures (due to pathway impairment) and neo-synthesis (upon gene induction) processes 
(Hakomori, 2002). In the ´80s, malignant transformation was also found to be often 
accompanied by the expression of oncofetal antigens decorating proteins and sphingolipids 
(Feizi, 1985; Hakomori, 1985), which allow neoplastic cells to usurp many of the events 
naturally occurring in development, i.e. cell adhesion and motility. At that time, further 
insights into the unique repertoire of glycans expressed on tumour cells emerged from their 
recognition by a variety of plant lectins of known binding specificity (Raedler et al., 1988).
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Evidently, elucidation of the glycosylation patterns in normal and tumour cells, as well as 
engineered living cells (Hudak et al., 2014) will help to correlate glycan structure and 
function. In a recent study, remodelling the sialylation status of the glycocalyx of distinct 
cancer cell types affected their susceptibility to innate natural killer cell cytotoxicity 
through the recruitment of the inhibitory sialic acid-binding immunoglobulin-like lectin 7 
(Siglec-7) (Hudak et al., 2014). Although the tumour-associated carbohydrate antigens 
represent altered self-epitopes rendering cancer cells mildly antigenic, they are rarely 
immunogenic or capable of eliciting strong humoral responses (Amon et al., 2014; Dube 
and Bertozzi, 2005) unless presented on an alternative scaffold, such as virus-like particles 
(Yin and Huang, 2015). A comprehensive study of interactions of endogenous lectins 
involved in the innate immunity, including selectins and other C-type lectins (Kohler et al., 
2009), galectins (Rabinovich and Toscano, 2009) or Siglecs (Macauley et al., 2014), will 
also shed light to the mechanisms that contribute to health and disease (Macauley and 
Paulson, 2014; Solís et al., 2015). Non-invasive screening of cancer-associated 
glycopatterns remains an aim hard to achieve: glycoproteins showing aberrant profiles are 
clinically utilised as serological biomarkers in cancer patients, but their use in early 
diagnosis is precluded because of their concurrent expression in benign diseases (Pinho 
and Reis, 2015).
Only recently, extracellular vesicles of both prokaryotic and eukaryotic origin were found 
to be capable of transferring molecular patterns, metabolites or effectors (siRNAs) in a 
horizontal manner, from one cell to another (Senfter and Mader, 2015). Extracellular 
membrane vesicles are heterogeneous structures and can be classified into several groups 
based on their size, antigenic features and mechanism of cellular release (Thery et al., 
2009), as described in Table 1.3 and Fig. 1.8. The two best characterised categories include 
exosomes (EXO) and microvesicles/microparticles (MVs), whose release by various cell 
Table 1.3  Key features of extracellular vesicle populations
Exosomes Microvesicles Apoptotic vesicles
Size range 50-150 nm ~100-500 nm >800 nm
Mechanism
of generation
Multivesicular bodies 
exocytosis
Plasmatic membrane 
budding and/or blebbing
Plasmatic membrane 
blebbing during apoptosis
Detection
Electron microscopy, 
western blotting, bead-
coupled flow cytometry 
Flow cytometry and 
capture-based assays Flow cytometry
Markers Annexin V, CD63, CD81, CD9, etc.
Annexin V, tissue factor 
and cell-specific markers Annexin V, DNA content
Adapted from (György et al., 2011b; Thery et al., 2009). 
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types is enhanced during cell activation and apoptosis (György et al., 2011b; Raposo and 
Stoorvogel, 2013).
Exosomes, membrane enclosed vesicles of 50-150 nm diameter, are singularly assembled 
and secreted following an orchestrated procedure (Trajkovic et al., 2008), and are thought 
to share glycosylation patterns with their parental cell. They carry aberrant glycoforms 
when excreted by malignant cells and this property could turn them into functional, 
pluripotent clinical biomarkers for non-invasive diagnosis. Indeed, in a recent study, the 
proteoglycan glypican 1 was used to distinguish circulating cancer exosomes from benign 
vesicle carriers, thus allowing early pancreatic cancer diagnosis (Melo et al., 2015).  These 
findings open new horizons for the search of glyco-biomarkers in the exosomes field, even 
though straight-forward and time-effective approaches for glycan profiling are currently 
missing. In parallel, comprehensive glycosylation pattern analyses of distinct vesicle 
populations are expected to answer questions as for their origin and natural role, and pave 
the way for cell-targeting applications.
Fig. 1.8 Cellular release of microvesicles and exosomes. MVs bud directly from the plasma membrane. 
EXO are formed by blebbing into early endosomes or multivesicular bodies (MVBs), then released by 
fusion of the latter with the cellular membrane. In some cases, they may also fuse with lysosomes. The 
point of divergence is suspected to lie on distinct early endosomes feeding or labelling.
Adapted from (Raposo and Stoorvogel, 2013).
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The establishment of structure-function correlations for glycans, known as functional 
glycomics, has reshaped post-genomics biology and is undoubtedly a complex task. 
Even though comprehensive glycan sequencing may not be always necessary for the 
attribution of functions, a multitude of other features still have to be taken into account: 
clustering of saccharide patches decorating the cellular surface, epitope 
microheterogeneity, or multivalency to overcome low intrinsic affinities. To achieve 
advanced glycan profiling and functional characterisation, the merge of the use of 
lectins as unique pattern-reading tools with a combination of well-established analytical 
methodologies seems compulsory.  
The use of lectins for decades in the glycophenotyping of glycoproteins, pathogens and 
tissues (Gabius et al., 2011) is only recently extending to undifferentiated cells 
(Hamouda et al., 2013) and extracellular vesicles (Gerlach et al., 2013; Gomes et al., 
2015). In the case of respiratory pathogens, the virulence degree of serological types 
distinguished by their surface carbohydrate structures appears to be associated with their
recognition, or lack of recognition, by lectins of the innate immune system (Sahly et al., 
2008). Thus, pathogen glycoprofiling and identification of epitopes recognised by 
endogenous lectins could pave the way for establishing virulence correlations.
To facilitate the task of identification of lectin ligands by high-throughput screening, 
glycan microarray platforms have been extensively used. Yet, a main limitation is that 
they are largely built with mammalian-like glycan libraries, whereas bacteria are known 
to display distinct monosaccharide units (Adibekian et al., 2011). More focused 
libraries that incorporate synthetic or natural bacterial glycans have also been developed 
(Stowell et al., 2014). Still, glycans’ presentation and density in the array may 
substantially differ from their natural arrangement, a factor reported to affect 
recognition, particularly in the case of weak binders (Godula and Bertozzi, 2012; Wang
et al., 2014). Consequently, the real accessibility and density of each glycan on the 
target surface, as e.g. bacteria, extracellular vesicles, or entire cells cannot be assessed. 
Furthermore, a possible binding event arising from a simultaneous recognition of 
different, neighbouring surface molecules would pass unnoticed in a carbohydrate 
microarray setup, where binding to individual glycans is tested. To overcome these 
limitations, a novel application of the microarray technology has been recently 
developed based on the generation of bacteria microarrays, using Klebsiella 
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pneumoniae, a Gram-negative, capsulated and LPS-containing bacteria, as model 
pathogen (Campanero-Rhodes et al., 2015). 
The core objective of this PhD Thesis is the design and development of novel platforms 
for the study of lectin-carbohydrate interactions directly on the probe surface, thus 
preserving the carbohydrate epitopes´ natural assembly and vicinity. Specific objectives 
are: 
 Development of designer’ microarray and QCM strategies for the analysis of 
pathogen surface glycosylation and exploration of the recognition by lectins of 
the innate immune system. Nontypeable Haemophilus influenzae (NTHi) was 
selected as relevant example of nonencapsulated opportunistic pathogen bearing 
a lipopolysaccharide without O-antigen and, therefore, a limited number of 
carbohydrate structures at its surface.  
 Design and establishment of extracellular vesicle microarrays as sensitive tools 
for profiling the glycosylation patterns of exosomes and microvesicles of 
different origin, in search of malignancy biomarkers. 
 Setting-up of microarrays for evaluation of the functionality of bacterial 
adhesins on live bacteria and the screening of carbohydrate-bearing 
nanosystems of potential use in anti-adhesive strategies.   
MATERIALS
& METHODS
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3.1 Bacteria culture, fixation and staining  
Nontypeable Haemophilus influenzae (NTHi) strains (Table 3.1) were seeded in a 
chocolate-agar plate (Biomérieux) directly from the stock conserved at -80 ºC, and 
grown overnight at 37 ºC in the presence of 5% CO2. Each strain was inoculated (1 to 5 
colonies) in 40 ml of brain-heart infusion medium supplemented with 10 μg/ml hemin 
and 10 μg/ml β-nicotinamide adenine dinucleotide (β-NAD), hereafter referred to as 
sBHI, and incubated under shaking at 180 rpm, 37 ºC and 5% CO2 for 12 h. Cultures 
having reached the stationary phase were then diluted (1:10) in 40 ml fresh sBHI and 
incubated, at 37 ºC and 5% CO2, till they reached the exponential growth phase (OD600
= 0.3-0.4). The viability of each culture was tested by serial dilution and plating on 
sBHI-agar. Subsequently, 15 ml of each culture was collected and centrifuged at 
4,000×g for 15 min at 4 ºC. Pellets were resuspended and adjusted to OD600 = 1 in 5 
mM sodium phosphate buffer, pH 7.2, containing 0.2 M NaCl (PBS).
For fixation, a previously established protocol was followed (Amann et al., 1990) with 
slight modifications. In detail, 4 ml of each adjusted culture was centrifuged at 4,000×g 
for 15 min at 4 ºC, subsequently resuspended in 750 µl PBS plus 250 µl cold 4% 
paraformaldehyde aqueous solution and incubated for 24 h at 4 ºC. Each preparation 
was centrifuged at 4,000×g for 10 min and washed twice with 500 µl Tris-HCl buffer 
saline (10 mM Tris, pH 7.8, containing 150 mM NaCl, TBS), resuspended in TBS, then 
conserved at 4 ºC until used. Culture and fixation of NTHi was carried out at the 
laboratory of Dr. Junkal Garmendia (Instituto de Agrobiotecnología, CSIC-UPNa-
Gobierno de Navarra, Mutilva, Spain).
The final preparations of fixed bacteria were labelled with SYTO® 13 green fluorescent 
nucleic acid stain (Life Technologies). SYTO® dyes belong to the class of substituted 
asymmetrical cyanine dyes, thought to have multiple nucleic acid binding modes, 
including intercalation and charge interactions with the phosphate backbone in the 
minor groove (Eischeid, 2011; Tárnok, 2008). Detailed structural information is 
generally not available for commercial dyes. SYTO® dyes have low intrinsic 
fluorescence with quantum yields (QY) typically <0.01 when not bound to nucleic acids 
or stand free in solution. When bound to DNA/RNA, SYTO® 13 has a QY of 0.4. Since 
its excitation maximum is 488 nm and its emission maximum is 509 nm, it can be 
excited by using a blue (488 nm) laser.
a For mutant designation, the symbol Δ is used to indicate disruption of the respective gene
Table 3.1 Nontypeable H. influenzae strains and mutantsa used in this Thesis
Strain Description Phenotypic traits Clinical data Source Reference or source
NTHi375 Clinical isolate Whole genome sequence, methylome, and LOS structure available Otitis media Middle ear (Mell et al., 2014)
86-028NP Clinical isolate Whole genome sequence available Otitis media Nasopharynx (Harrison et al., 2005)
NTHi398 Clinical isolate Whole genome sequence available COPD, exacerbation Sputum
(De Chiara et al., 
2014)
NTHi1566 Clinical isolate Whole genome sequence available COPD, exacerbation Sputum
(De Chiara et al., 
2014)
NTHiP131 Clinical isolate Genome not sequenced.  Distinct PFGE profile Pediatric healthy carrier
Nasopharyngeal 
swab
(Kalograiaki et al., 
2016)
NTHiP133 Clinical isolate Genome not sequenced. Distinct PFGE profile Pediatric healthy carrier
Nasopharyngeal 
swab
(Kalograiaki et al., 
2016)
Rd KW20 Laboratory strain Whole genome sequence available. Capsule-deficient, serotype d
(Fleischmann et al., 
1995)
Rd hmw1strain12 Laboratory derivative
Rd strain expressing hmw1 locus of NTHi12 
(R2846) – hmw1A, hmw1B, hmw1C (Grass et al., 2003)
NTHi375ΔopsX opsX::ermC, Ermr LOS molecule is truncated at Kdo level, it does not contain tri-Hep backbone (Morey et al., 2013)
NTHi375ΔlgtF lgtF::ermC, Ermr LOS molecule lacks oligosaccharide extensions at HepI (Morey et al., 2013)
NTHi375ΔlpsA lpsA::ermC, Ermr LOS molecule lacks oligosaccharide extensions at HepIII (Morey et al., 2013)
NTHi375ΔlgtFΔlpsA lgtF::ermC, lpsA::km, Ermr Kmr LOS molecule lacks oligosaccharide extensions at HepI and at HepIII (Morey et al., 2013)
NTHi375Δlic2A lic2A::ermC, Ermr LOS molecule lacks digalactose (Morey et al., 2013)
NTHi375ΔsiaB siaB::ermC, Ermr LOS molecule lacks sialic acid (Morey et al., 2013)
NTHi375ΔompP5 OmpP5::ermC, Ermr Porin P5 is not expressed (Euba et al., 2015)
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For optimal staining, 1 µl of SYTO® 13 dye (5 mM stock solution in DMSO) was added 
to the bacterial suspension of a total volume of 500 µl, giving a final concentration of 10 
μM. Bacterial suspensions were vortexed upon addition of the dye and incubated for 10 
min at 20 ºC. Then, they were centrifuged at 4,000×g for 15 min and the pellets were 
washed twice with fresh TBS and conserved at -20 ºC until used. When manipulated 
mostly in the dark, no loss of fluorescent signal was observed, as evaluated after 2, 4, 6 
and 12 months of storage.  
Escherichia coli strain UTI89 was kindly provided by Prof. Jean-Jacques Letesson 
(Laboratory of Infection, Cell & Host, Research Unit in Microorganism Biology, 
Université de Namur – FUNDP, Namur, Belgium). The above-described culture 
protocol was followed with the difference that the culture medium used was enriched 
lysogeny broth (LB2YT) containing 8 g of tryptone, 5 g of yeast extract and 5 g of NaCl 
per 500 ml. The concentration of E.coli was estimated by correlating turbidity 
measurements with number of colonies obtained after plating serial dilutions (0.88-
1.13×109 colony-forming units (cfu) per ml. Fifteen ml of culture in the desired growth 
phase (either exponential or stationary) was collected and centrifuged at 4,000×g for 15 
min at 4 ºC. Pellets were washed and resuspended in 5 ml of 10 mM HEPES buffer, pH 
7.4, containing 150 mM NaCl and 10 mM CaCl2 (HBSC). For staining, 10 µl of SYTO®
62 red fluorescent nucleic acid stain (5 mM solution in DMSO, Life Technologies) was 
added to the bacterial suspension, giving a final concentration of 10 μM. SYTO® 62 
when bound to DNA/RNA has a QY of 0.27, excitation maximum at 652 nm and 
emission maximum at 676 nm, and can be excited by using a red (635 nm) laser. 
Following 10 min incubation in the dark, the bacteria were centrifuged and washed, 
then resuspended in HBSC buffer containing 0.1% Tween®20 and used directly. 
Labelling efficiency with SYTO® dyes was evaluated by fluorescence spectroscopy 
using a FluoroMax®-4 (Horiba Jobin Yvon) spectrometer and Suprasil®-quartz (QS) 
micro-cuvettes with PTFE stopper (lightpath: 5 mm × 5 mm, max. volume: 850 μl, 
Hellma Analytics). Emission spectra were acquired for bacterial suspensions of 
turbidity OD600 ~0.5 with the assistance of FluorEssence™ software (Horiba Jobin 
Yvon), using as excitation wavelength 488 nm and 652 nm for SYTO® 13 and 62, 
respectively. Increment was set at 1 nm and the excitation and emission slit at 2 nm. 
Optimal integration time resulting in an acceptable signal-to-noise (S/N) ratio was
determined to be 0.5 sec. Both Signal (counts per second, cps) and Reference 
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(microAmps) detectors were activated in current-acquisition mode and the S/R ratio was 
registered. The ratio acquired resulted in signal counts independent of changes in the 
light-source intensity through time. 
For SYTO® 13-stained bacteria, the maximum of the emission spectra was at 507 nm 
and for SYTO® 62 was at 676 nm. Each spectrum was acquired twice and the mean 
value at 507/676 nm for each strain was correlated with the turbidity of the sample and 
colony counts before bacteria fixation, to compare labelling efficiency among strains. 
3.2 Isolation of nontypeable Haemophilus influenzae lipooligosaccharide 
Lipooligosaccharide (LOS) molecules of selected NTHi strains were extracted using a 
phenol-water extraction protocol (Johnson and Perry, 1976), followed by enzymatic 
treatment to eliminate contaminating protein and nucleic acids. In detail, NTHi strains 
grown on chocolate-agar plates were inoculated (3 to 5 colonies) in 400 ml sBHI and 
incubated for 12 h under shaking at 180 rpm, 37 °C and 5% CO2. Viability was 
determined by serial dilution and plating on sBHI-agar, yielding a comparable number 
of bacterial cfu per ml for all cultures. Bacterial pellets were collected by centrifugation 
at 6,000×g for 15 min at 4 ºC, resuspended in water (33.33 ml water/g of dry pellet), 
and thoroughly mixed with an equal volume of equilibrated phenol solution (Sigma-
Aldrich) at 66 ºC. Following centrifugation at 8,000×g for 15 min at 4 ºC, the phenol 
layer was discarded and the LOS, present in the aqueous layer, was precipitated by 
adding four volumes of methanol containing 1% of methanol saturated with sodium 
acetate, and freezing at -20 ºC for at least 12 h. The precipitate was recovered by 
centrifugation, resuspended in 5 ml of water and exhaustively dialyzed against high-
purity water (milli-Q®). The dialysate was then centrifuged at 100,000×g for 6 h at 4 ºC 
and the resulting pellet was resuspended in 2 ml of water and lyophilised. For 
elimination of contaminating nucleic acids, the lyophilisate was resuspended at 10 
mg/ml in 100 mM Tris-HCl buffer, pH 7.0, containing 0.05% (w/v) NaN3, and digested 
with 50 μg/ml DNase II and RNase I (Sigma-Aldrich) for 30 min at 37 ºC. Next, protein 
traces were also digested thrice by incubation with 50 µg/ml of proteinase K (Sigma-
Aldrich) at 55 ºC for 3 h. The purified LOS was precipitated with methanol/sodium 
acetate using the protocol described above, dialysed and high-speed centrifuged, and the 
resulting pellet was finally resuspended in 200 μl of milli-Q® water. LOS isolation and 
purification was carried out at the laboratory of Dr. Junkal Garmendia. 
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3.3 Isolation and physical characterisation of extracellular vesicles  
3.3.1 Isolation of extracellular vesicles 
Extracellular vesicles were isolated from human blood and from the THP-1 human 
acute monocytic lymphoma cell line (ATCC® TIB-202™), one of the most widely used 
cell lines to investigate the function and regulation of monocytes in different 
physiological systems. Isolation took place at the laboratory of Prof. Edit Buzás 
(Semmelweis University, Budapest, Hungary).
THP-1 cells were cultivated in RPMI-1640 medium (GIBCO®, Life Technologies) 
containing 1% L-glutamine, 10% (v/v) centrifuged foetal calf serum and 1% (w/v) 
penicillin/streptomycin (all acquired from Sigma-Aldrich), in 150 ml flasks at 37 ºC 
until they reached 3-5×105 cells/ml, as described previously (Osteikoetxea et al., 2015). 
Then, they were changed to 60 ml fresh serum-free medium and left to vesiculate for 24 
h (“vesicle farming”). Cell viability was confirmed by fluorescence-activated cell 
sorting (FACS) upon labelling with an Annexin V-FITC and propidium iodide 
Apoptosis Detection Kit (Sigma-Aldrich Life Science). The culture was centrifuged 
initially at 300×g for 10 min to pellet and discard cells (Fig. 3.1, a). The supernatant 
(SB) was filtered by gravity through 0.8 μm filters to exclude apoptotic bodies (Fig. 3.1, 
Fig. 3.1 (a) THP-1 cell culture and culture supernatant (SB) isolation.
(b) Fractionation of MV and EXO populations
(a) (b) 
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b). The filtered supernatant (SC) was centrifuged at 12,500×g for 20 min at 4 ºC to pellet 
MVs. The pellet was washed once with PBS, and MVs were resuspended in 300 μl 
fresh PBS by gentle pipetting. The supernatant (SD), containing smaller MVs 
populations close to EXO size, was centrifuged for 40 min at 20,000×g and 4 ºC, and 
the pellet was discarded. The supernatant (SE), containing EXO only, was then 
centrifuged at 100,000 ×g for 70 min at 4 ºC (Fig. 3.1, b). The supernatant (SF) was 
separated and the EXO pellet was washed once with PBS, centrifuged under the same 
conditions and resuspended in 300 μl of PBS by gentle pipetting. All supernatants (SB-
SF) were kept as controls.  
Blood-derived extracellular vesicles were isolated as described before (György et al., 
2011a). In detail, 500 ml of normal human blood was collected from healthy donors and 
centrifuged at 250×g for 10 min to eliminate blood cells. The samples were aliquoted 
and stored at -20 ºC up until used. Platelets, cell debris, and apoptotic bodies were 
pelleted at 3,000×g for 10 min, followed by filtration of the supernatant through an 0.8
μm filter (Millipore®) by gravity. MVs and EXO were sedimented by centrifugation and 
resuspended in PBS as described above.
MVs and EXO samples in PBS were stored at -20 ºC until used. MVs stability was 
estimated to be 3 months by FACS and Annexin V-FITC staining. EXO are expected to 
be stable for longer due to their compact size and microdomain-lipid origin. 
3.3.2 Characterisation of THP-1 derived EV preparations by Resistive Pulse 
Sensing 
EV preparations were submitted to TRPS analysis using a qNano instrument (IZON 
Science, New Zealand). Serial dilutions were prepared from each EV preparation, EXO 
and MVs. Particle numbers were then counted for 5 min using 5 mbar pressure and 
NP200, NP400 and NP2000 nanopore membranes stretched between 45 and 47 mm. 
Voltage was set in between 0.1 and 0.25 V in order to achieve a stable 115 nA current. 
Particle size histograms were recorded when root mean square noise was below 12 pA, 
particle rate in time was linear, and at least 500 events were counted. Calibration was 
performed using known concentration of beads CPC100B (mode diameter: 110 nm), 
CPC200B (mode diameter: 203 nm) or CPC400E (mode diameter: 340 nm) and 
CPC2000C (mode diameter: 1,900 nm) (all from IZON) diluted 1:1,000 in 0.2 μm 
filtered PBS. 
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3.3.3 Morphological characterisation by Transmission Electron Microscopy 
This experimental part was carried out by the PhD candidate at the laboratory of Dr. 
Ágnes Kittel (Department of Pharmacology, Institute of Experimental Medicine, 
Hungarian Academy of Sciences, Budapest, Hungary). Shortly after ultracenrifugation 
resulting in a pellet that contained extracellular vesicles, the supernatants were carefully 
withdrawn and the pellets fixed with 4% paraformaldehyde in PBS for 60 min at room 
temperature. Following washing with PBS, the preparations were post-fixed in 1% 
OsO4 (Taab, werAldermaston, Berks, UK) for 30 min. After rinsing the intact fixed 
pellets within the centrifugation tubes with distilled water, the pellets were dehydrated 
in graded ethanol (50, 70, 90, 96 and absolute ethanol), including block-staining with 
1% uranyl-acetate in 50% ethanol for 30 min, then embedded in Taab 812 (Taab). After 
overnight polymerization at 60 °C and sectioning for EM, the 50-70 nm ultrathin 
sections were analyzed using a Hitachi 7100 electron microscope (Hitachi Ltd., Japan) 
equipped with a side-mounted Veleta CCD camera (lower resolution, Olympus Soft 
Imaging Solutions) digital camera. 
3.3.4 Examination of the membrane lipid order 
In order to investigate the membrane lipid bilayer order of EV preparations, EVs were 
stained with the membrane probe Di-4-ANEPPDHQ (Life Technologies) at 5 μM final 
concentration for 30 min at RT as described previously (Frescatada-Rosa et al., 2014; 
Osteikoetxea et al., 2015; Owen et al., 2012). Staining was evaluated by fluorescence 
spectroscopy using FluoroMax®-4 spectrometer as described in section 3.1. Emission 
spectra (range 500-750 nm) were acquired at steady phase without previous dilution, 
using as excitation wavelength 488 nm. Increment was set at 1 nm, the excitation slit at 
2 nm and the emission slit at 5 nm and the S/R ratio was registered. Optimal integration 
time resulting in an acceptable signal-to-noise (S/N) ratio was determined to be 0.5 sec. 
Intensities corresponding to the membrane ordered (I570) or disordered (I630) regions 
were denoted (in cps) at 570 nm and 630 nm respectively, their ratio revealing the 
general membrane polarization (GP), characteristic for each vesicular population. GP 
was calculated using the formula, 
GP=
I  – I570 630G   
I  + I570 630G   


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where G corresponds to a compensation factor. In order to obtain the G factor, the same 
fluorimeter set-up was used to image the fluorescence of a similar stock dilution in 
DMSO and GPmes values were calculated (using the previous equation with G = 1). The 
G factor was calculated according to the equation: 
G =
G P  + G ref P   G ref P G mes – P 1 mes – 
G P  +G mes P G mes – P 1 ref – P   G ref
 where GPref is a reference value for di-4-ANEPPDHQ in DMSO, here fixed at -0.85 as 
recommended (Owen et al., 2012). In our set-up, the G factor was defined as G = 0.19.  
3.4 Synthesis of glyconanoparticles 
 Glyconanoparticles (GNPs) – nanoparticles carrying surface-tethered carbohydrate 
ligands – have demonstrated a great potential in biomedical imaging, therapeutics, and 
diagnostics. Two general strategies for functionalisation can be discerned, based on 
either non-covalent or covalent protocols. Covalent binding is generally preferred due to 
the ordered ligand attachment to the constructs and their considerably higher stability 
(Wang et al., 2010). The coupling chemistry used here is based on the established 
procedure for covalent attachment of carbohydrates to solid substrates (e.g. silica 
nanoparticles) by using functionalised perfluorophenyl-azides (PFPAs) (Wang et al., 
2011a). Photo-initiated coupling chemistry does not require derivatisation of the 
carbohydrates. The azide (N3-) moiety on PFPAs can be activated by UV light and 
converted into a highly active nitrene, which can undergo insertion reaction into diverse 
CH bonds or addition reaction to C=C bonds. As the establishment of only one covalent 
bond is necessary for insertion, the probability of bond formation increases with the 
number of CH bonds present in the sugar (i.e. 57% for α-D-mannose, 74% for di-
mannosides, 81% for tri-mannosides, etc).
GNPs were synthesized at Prof. Olof Ramström´s laboratory (Division of Organic 
Chemistry, School of Chemical Science and Engineering, Kungliga Tekniska 
Högskolan, Stockholm, Sweden). Silica nanoparticle cores (SNPs) were synthesised 
following an established protocol (Stöber et al., 1968) with slight modifications. 
Tetraethylorthosilicate (2.8 ml) was added to 200-proof absolute ethanol (34 ml) 
followed by NH4OH (35%, 2.8 ml). The reaction was allowed to proceed overnight at 
20 ºC with vigorous stirring to yield a white colloidal solution. To this solution, PFPA-
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silane (80 mg) prepared by adding ΝΗ2(CH2)3Si(OMe)3 to PFPA-N-hydroxysuccini-
mide, NHS, (Yan and Ren, 2004) was added, and the mixture was left to react overnight 
(Fig. 3.2). The resulting PFPA-SNPs were purified as previously described (Wang et 
al., 2011b).
Then, 70 mg of PFPA-SNPs was dispersed in 20 ml of acetone and sonicated for 5 min 
to achieve a NP-dispersion of 3.5 mg/ml. For one-pot covalent attachment (Fig. 3.3), 
one ml of the PFPA-SNP dispersion in acetone was placed in a flat-bottom dish and 0.5 
ml of 3.5 mg/ml sugar solution in water was added. The mixture was covered with a 
280 nm long-path optical filter (WG-280, Schott Glass) and irradiated with a 450 W 
medium-pressure mercury vapor 
lamp (Hanovia) for 20 min under 
rigorous magnetic stirring. The 
dispersion was then centrifuged at 
4,600×g for 20 min to sediment 
the GNPs. These were washed 
once with milli-Q® water, dialysed 
against circulating water overnight 
using a 12-14 kDa-limit cellulose 
membrane (Spectra/Por® 4, 45 mm 
flat-width), centrifuged and re-
suspended in 1 ml of acetone.  
Upon rotary evaporation of the solvent for 15 min at 20 ºC, each sample was dried 
under vacuum overnight. The product was weighed and checked by infra-red (IR) 
spectroscopy for the presence of the azide peak (2075 cm-1) (Annex I). GNPs 
Fig. 3.2 Preparation of PFPA-SNPs.
Fig. 3.3 SNP UV-assisted derivatisation.
PFPA-SNPs in acetone and underivatised sugar in water 
were mixed under UV radiation to yield GNPs.
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synthesised included galactose- (Gal, Sigma), α-methyl-mannoside- (α-Me-Man, 
Sigma) and methyl-3-O-(α-D-mannopyranosyl)-α-D-mannopyranoside (manα(1,3)man -
α-OMe, Carbosynth) derived GNPs. 
Quantitation of the immobilised ligand was carried out by hexose determination using 
the phenol–sulphuric acid micro-method (section 3.10.2). As opposed to the anthrone–
sulphuric acid method previously employed with the same purpose (Wang et al., 
2011a), no background noise was produced. GNP-size was determined to be 110 nm by 
Trasmission Electron Microscopy, using a JEOL 100CX TE microscope operating at an 
accelerating bias voltage of 100 kV (Wang et al., 2011c).  
3.5 Designer´s microarrays 
“Designer´s microarrays”, a term introduced in the literature in 2006 (Palma et al., 
2006), permit the “designer” to incorporate any kind of probes in the array, by 
employing diversely functionalised slide surfaces, and to achieve multiplexed results by 
varying the assay conditions. In this Thesis, different microarray platforms have been 
developed and optimised following this concept, including protein, neoglycopeptide, 
polysaccharide, lipopoly-/lipooligo-saccharide, bacteria and extracellular vesicle 
microarrays. All platforms have been evaluated for printing quality, probe-retention 
capacity, stability and applicability in functional analyses.  
3.5.1 Protein, neoglycopeptide and lipopoly-/lipooligo-saccharide probes 
Naturally occurring glycoproteins usually contain complex and heterogeneous mixtures 
of oligosaccharide chains, making them outstanding detectors of lectin-carbohydrate 
interactions. In this Thesis, controls were carefully selected among a variety of 
glycoproteins with characterised glycosignatures (Fig. 3.4), to confirm carbohydrate-
binding activity of the lectins tested.  
Fetuin (FET, Type IV) and asialofetuin (AFET, Type I) from foetal calf serum, human 
fibrinogen (Fg, Type I) and ribonuclease B (RNase B, TypeXII-B) from bovine 
pancreas were purchased from Sigma-Aldrich. As negative control, bovine pancreatic 
ribonuclease A (RNase A, Type XII-A, Sigma-Aldrich) was also included as probe. 
RNase A is the non-glycosylated major form of the enzyme (coexisting with RNase B) 
and was used to detect possible non-carbohydrate-mediated interactions of the lectins  
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tested. The proteins were dissolved in 150 mM NaCl and their absorbance at 280 nm 
was measured by UV spectrophotometry (Cary 1E UV/Vis spectrometer, Agilent 
Technologies). Concentrations were calculated using an extinction coefficient E1cm1% = 
4.94 for FET and AFET, 15.1 for Fg and 7.1 for RNase A and B, as found in the 
literature. Serial dilutions of 1, 0.3, 0.1 and 0.03 mg/ml were prepared in printing buffer 
as for printing needs (sections 3.5.2.2 and 3.5.2.3). 
For immobilisation of the high molecular weight polysaccharide mannan, 
neoglycopeptides were first generated by glutaraldehyde-mediated cross-linking of 
mannan and the polypeptide poly-L-lysine, responding to the double need of increasing 
printing efficiency and covalently capturing the probe on functionalised array surfaces.  
Ten mg of mannan from Saccharomyces cerevisae (Sigma-Aldrich) was dissolved in 1 
ml of 50 mM NaHCO3 buffer, pH 9.6, in a glass tube. To favour cross-linking of the 
glycans, 40 μl of glutaraldehyde solution (25% in water, Grade I, Sigma) was added 
(1% final concentration) and the mixture was incubated at room temperature for 60 min 
Fig. 3.4 Examples of carbohydrate structures present in the control glycoproteins selected.
(a) N-linked biantennary complex-type glycan found in fibrinogen and fetuin; (b) N-linked triantennary 
complex-type glycan of fetuin; (c) N-linked high-mannose-type glycan of ribonuclease B; (d) O-linked 
hexasaccharide and (e) O-linked trisaccharide of fetuin.
(a)
(b)
(c)
(d)
(e)
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with periodic agitation. Subsequently, 136 μl of poly-L-lysine hydrobromide (Mw 
30,000-70,000, Sigma-Aldrich) at 1.67 mg/ml in NaHCO3 buffer was added (200 μg/ml 
final concentration), and the mixture was further incubated for 30 min at room 
temperature with periodic agitation. Aldehyde groups form a rather stable but reversible 
bond with Schiff bases (amines). This cross-linking bond was rendered irreversible by 
addition of NaBH4 traces. Neoglycopeptide preparations were then exhaustively 
dialysed against milli-Q® water and finally PBS. The hexose content in each preparation 
was determined by the phenol–sulphuric acid method, as described in section 3.10.2. 
Dilutions of 6, 3, 2, 1, 0.3 and 0.1 mg/ml of mannan and mannan-poly-L-lysine 
conjugate were prepared in printing buffer. 
Different LPSs were also printed in the arrays, including Salmonella enterica serotype 
minnesota smooth and rough (R345, Rb) LPS (Seydel et al., 1993), purchased from 
Sigma-Aldrich and Enzo Life Sciences respectively, and O-antigen containing LPSs 
from Klebsiella pneumoniae strain Kp52145, provided by Dr. Enrique Llobet. The LOS 
from different NTHi strains was isolated as described in section 3.2 and included in the 
arrays upon quantitation (see sections 3.11.3 and 3.12.2). 
To enable probe detection in the array, 1 μl per ml of Cy3® mono-reactive NHS ester 
(Fig. 3.5, GE Healthcare) was added to all the above described samples. Under neutral 
pH conditions, the samples are not expected to be covalently labelled, as NHS 
conjugation to amine groups occurs at pH above 8.5. The dye can be easily naked-eye 
detected in solution (pink colour), thanks to its high extinction coefficient. Since its 
excitation maximum is 548 nm and 
emission maximum is 568 nm, it can 
be excited by either using the blue (488 
nm) or the green (532 nm) laser. 
Scanning directly upon printing in the 
arrays allows probe tracing. 
Fig. 3.5 Cy3® mono-reactive dye structure.
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3.5.2 Preparation of manual and robotic microarrays 
3.5.2.1 Slide surfaces 
Several slide surfaces are currently commercially available. Selection of the appropriate 
surface for the experiment to be performed should be based on probe immobilisation 
efficiency, spot morphology and array reproducibility. In addition, the slide coating 
should be of low fluorescence, so that background “noise” is minimised. In this Thesis, 
nitrocellulose- (NC) and hydrogel-coated slides were used as probe immobilisation 
surfaces.  
 NC-coating of glass slides (Fig. 3.6) constitutes 
the most common surface for non-covalent 
attachment. The immobilisation mechanism is 
presumably based on the hydrophobic adsorption 
of the arrayed molecules on the membrane. 
Compared to non-coated glass slides, the 
nitrocellulose membrane layer allows a 3-D presentation of the 
probes and more even morphology of spots. NC slides have been used to array a huge 
variety of probes, including glycoproteins, neoglycolipids, underivatised or conjugated 
polysaccharides (Feizi et al., 2003; Wang et al., 2002), up to intact cells (Campanero-
Rhodes et al., 2015). A drawback of the NC-coated slides is the strong intrinsic 
fluorescence of the membrane at wavelengths used for the detection of common green 
fluorescent dye-signals (e.g. fluorescein or AlexaFluor®488), what limits the detection 
of immobilised probes or interacting targets.
3D-hydrogel-coated slides (NEXTERION® Slide H, Schott AG) are ideally suited for 
the covalent attachment of amine-containing probes, including peptides and proteins, 
Fig. 3.6 16-pad NC-coated glass slide.
Adapted from www.scienion.com
Fig. 3.7 Covalent probe immobilisation on a Slide H surface by amine-reactive chemistry.
The protein native structure and biological function is preserved. Inspired from www.schott.com.
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amino-modified oligonucleotides and amino-linked glycan structures (Alvarez and Blixt, 2006; Blixt et al., 2004; Song et al., 2009). Slide H coating consists of a cross-linked 
multi-component hydrophilic polymer layer with long and flexible spacers, activated 
with NHS esters (Fig. 3.7). This permeable polymer coating helps to preserve the native 
three-dimensional structure of complex biomolecules. Furthermore, slides H produce 
low background noise, as a low-fluorescence glass is coated with a low-fluorescence 
polymer. 
3.5.2.2 Manual printing 
 Manual arrays were prepared by printing the probes on single-pad NC-coated glass 
slides (FAST®-Slide, Whatman) using a manual glass-slide indexing system (VP 470, 
V&P Scientific) and a floating pin replicator. The replicator contains 4 rows of 8 pins 
(32 pins in total) on 4.5 mm centres (VP 478A, V&P Scientific) and is ideal for 
sampling from 384-well microplates (Fig. 3.8). Two slides can be printed at the same 
time, facilitating the production of duplicates and making printing time effective. The  
replicator pins (FP1S6, V&P Scientific) have a 6 
nl slot. The probe solution is transferred in the slot 
along with a hanging drop at the tip of the pin and 
on the sides of the pin (up to ~30 nl in total). Each 
probe was printed in a four-level dose-response 
format, in quadruplicate spots, by applying 
approximately 8 nl per spot. The precise amount 
finally deposited on the slide depends on the 
surface tension of both the solution and the slide.  
3.5.2.3 Non-contact robotic printing 
Contact printing microarrayers, first developed in 1995, usually have solid, split or 
microspotting pins that come into direct contact with the slide surface. One of the main 
disadvantages of this printing technique is that the slide surface may get damaged 
during the printing process. To avoid this problem, non-contact robotic arrayers gained 
ground lately, being characterised by a high-yield performance and great versatility.  
Fig. 3.8 The VP 470 manual glass-slide 
indexing system. Illustration of the
VP 478A floating pin replicator.
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Robotic arrays were printed using a 16-pad layout on either NC- (FAST®-Slide, 
Whatman) or 3D-hydrogel-film-coated slides, using a non-contact piezoelectric arrayer 
(Sprint, Arrayjet Ltd, Fig. 3.9) equipped with an environmental control system 
(JetMosphere™, Arrayjet Ltd) for maintaining temperature and appropriate relative 
humidity (~50%) conditions, thus providing a consistent environment for array printing. 
The arrayer is fitted with a 12-pin loading device (JetSpyder™, Arrayjet Ltd, Fig. 3.9, 
A, B) with capacity for enabling the printhead to print up to twenty 16-pad slides at a 
charge. The samples are aspirated through the loading device into the printhead, which 
has linearly arranged nozzles. After sample loading, the JetSpyder™ is detached from 
the printhead and sample droplets are ejected from the printhead nozzles after a 
piezoelectric impulse (Fig. 3.9, c). Careful washing between each sample-set print 
assures correct loading and dispensation. In this Thesis, up to 6 slides have been 
successfully printed at a time, following the same indexing pattern. Probes were printed 
in a multi-level dose-response format at customised concentrations by applying 100 pl 
per spot under precise XYZ control in different patterns.
One limitation of the robotic arrayer is the obligatory use of a high-density printing 
buffer, containing 47% glycerol and 0.06% (v/v) Triton X-100, to guarantee uniform 
distribution of the samples and cleanliness of the instrument. Once printed, NC-coated 
slides were kept overnight in a dry place to allow glycerol evaporation and then stored 
at 20 ºC. Hydrogel-coated slides were kept overnight under JetMosphere™-control 
(relative humidity 50%, temperature 25 ºC) and then stored at  -20 ºC in sealed boxes in 
the presence of desiccant. 
Fig. 3.9 (a) Sample loading by JetSpyder into the printhead;
(b) sampling and (c) arraying scheme. Adapted from www.arrayjet.co.uk.
(a) (b) (c)
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3.5.2.4 Microarray quality control 
 In order to monitor printing quality and immobilisation efficiency, slides were scanned 
upon printing with a GenePix 4200-Autoloader microarray scanner (Axon, Molecular 
Devices), using the appropriate excitation laser (blue/488 nm for SYTO® 13 or 
green/532 nm for Cy3®) and emission-detection range (Fig. 3.10). Fluorescence signals 
were quantified with the GenePix Pro 6.1 software (Molecular Devices).  
Microarray stability was examined by scanning slides after different storage periods. In 
addition, retention of the probes in the arrays after the binding assays was confirmed 
using the appropriate scanning parameters.  
3.5.3 Preparation and biotin labelling of target proteins 
 Surfactant pulmonary-associated protein D (SP-D) is a member of the collectin family 
(C-type animal lectins) consisting of four discrete structural domains: a short N-terminal 
domain, a relatively long collagenous tail domain, a coiled-coil neck domain, and a C-
terminal CRD (Crouch, 2000). In this Thesis, N-terminally histidine-tagged human 
recombinant SP-D (BioVision Inc), consisting of the CRD+Neck domain (18.9 kDa, 
aminoacids 224-375 of the full-length SP-D sequence), was used without any further 
modification (Fig. 3.11, a). 
Human Siglec-14 is a member of the Ig-like family (I-type animal lectins) which are 
transmembrane proteins with an extracellular N-terminal Ig-like V-set domain followed 
by a varying number of Ig-like C2-set domains (Crocker and Varki, 2001). For binding 
assays in solution, a chimeric protein consisting of the human Siglec-14 V-set domain 
(aminoacids 18-358 of the full-length Siglec-14 sequence) linked by peptide IEGRMD 
to human IgG1-Fc domain (aminoacids 100-330), expressed in mouse myeloma NS0-
derived cell line was purchased from R&D Systems Inc and used without any further 
modification (Fig. 3.11, b).
Fig. 3.10 Probes monitoring/localisation upon printing, and microarray quality assessment.
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Fig. 3.11 Endogenous lectins used in this Thesis.
(a) Human recombinant SP-D (CRD + neck region); (b) human, chimeric Fc-Siglec 14;
(c) homodimeric, chimeric and tandem-repeat human galectins (also see section 4.1.10)
Unless otherwise stated, recombinant galectins used (Fig. 3.11, c) were expressed in E. 
coli and purified by affinity chromatography on lactose-Sepharose 4B columns (Kaltner
et al., 2008) at the laboratory of Prof. Hans-Joachim Gabius (Lehrstuhl für 
Physiologische Chemie, Ludwig-Maximilians-Universität, Munich, Germany). For 
biotin labelling, galectins were exhaustively dialysed at 4 ºC against PBS containing 4 
mM β-mercaptoethanol (PBSβ), followed by a single dialysis against PBSβ containing 
20 mM lactose, in order to prevent a potential modification upon labelling of free amino
groups of the carbohydrate-binding site. Galectins were then incubated with 
biotinamido-caproate ester derivative (GE Healthcare) in 36 mM NaHCO3 buffer, pH 
8.6, at 20 ºC for 1 h under constant shaking, according to the manufacturer’s 
recommendations. After labelling, galectins were exhaustively dialysed against PBSβ at 
4 ºC and their concentration was estimated spectrophotometrically at 280 nm by using 
the extinction coefficient calculated from the amino acid sequence with the ProtParam 
tool (http://web.expasy.org/protparam). The purity of the preparations was assessed by 
SDS-PAGE, as described in section 3.11.1. Commercial (ATGen Ltd.) recombinant 
galectins used included N-terminally His-tagged human galectins-3, -4 and -8.
Concanavalin A (jack bean lectin, ConA), Galanthus nivalis (snowdrop) agglutinin 
(GNA), Ricinus communis agglutinin (RCA) and Triticum vulgaris (wheat germ) 
agglutinin (WGA) were purchased from VECTOR Labs, and used either unlabelled or 
biotin-labelled depending on the experiment. For biotin labelling, a protocol similar to 
that described above was followed, except that no reducing agent was used in the 
dialysis buffer, and 20 mM α-Me-Man, lactose (Lac) or N-acetylglucosamine (GlcNAc)
was used to protect the binding site according to the lectin binding specificity (please 
see Table 3.2).
(c)(b)(a)
Neck
CRDs
Fc
fragment
CRD
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Commercial biotinylated lectins used were Arachis hypogaea (peanut) agglutinin 
(PNA), Datura stramonium lectin (DSL), Hippeastrum hybrid lectin (HHL), Maackia 
amurensis lectin-I (MAL-I), Sambucus nigra (elderberry) agglutinin (SNA) and 
Wisteria floribunda agglutinin (WFA) from VECTOR Labs; Griffonia simplicifolia
lectin-I and isolectin B4 (GSL-I, GSL-IB4), Helix pomatia (edible snail) agglutinin 
(HPA) and Lycopersicon esculentum lectin (LEL) from Sigma-Aldrich; Glycine max
(soybean) agglutinin (SBA), Limulus Polyphemus (horseshoe crab) agglutinin (LPA), 
Pisum sativum (garden pea) agglutinin (PSA), Polyporus squamosus (mushroom) lectin 
(PSqL) and Viscum album (mistletoe) agglutinin (VAA) from EY Labs. 
Rabbit anti-NTHi serum, raised against a mixture of acetone-killed NTHi strains 375, 
398 and 2019 as previously described (Morey et al., 2011), was a generous gift of Dr. 
Junkal Garmendia. Fluorescein-labelled Annexin V, mouse monoclonal anti-
polyhistidine (His-tag), clone HIS-1, and anti-human-CD63, clone MEM-259, 
antibodies were purchased from Sigma-Aldrich. Mouse polyclonal anti-Salmonella 
typhimurium and goat polyclonal anti-E.coli O157-lipid A antibodies were purchased 
from Abcam plc, and biotinylated mouse anti-human IgG1 Fc was from Life 
Technologies Inc. Biotinylated goat anti-rabbit IgG and goat anti-mouse IgG (Sigma-
Aldrich) and rabbit anti-goat IgG (Abcam plc) were used as secondary antibodies. All 
antibodies mentioned, as well as the anti-NTHi serum, were diluted in the appropriate 
buffer directly before use without any further preparation.
3.5.4 Microarray binding and competition assays 
Specific set ups for the different binding and competition assays, according to the slide 
coating/functionalization and nature of immobilised probes and/or targets were 
established. 
3.5.4.1 Antibody binding to NTHi and NTHi LOS microarrays 
Serial dilutions of SYTO® 13-labelled NTHi clinical isolates and NTHi375 wild type 
and mutant strains presenting a sequentially truncated LOS (please see section 4.1.1 for 
description), as well as isolated LOSs and lipid A, were manually or robotically printed 
in NC-coated glass slides as described in sections 3.5.2.2-3. 
NC-pads were hydrated using milliQ® water and directly blocked for 60 min with 
blocking buffer composed of PBS, 2% bovine serum albumin (BSA) and 0.25% 
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Tween®20 (both from Sigma-Aldrich). Slides were carefully washed with PBS 
containing 0.05% Tween® 20 (washing buffer) and subsequently incubated for 60 min 
with a 1:500 dilution of rabbit anti-NTHi serum, mouse polyclonal anti-Salmonella 
typhimurium antibody or goat polyclonal anti-lipid A antibody in PBS containing 1% 
BSA and 0.1% Tween® 20 (overlay buffer). After three short washes with washing 
buffer, the slides were incubated for 45 min with a 1:1000 dilution of the respective 
biotinylated secondary antibody in overlay buffer. Following three additional washes, 
the slide was finally incubated for 35 min with streptavidin-AlexaFluor®647 (AF647) 
conjugate (Molecular Probes™, Life Technologies) at 1 μg/ml in overlay buffer. 
Finally, slides were thoroughly washed with washing buffer, PBS and then milliQ®
water and dried under a nitrogen stream. All incubation steps took place in a dry, dark 
place, at 20 ºC. 
 Following the binding assay, microarrays were scanned for SYTO® 13 signals of 
printed bacteria and for AF647 signals, using the GenePix® 4200-AL microarray 
scanner. AF647 has excitation/emission maxima at 650/668 nm, being therefore excited 
by a red laser (635 nm). Image analysis and quantification of fluorescence signals was 
performed with the GenePix® Pro 6.1 software (Molecular Devices) and statistical 
analysis was carried out with the assistance of Microsoft® Excel. 
3.5.4.2 Lectin binding and competition assays 
3.5.4.2.1 Binding and competition assays on nitrocellulose-coated slides
 Probes including bacteria, LPS/LOS, extracellular vesicles and control (glyco)proteins 
were printed on NC-coated slides as described in section 3.5.2.3. NC-pads were 
hydrated using milliQ® water and blocked for 60 min with blocking buffer composed of 
saline buffer and 0.25% Tween® 20. When working with lectins as targets, BSA was not 
included in the blocking buffer because it increases the background noise and thus 
reduces the sensitivity. After blocking, the slides were carefully washed with washing 
buffer containing 0.05% Tween® 20, and incubated for 75 min with the biotin-labelled 
lectin of choice in buffer containing 0.1% Tween® 20 (Fig. 3.12, a). The buffer was 
selected according to the lectin preferences as for pH, presence of Ca2+ and ionic 
strength (the default NaCl concentration was 150 mM). PBS, TBS or HBS (10 mM 
HEPES, pH 7.4, containing 150 mM NaCl) buffer were used as detailed in Tables 3.2 
and 3.3. Lectin dilutions were prepared immediately before the assay in the 
aMolar concentration of binding sites was calculated taking into account the number of sites per subunit; b3’SL, 3’ sialyl-lactose. 
Table 3.2 Plant and animal lectins used for glycophenotyping in this Thesis
Experimental conditions
Lectin Abbreviation Nominal specificity Concentration
(µg/ml)
[Binding sites] 
(µM)a
Buffer Ca
2+
(10 mM)
Inhibitory
hapten
Griffonia simplicifolia lectin I, 
isolectin B4 GSL-IB4 Galα 171 6 TBS + 0.1 M Gal
Viscum album agglutinin VAA Gal > GalNAc 115 2 PBS - 0.1 M Gal
Ricinus communis agglutinin RCA Galβ, Galβ(1,4)Glc/GlcNAc 12 0.2 PBS - 0.1 M Lac
Maackia amurensis lectin I MAL-I [Neu5Acα(2,3)]Galβ(1,4)GlcNAc/Glc 130 3.5 PBS - 0.1 M Lac
Glycine max agglutinin SBA Terminal GalNAc > Gal 82.5 2.75 PBS - 0.1 M GalNAc
Griffonia simplicifolia lectin I GSL-I Galα, GalNAcα 57 2 TBS + 0.1 M Gal
Arachis hypogea agglutinin PNA Terminal Galβ, Galβ(1,3)GalNAc 180 6.5 TBS + 0.1 M Gal
Wisteria floribunda agglutinin WFA Terminal GalNAc, GalNAcα(1,3/6)Gal 34 1.2 PBS - 0.1 M GalNAc
Helix pomatia agglutinin HPA GalNAc > Galα 395 30 TBS - 0.1 M Gal
Datura stramonium lectin DSL GlcNAcβ(1,4)GlcNAc oligos, LacNAc 64.5 3 PBS - 0.1 M GlcNAc
Lycopersicon esculentum lectin LEL GlcNAcβ(1,4)GlcNAc oligos 71 4 PBS - 0.1 M GlcNAc
Triticum vulgaris agglutinin WGA GlcNAc > Neu5Ac 9 0.5 TBS + 0.1 M GlcNAc
Limulus polyphemus lectin LPA Neu5Acα(2,3/2,6)GalNAc > Neu5Ac> GlcNac > PCho 40 4.2 TBS + 20 mM 3´SL
Polyporus squamosus lectin PSqL [Neu5Acα(2,6)]Galβ(1,4)GlcNAc/Glc 14 1 PBS - 0.1 M Lac
Sambucus nigra agglutinin SNA Neu5Acα(2,6)Gal/GalNAc, GalNAc, Lac 70 2 PBS - 0.1 M Lac
Concanavalin A ConA Manα > Glcα 10 0.4 HBS + 0.2 M α-Me-Man
Galanthus nivalis agglutinin GNA Terminal Manα(1,3)Man 52 4 PBS - 0.1 M Man
Hippeastrum hybrid lectin HHL Manα(1,3/1,6)Man 125 10 PBS - 0.1 M Man
Pisum sativum agglutinin PSA Manα, Glcα, GlcNAcα 24.5 1 TBS - 0.1 M Man
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absence/presence of different concentrations of inhibitors (Table 3.2, see also Chapter 4 
of this Thesis). In the case of His-tagged lectins, before incubation with streptavidin the 
slides were incubated for 1 h with a dilution in overlay buffer of mouse anti-His-tag 
antibody (1:1,000) and biotinylated anti-mouse IgG secondary antibody (1:300), pre- 
complexed for 1 h (Fig. 3.12, b). In the case of human Fc-chimeric Siglec-14, 1 μg/ml
was pre-complexed for 2 h with a 30 μg/ml solution of biotinylated mouse anti-human 
IgG1 Fc antibody in PBS containing 0.1% Tween® 20 (Fig. 3.12, c). The slides were 
then briefly washed with washing buffer and incubated for 35 min with 1 μg/ml AF647-
Table 3.3 Endogenous lectins used in this Thesis
Experimental conditions
Lectin Abbrev. Concentration
(µg/ml)
[Binding Sites]
(µM)
Buffer
Human galectin-1 hGal-1 30 2 PBSβ
Human galectin-2 hGal-2 73 5 PBSβ
Human galectin-3 (full length) hGal-3 26 1 PBSβ
Human galectin-3 (CRD) hGal-3tr 18 1 PBSβ
Human galectin-4 (full length) hGal-4 9-18 0.25-0.5 PBS/PBSβ
Human galectin-4 (N-domain) hGal-4N 85 5 PBSβ
Human galectin-4 (C-domain) hGal-4C 8.5-17 0.5-1 PBSβ
Human galectin-8 (full length) hGal-8S 18 0.5 PBSβ
Human galectin-8 (N-domain) hGal-8N 9 0.5 PBSβ
Human galectin-8 (C-domain) hGal-8C 18 1 PBSβ
Human galectin-9 (full length) hGal-9 20 0.5 PBSβ
Human Siglec-14-Fc chimera Siglec-14 1 0.015 PBS
Human surfactant pulmonary-
associated protein D SP-D 6 0.3 HBSC
Fig. 3.12 Steps for detecting binding on NC-based microarray experiments. (a) Biotin-labelled lectins, (b)
His-tagged lectins, including incubation with pre-complexed anti-His-tag & biotin-anti-mouse IgG, and 
(c) chimeric Siglec-14-Fc pre-complexed with biotinylated mouse anti-human Fc.
Adapted from (Kalograiaki et al., 2016).
(a) (b) (c)(b) (c)
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streptavidin in overlay buffer for detection of bound biotinylated lectin or 
antibody.Slides were finally washed thoroughly with washing buffer, Tween® 20-free 
buffer andthen milliQ® water, and dried under nitrogen stream. All incubation steps 
took place in a dry, dark place, at 20 ºC. Arrays were scanned with the blue and red 
lasers for detection of SYTO® 13 and AF647 signals, respectively (Fig. 3.10 and 3.12). 
3.5.4.2.2 Binding and competition assays on hydrogel-coated slides 
This protocol was followed for assessment of the inhibitory potential of 
monosaccharides, polysaccharides as well as synthetic glyconanoparticles (section 3.4) 
and glycofullerenes (for description please see section 4.3.2.2). 
Following printing of (glyco)proteins and neoglycopeptides on Slides H, these were 
washed with milli-Q® water, then with HBS buffer, and any remaining active site was 
finally de-activated by incubation for 90 min with 50 mM ethanolamine in 0.1 M boric 
acid, pH 8.5. The de-activated slides were thoroughly washed with milli-Q® water and 
were ready to use for binding assays. Alternatively they were dried under nitrogen 
stream and stored at -20 °C, remaining stable for at least 12 months (also see 4.3.1). 
Slides were carefully washed with HBS containing 0.1% Tween® 20 (HBS-T) and 
incubated for 75 min in the same buffer with the biotinylated lectins in the absence or 
presence of diverse inhibitor concentrations. Hybridised slides were then washed twice 
with HBS containing 0.05% Tween® 20 and incubated for 35 min with 1 μg/ml 
streptavidin-AF647 in HBS-T. After washing with HBS-T and milli-Q® water, the 
slides were dried under nitrogen stream and scanned for AF647 signals.  
Alternatively, the de-activated slides were washed and incubated with non-labelled 
lectins in the absence of inhibitors, using the same protocol. After washing, slides were 
incubated with 0.1 mM biotinylated heptyl-mannoside (MAF285, Fig. 3.13), in HBS for 
60 min at 20 ºC, in the absence or presence of different concentrations of inhibitors.  
Detection of lectin-bound MAF285 by incubation with streptavidin-AF647 was 
performed as described above. Inhibitory activity (IC50 values) was determined by semi-
Fig. 3.13 Biotinylated heptyl-mannoside.
53
logarithmic plotting of the percentage of bound MAF285 versus inhibitor concentration, 
considering as 100% the binding in the absence of inhibitors, and sigmoidal fit to 
experimental data using the Origin 7.0 software (OriginLab). MAF285 was synthetised 
in the laboratory of Prof. Stéphane Vincent (Unité de Chimie Organique, Université de 
Namur-FUNDP, Belgium). 
3.5.4.3 Bacteria binding and competition assays 
Different mannose-containing glycoproteins and neoglycopeptides were printed in a 16-
pad format on hydrogel-coated Slides H (NEXTERION®), followed by slide washing 
and deactivation as described in the previous section. 
E. coli strain UTI89 (E. coli) was grown and stained with SYTO® 62 as described in 
section 3.1. Slides H were incubated for 1 h with 100 μl of SYTO® 62-stained bacteria 
(red) at OD600 = 1, in the absence or presence of different concentrations of natural or 
synthetic potential inhibitors. After a short wash in HBS and another in milliQ®, the 
slides were dried under nitrogen stream and scanned with a 635 nm laser for detecting 
SYTO® 62 signals (Fig. 3.14). The inhibitory activity (IC50 values) for each compound 
was determined by semi-logarithmic plotting of the percentage of bound bacteria versus 
inhibitor concentration, taking as 100% the binding in the absence of inhibitors, and 
sigmoidal fit to experimental data using the Origin 7.0 software. 
3.6 Piezoelectric and optical biosensor assays 
In this Thesis, the term biosensor is applied to sensors using biomolecules as 
recognition elements that selectively interact with an analyte. A suitable transducer 
converts the biological response into a digital electronic signal directly proportional to 
the quantity of bound analyte (Lowe, 1985). Affinity biosensors are characterised by the 
presence of optical, magnetic or piezoelectric transducers that interconvert light 
Fig. 3.14 Concept of the bacteria binding and glycofullerene competition experiments on hydrogel slides.
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intensity, mechanical deformation or voltage to measure mass or viscoelastic effects 
(Turner, 2000). In this work, assays were conducted using either piezoelectric/acoustic 
(Quartz Crystal Microbalance, QCM) or optical (Surface Plasmon Resonance, SPR) 
label-free biosensor devices, which permit kinetic evaluation of biological interactions.  
3.6.1 Quartz Crystal Microgravimetry 
Acoustic sensors comprise one or more vibrating elements creating acoustic waves that 
propagate on the surface or in the bulk of the resonator (bulk acoustic wave, BAW). The 
properties (amplitude or frequency) of these waves change when molecules bind to the 
sensor surface (Marx, 2003). 
In particular, quartz crystals attained significance as 
analytical tool after the discovery that their resonant 
frequency (f) decreases linearly when additional 
mass is attached to the sensor (Sauerbrey, 1959). 
The QCM is a BAW device, consisting of a 
piezoelectric quartz crystal that resonates when electrically excited by two electrodes 
(Fig. 3.15) (Janshoff et al., 2000). The electrodes can be one of a number of metals 
(frequently gold) sputtered on the upper and lower quartz surfaces. By applying an 
alternating electric field, a mechanical oscillation of characteristic frequency, f, is 
produced in the crystal. Typically, the continuous resonance mode is utilised and 
relative shifts in crystal f are measured.
For resonators operating in the Thickness-Shear-
Mode (TSM), AT-cut crystals (angle of 35.25º to 
the z-axis, Fig. 3.16) are commonly used. This 
geometry provides a stable oscillation with almost 
no temperature fluctuation in  f  between 0 and 50 
ºC (frequency stability Δf / f ≈ 10-8) (Bottom, 1982). 
TSM oscillation is primarily lateral to the surface 
(Fig. 3.16), the amplitude of a vibrating crystal 
being 1-2 nm (Marx, 2003). Any mass bound to the 
surface will cause the crystal oscillation frequency to decrease.  
In this Thesis, QCM measurements were performed at Attana AB (Stockholm, Sweden) 
using a two-channel Attana Cell™ 200 instrument (Fig. 3.17, a). The instrument has an 
Fig. 3.15 Schematic diagram of a 
QCM Thickness-Shear-Mode 
resonator, excited by two electrodes.
Adapted from (Johannsmann, 2008)
Fig. 3.16 AT-cut of a quartz crystal 
and an end on crystal view of the
thickness-shear-mode of oscillation.
Adapted from (Janshoff et al., 2000)
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integrated injecting robot (C-Fast) and a peristaltic pump that ensures a continuous flow 
of running buffer. The flow runs through a pulse dampener to reduce the fluctuations in 
pressure generated by the pump. The whole system is controlled by the Attester 
software (Attana AB), which also provides frequency shift information in real-time.  
 One chip is used per channel, each housing a quartz crystal in a small cylindrical 
chamber (height: 50 µm, diameter: 5.6 µm, volume: 1.25 µl). For preparation of LNB 
(Low Non-specific Binding)-carboxyl QCM chips (Attana AB, Fig. 3.17, b), quartz 
crystals were pre-treated as follows. AT-cut quartz crystals of 10 MHz nominal 
frequency and ~8 mm diameter, sputtered with gold electrodes of 4.5 mm diameter and 
140 nm thickness on each side, were cleaned in fresh "piranha" solution (30%   
H2O2/H2SO4, 1:3 v/v) for one min, rinsed with milliQ water and washed thrice in CHCl3.  
The gold-coated crystal surface was then functionalised with a self-assembled 
monolayer (SAM) bearing carboxyl groups, by immersion in an alkanethiol derivative 
(eg. 10-carboxy-1-decanethiol) ethanol solution of 3-5 mM (Bain et al., 1989) and 
soaking for ~3 h. The method takes advantage of the rapid and strong chemisorption of 
long-chain alkanethiols on gold surfaces, leading to the formation of an ordered and 
oriented monolayer (Fig. 3.18). When the monolayer formation was complete, the chip 
core was washed with ethanol and distilled water, then dried under nitrogen stream. The 
carboxy-functionalised gold-coated crystal was finally assembled into the plastic chip
Fig. 3.17 (a) Attana Cell™ A200 instrument, C-Fast robot-assisted quartz crystal microgravimetric 
system; (b) LNB-Carboxy Chips.
Fig. 3.18 Formation of alkanethiol-based ordered monolayers.
Alkanethiols begin to chemisorb to the gold-coated glass plate (Au-S) when the latter is immersed in an 
alkanethiol derivative solution. Increase in bond number results in stronger intermolecular interactions,
SAMs of higher density and orientation being formed.
(a) (b)
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holder (Fig. 3.17, b).
 Two assembled chips were washed with 20 μl milli-Q® water and docked into the 
Attana Cell™ 200 instrument in channels A and B. Upon chip insertion, the crystals 
were exposed to the flow of running buffer on a single (gold) surface, avoiding direct 
contact between liquid and quartz. The temperature was set at 22 ºC and the buffer flow 
rate at 50-100 μl/min, until stabilisation of the baseline (frequency shift ≤ 0.2 Hz over 
600 s). Flow rate was then reduced to 10 μl/min and a fresh activation mix containing 
0.2 M 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and 0.05 M sulfo-NHS 
(Amine Coupling Kit, Attana AB) was injected for 5 min (Fig. 3.19, a). Flow was 
switched again to running buffer (PBS or HBS containing 0.005% Tween® 20). Lectins 
to be covalently coupled (ConA and GNA), were diluted at ~50 and 100 μg/ml,  
respectively, in 10 mM acetate buffer, pH 4, below their isoelectric point (6 for ConA 
and 4.5 for GNA) in order to facilitate NHS-assisted amine-coupling, and injected twice 
over both channel A and B surfaces for a total contact time of 10 min. Activation with 
EDC/sulfo-NHS results in the replacement of the carboxyl groups by more negatively 
charged sulfo groups (Fig. 3.19, b), enhancing initial electrostatic attraction and 
resulting in efficient protein coupling. 
The complete immobilisation process was monitored by frequency shifts (Fig. 3.19, a). 
Following immobilisation, a de-activation solution (1 M ethanolamine, pH 8.5) was 
injected in both channels for 5 min, and finally, flow was switched to running buffer at 
20 μl/min over the lectin-derivatised surface till stabilisation of the baseline. Coupling 
of ConA on the chip surfaces resulted in a shift of 60-80 Hz in the frequency of the 
Fig. 3.19 (a) QCM sensogram for lectin immobilisation by two consecutive injections in LNB-Carboxy chips 
with previous EDC/sulfo-NHS activation, as indicated; (b) EDC/sulfo-NHS amine coupling chemistry.
(b)(a)
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quartz crystal resonator versus ~50 Hz for GNA. 
Following the Sauerbrey law, the frequency value is decreased with the enhancement of 
mass on the QCM electrode surface. However, the specific set-up of the Attana 
instrument includes a third crystal inside the machine which is used as reference, and 
the reported frequencies correspond to the frequency of this internal crystal (fixed for 
each instrument) minus the frequency of the experimental crystal. When the mass is 
increased at the experimental crystal, its frequency is reduced, so after subtraction from 
the frequency of the internal crystal the final observed frequency shift yields positive 
values. The read-out from the detector is thus given as -Δf values (Fig. 3.19a, and Fig. 
3.22).
For QCM analysis of lectin binding to EVs, two strategies were followed. First, the 
interaction of EVs directly injected over immobilised GNA was monitored. To this end, 
1:10 dilutions in PBS of THP-1-derived exosome and MV- preparations were injected 
in duplicate (injection volume 250 μL). An activated/deactivated chip without GNA 
immobilisation was used as reference in channel B. After each injection, the GNA-
derivatised chip was regenerated with glycine 10 mM, pH 2.5.
v. Lectin injection
vi.  Surface
regeneration 
LNB-carboxyl
surface
i  Activation.
 ConA injectionii.
COO
H
COO
H
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Fig. 3.20 Preparation of bacteria-QCM chips. Adapted from (Kalograiaki et al., 2016)
Second, lectin-captured EV chips were developed for the analysis of lectin binding to 
the EV surface (sandwich assay). Following GNA derivatisation, as described above, 
both A and B chips were undocked from the machine and disassembled to permit ex situ
EV capture. Chip A was then incubated for 1 h with 50 µl of THP-1 exosome stock 
solution (see section 3.3). Chip B, in this case also GNA-derivatised, was incubated 
under the same conditions with 50 µl of PBS to be used as reference. Following 
incubation, the surfaces were washed 3 times with PBS, containing 0.05% Tween-20 
(running buffer), fixed for 10 min at 4 ºC with 3.7% (v/v) formaldehyde (Sigma-
Aldrich, 37% stock solution diluted in PBS), and washed again extensively with 
running buffer. The chips were then reassembled, docked into the instrument, and the 
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flow rate was set at 20 μl/min at 22 ºC, until stabilisation of the baseline (frequency shift
≤ 0.2 Hz over 600 s).
For QCM analysis of lectin binding to bacteria, lectin-captured bacteria chips were 
developed in a similar manner. ConA was selected as bacteria capturer. Following 
ConA-derivatisation, both chips were undocked from the machine as described for EVs 
to permit ex situ bacteria capture (Fig. 3.20). Chip A was incubated for 30 min at 22 ºC 
with 50 µl of a NTHi suspension of OD600 = 1, corresponding to ~1×109 bacteria/ml, in 
PBS (cultured and fixed as described in section 3.1). Chip B was incubated under the 
same conditions with 50 µl of PBS as reference. Chips were washed and fixed with 
formaldehyde as described above.
Then, the bacteria-derivatised surface was incubated with a 0.1 μg/ml DAPI solution in 
running buffer for 15 min in the dark. DAPI (4´,6´-diamidino-2-phenylindole, 
Invitrogen) is a membrane permeable dye, not interfering with membrane molecules, 
used for staining bacterial nucleic acids. To evaluate the cell coverage of the surfaces, 
fluorescence microscopy pictures were obtained using an Eclipse 80i microscope 
(Nikon) equipped with 340-380 nm, 400 nm, and 435-485  nm excitation filter, dichroic 
mirror and emission filter, respectively. The chips were then reassembled, docked into
the instrument and left overnight at 20 μl/min flow rate and 22 ºC, to permit 
stabilisation of the baseline.
Once the chip frequency was stabilised, full binding kinetic analysis was performed for 
selected lectins over the fixed bacteria/EVs chips. Increasing concentrations of the 
lectins in running buffer were injected for 84 s in consecutive duplicates, each injection 
followed by one of running buffer for 600 s. For information on the concentration range 
Table 3.4 Lectins used in QCM kinetic analyses
Lectin MW (kDa) Concentration range
in μg/ml in nΜ*
RCA 120 0.15-5 1-42
VAA 115 0.15-5 1.31-43.8
PNA 110 73-330 660-3,000
WGA 36 6.25-100 175-2,800
ConA 104 10-150 100-1,500
GNA 52 34-312 660-6,000
For lectin specificity please see Table 3.2. *For calculation of the molar concentration, the 
quaternary structure molecular weight was considered for each lectin.
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tested, please see Table 3.4. After each cycle, a pulse injection (30 s) of 10 mM glycine, 
pH 1.2-1.5 (for bacteria-chips also containing 0.5 M NaCl) led to efficient regeneration, 
surfaces being immediately re-equilibrated with running buffer (Fig. 3.21). In the 
competition experiments, the lectins were preincubated with their specific hapten for 1 h 
in running buffer before injection.  
Fig. 3.21 QCM sensogram corresponding to the interactions taking place upon lectin injection over a 
bacteria-derivatised sensor chip. Regeneration clears analyte bound molecules.
Experimental data were collected using Attester software (Attana AB) and analysed 
with the evaluation software provided by the manufacturer along with TraceDrawer  
(Ridgeview). In order to calculate the kinetic parameters (kon and koff) and affinity 
constant (KD), the experimental data were fitted using 1:1 or 1:2 models (for details, 
please see sections 4.1.4 and 4.2.5). Real-time biosensor response for the reference 
surface (chip B) was subtracted from sensograms obtained for the chip A, ligand 
surface. 
In order to assess chip quality and regeneration capacity, ConA-bacteria chips were 
removed from the device after the binding analysis and retention of the bacteria was 
evaluated ex situ by DAPI imaging using fluorescence microscopy, as described before. 
In addition, lectin binding to the bacteria chips was visualized by incubation for 30 min 
with 150 μg/ml fluorescein-labeled ConA (FITC-ConA) in running buffer. After 
thorough washing, fluorescence microscopy pictures of the surface were obtained using
a Nikon microscope Eclipse 80i equipped with 465-495 nm, 505 nm, and 515-555 nm 
excitation filter, dichroic mirror and emission filter, respectively.
-Δf
 (H
z)
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3.6.2 Surface Plasmon Resonance  
 The SPR phenomenon occurs when surface plasmon waves (SPWs) related with 
collective excitations of electrons are excited by light at a metal/liquid interface (Homola, 2003; Kretschmann and Raether, 1968; Otto, 1968; Raether, 1988). Most of the 
commercially available SPR-sensing devices still use the “attenuated total reflection” 
geometry proposed by Kretschmann and Raether in the late 60s (Fig. 3.22). This 
consists in directing plane polarised light from a laser source through a high refractive 
index (RI) prism, and totally reflect it at the base of the prism where a thin gold film 
(~50 nm) is deposited (De Crescenzo et al., 2008) (Fig. 3.22).
Total internal reflection (TIR) occurs at an interface between non-absorbing media of 
different RI (Mirabella, 1985). When a light beam propagating in a medium of high RI 
meets the interface with a medium of lower RI and is totally reflected, it propagates 
back into the high RI medium. Although the reflected beam does not lose any net 
energy across the interface, it leaks electrical field intensity, called evanescent field 
wave, into the low RI medium. The amplitude of this evanescent field wave decreases 
exponentially with distance from the interface into the medium. If the TIR-interface is 
sputtered with a layer of a suitable conducting material (usually gold), the evanescent 
field wave may penetrate the metal layer and excite electromagnetic SPWs propagating 
within the gold surface, thus creating an enhanced SPR-evanescent wave. For energy of 
the photons pumping on the thin 
gold surface to be transferred to 
surface plasmons, the tangential 
x-component of the incident 
optical wave vector (kx) has to 
match the SPW vector, ksp, in 
magnitude and direction. This 
resonant absorption of energy, 
causing plasmon excitation, leads 
to the appearance of a sharp 
resonant dip in the reflected light 
intensity at a definite angle (θspr) 
(Fig. 3.22). 
Fig. 3.22 SPR detection principle.
When surface plasmon resonance occurs, a dip in the 
reflected light is observed at a defined angle (θspr). Time-
dependent accumulation of analyte mass within the vicinity of 
the surface results in variations of θspr that are followed in real 
time. Adapted from (De Crescenzo et al., 2008).
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 The wave vector of the light, kx, can be adjusted to match that of the surface plasmon 
by controlling the angle of incident light (Homola, 2008). On the other hand, the SPW 
vector depends on the RI of the conductor and of the dielectric within the decay length 
of the wave from the solid–solution interface (typically ~300 nm). Most of the SPR 
sensors, including Biacore (GE Healthcare), employ this property to monitor binding 
events in the close vicinity of the gold layer. The binding of an analyte will produce a 
local increase in the RI and, consequently, the angle of incidence required for resonance 
(θspr) is altered. θspr changes upon binding events are then translated into a resonance 
signal (Fig. 3.23), where one resonance/response unit (RU) is equal to a θspr shift of 10−4
deg. The displacement in the angle is proportional to the analyte mass and the detection 
limit achieved may be down to 10-7 RI units in terms of the RI shift, corresponding to 
about 0.1 pg/mm2 of analyte accumulating on the sensor surface (De Crescenzo et al., 
2008). 
The real-time response of the SPR experiment is usually presented in the form of a 
sensogram (Fig. 3.23). At the start of the experiment, the surface has not yet been 
exposed to analyte molecules and the 
RU value (baseline) corresponds to the 
starting critical angle I. When analyte 
molecules are injected and bind to the 
surface, the RI and associated θspr (II) 
change, leading to an increase in the 
resonance signal (Fig. 3.23). 
In this Thesis, SPR experiments were performed using a Biacore® X-100 biosensing 
device (GE Healthcare) located at Instituto de Química Médica, Centro de Química 
Orgánica “Lora Tamayo” (CSIC, Madrid, Spain). In Biacore® instruments, the incident 
light is focused into a wedge-shaped beam simultaneously providing a continuous 
interval of kx vectors that covers the working range for the SPW vector, kspr. Changes in 
the SPR angle are evidenced by changes in the position of the reflected intensity dip 
(from I to II, Fig. 3.23). The analyte is supplied in a controlled fashion to the sensor 
surface through a microfluidic system. 
 Many types of sensor-chips are commercially available, each covered with a different 
surface matrix. In this work, we used Biacore® CM5 chips, which consist in a glass 
surface covered by a thin gold layer (~50 nm thick). The latter is first covered with a 
Fig. 3.23 Functional modes of SPR detectors.
The reflection angle θspr is dependent on the RI of the 
medium within 300 nm of the gold surface (I). Upon 
an analyte-binding event, the RI is translated into an 
angle shift (II). The signal is finally represented as 
resonance units versus time.
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covalently bound monolayer of alkanethiol molecules, which is functionalised with a 
matrix of carboxymethylated dextran, a flexible unbranched carbohydrate polymer 
forming a thin surface layer, ~100 nm thick (Fig. 
3.24). The dextran matrix provides a hydrophilic 
environment favourable to biomolecular 
interactions, as well as a tridimensional, well-
defined chemical basis for covalent attachment of 
biomolecules. The sensor chip has two channels: 
one is a reference channel (untreated) while the 
second is used for target immobilisation. Kinetic 
analysis of the binding event can be performed by 
monitoring the SPR angle as a function of time. 
For this study, ConA was immobilised on the chip as follows. The carboxymethylated-
dextran surface was first activated for 7 min with a 0.2 M EDC/0.05 M NHS mix 
injection at a flow rate of 10 μl/min. Then, a 50 μg/ml ConA dilution in 10 mM acetate 
buffer, pH 4, was injected for 2 min, followed by de-activation with 1 M ethanolamine-
HCl, pH 8.5, for 7 min (also serving to remove non-covalently bound ligand), Fig. 3.25.
ConA immobilisation resulted in a response of 2700-2900 RU. Upon baseline 
stabilization, increasing concentrations (0.25-10 μΜ) of α-D-mannose- as well as 
galactose-bearing glycofullerenes in HBS were injected for 80 s in both channels at a
flow rate of 50 μl/min, at 22 °C. Each fullerene injection was followed by continuous 
buffer flow for 100 s (flow rate 50 μl/min, dissociation phase), and a single injection of 
regeneration solution (10 mM glycine-HCl, pH 3.0) for 20 s at 10 μl/min to remove any 
remaining bound fullerene from the chip surface, then switching again to running buffer 
at the initial flow rate (50 μl/min), Fig. 3.25. 
Fig. 3.25 Steps followed for the kinetic analysis of mannofullerene binding to immobilised ConA by SPR.
Response data were collected at real-time, analysed with the Biacore® X-100 evaluation 
software and plotted as response shift versus analyte concentration. The interaction 
apparently followed pseudo-first order kinetics, and the dissociation constant (KD) was 
calculated in equilibrium following a 1:1 interaction model, using the equation: 
Fig. 3.24 Schematic illustration of the 
sensor chip surface of the CM-series.
Source: Biacore®website
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where Req corresponds to the biosensor response in equilibrium (RU), Rmax to the 
maximum response registered and [A] to the injected analyte (fullerene) concentration. 
The bulk index (the difference in RI between the running and sample buffer) was zero 
in all cases. 
 3.7 Isothermal titration calorimetry 
Isothermal titration calorimetry (ITC) measures directly the energetics of a binding 
process upon mixing of two components, including protein-ligand interactions (Freire et 
al., 1990; Wiseman et al., 1989).
 A power compensation ITC instrument has two 
identical coin-shaped cells, sample and reference, 
enclosed in an adiabatic shield (Fig. 3.26). A feedback 
control system monitors the difference in temperature 
between the two cells through a semiconductor Peltier 
sensor device sandwiched between them. In order to 
maintain the difference in temperature constant, 
controlled power is continuously supplied to the sample 
cell, what determines the baseline level. 
One of the reactants (usually the macromolecule, M) is placed in the sample cell and the 
other one (usually the ligand, L) is added to the cell in a stepwise fashion with the use of 
a syringe, at the same time stirring the solution in the sample cell to achieve fast mixing 
(Fig. 3.26). Upon each titrant injection, a certain amount of macromolecule/ligand 
complex (ML) is formed, depending on the affinity and the concentration of reactants in 
the sample cell. The reaction may be accompanied by the release (exothermic reaction) 
or absorption (endothermic) of heat, what causes a difference in temperature between 
the sample and reference cells. The feedback system then responds by either lowering or 
rising the thermal power applied to the sample cell, so that the temperature balance is 
restored and the system reaches equilibrium. Hence, the measured signal is the power 
applied (µcal/sec) to return to the baseline and shows a typical deflection pattern in the 
form of a peak (Fig. 3.27, upper panel). Using the baseline as reference, integration of  
Fig. 3.26 Schematic illustration of 
a power compensation ITC 
instrument. Adapted from
(Velázquez-Campoy et al., 2004)
D
eq KA
ARR 

][
][max
64
the area under the peak 
provides the amount of heat 
associated with each injection, 
which is proportional to the 
complex formation.  
For the binding parameters to 
be determined, the reaction 
heat should be both 
measurable for each injection 
and also vary for subsequent 
injections (Fig. 3.27, upper 
panel). As the degree of 
saturation of the 
macromolecule in the cell 
increases, the heat signal 
diminishes until only the background heat, due to ligand dilution or mechanical effects, 
i.e. liquid friction, is observed (Velázquez-Campoy et al., 2004).  
Analysis of the heat change per mole of injected ligand as a function of the 
ligand/protein ratio (Fig. 3.27, lower panel) using the appropriate binding model 
provides a direct estimation of the binding (equilibrium) constant, Keq, the enthalpy 
change of binding, ΔH, and the binding stoichiometry, n, whereas the entropy change of 
the binding, ΔS, can be calculated using the equation:
ΔG = -R × T × lnKeq = ΔH - T × ΔS
where R is the universal gas constant (1.987 cal K-1mol-1) and T the absolute 
temperature (K).  
 ITC analyses of lectin-carbohydrate interactions were carried out either in a 
MicroCal™ VP-ITC power compensation calorimeter (GE Healthcare) equipped with a 
1400 μl sample cell and a 250 μl Hamilton glass syringe, or in a Malvern Microcal 
PEAQ-ITC instrument equipped with a 200 μl sample cell and a 50 μl Hamilton glass 
syringe. The lectin of interest was dissolved in HBS, pH 7.4, and exhaustively dialysed 
against the same buffer. Protein concentration was calculated spectrophotometrically at 
280 nm using an extinction coefficient E1cm0.1% = 1.24 for ConA and 1.80 for GNA. 
Fig. 3.27 Representative ITC dataset.
In the upper panel each peak represents one injection. In the 
lower panel, the fit obtained by nonlinear regression analysis 
of the data can be observed. 
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Lectin solutions were loaded in the sample cell at a monomer concentration of ~300 
μM, while the ligands were loaded in the syringe. Ligands included α-Me-Man, 
Man(α1,3)man-α-OMe (Carbosynth), both at 15 mM, and different glycofullerenes at 
0.2 mM (see section 4.3.2.2 for molecules description). A monovalent ligand 
comprising a α-D-mannose moiety and a pegylated linker, used for attachment to the
fullerene C60 core, was also evaluated (11.7 mM, as calculated by the phenol-sulphuric 
assay, section 3.11.2). The last buffer used for protein dialysis was employed to prepare 
the ligand solutions to minimise heat artefacts derived from solvent mixing, and both 
protein and ligand solutions were degassed prior to filling the cell and the injection 
syringe to avoid the generation of bubbles and, therefore, spurious heat signals (Freyer 
and Lewis, 2008). The ITC experiments were run at 22/25 °C and were set to deliver 
approximately 20 injections at 300-sec intervals, the precise volume series being 
adjusted according to the experiment. For each protein, one or two titration experiments, 
depending on ligand availability, were run followed by one ligand dilution experiment, 
in which the ligand solution was added to dialysis buffer in the cell. The dilution-
corrected integrated data were fit with a suitable binding model using the Origin-6™ 
software (OriginLab) provided with the MicroCal VP-ITC instrument. ConA functional 
monomer concentration, previously determined by titration with α-Me-Man was used as 
input for ligand concentration in the fitting of dodecamannosylated fullerene titrations, 
carried out using the “ligand-in-cell” option.
3.8 Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is a versatile biophysical technique 
that permits the elucidation of molecular recognition events at atomic resolution, 
including the recognition of sugars by their receptors (Weis and Drickamer, 1996). The 
development of approaches leading to structural determination, as well as the study of 
the conformation and dynamics of complex oligosaccharides, has contributed to the 
expansion of its use. Of note, NMR techniques provide the possibility to work in 
solution and in a vast range of pH, thus in conditions akin to physiological. 
All nucleons (neutrons and protons) composing any atomic nucleus, have the intrinsic 
quantum property of spin. All nuclei are electrically charged (positively, off the protons) 
and many of them have spin, when the total spin quantum number S is not zero. Such 
nuclei generate a magnetic field of a magnetic moment, μ (Fig. 3.28, a), proportional to 
the spin but also depending on the gyromagnetic ratio γ, characteristic for each nucleus  
66
Fig. 3.28 The basis of Nuclear Magnetic Resonance. (a) Precession of a m = +½ nucleus with an 
associated magnetic moment, μ, around the external magnetic field vector, B0, under a Larmor frequency,
ω; (b) two possible momentum states of a nucleus with S = ½ exist when an external magnetic field, B0, is 
applied; and (c) the dependence of the energy difference (ΔE) between the two momentum states on the 
external magnetic field strength.
 (μ = γ  S). The angular momentum corresponding to the nuclear spin is quantised, so 
that its orientation can only adopt a limited number of values. For a given nucleus of 
spin S, there exist 2S+1 possible angular momentum states, of values –S to +S. Thus, for  
nuclei of spin S = ½, such as 1H, 13C or 15N, there are two possible spin states: m = +½ 
and m = -½ (Fig. 3.28, b). In the absence of an external magnetic field, both states have 
the same energy and the nuclei are equally distributed between them. However, when an 
external magnetic field (B0) is applied, this equilibrium is broken and the energy 
difference between the momentum states is dependent on the external field strength
(please see below, eq. 1, where ħ is Planck’s constant divided by 2π). As a result, states 
of lower energy will always have a higher probability of being occupied or, in other 
words, a slightly larger fraction of the nuclei is present in the lower energy spin state
following the Boltzmann distribution (eq. 2, where k is the Boltzmann’s constant). As it 
can be appreciated from eq. 2, the ratio of nuclei populations at certain temperature only 
depends on the states’ energy difference.
Nlow
Nhigh
=e
-ΔΕ  kT/Δ γ ΒΕ ħ 0= (eq. 1) (eq. 2)
The signal in NMR spectroscopy results from the difference between the energy 
absorbed by the spins that make a transition from the lower to the higher energy state, 
and the energy emitted by the ones that make a transition from the higher towards the 
lower energy state. The magnetic moment of each nucleus precesses around the external 
magnetic field vector, B0 (Fig. 3.28, a). The precession frequency, called Larmor 
frequency (ω0), is the frequency of resonance for each nucleus and is equivalent to the 
energy difference between the two energy levels, ΔE (see below, eq. 3). Thus ω0
(a) (b) (c)
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depends on both the gyromagnetic ratio and the field strength: the stronger the field, the 
bigger ΔE and the nucleus precession frequency (Fig. 3.28, c).
ω0 = γ  Β0 → ω0 = ΔE/ħ (eq. 3)
Nonetheless, local perturbations experienced by every nucleus exist, mainly due to the 
shielding exerted by nearby electrons. As expected, nuclei with different chemical 
environments are nonequivalent, precess at slightly distinct frequencies ω (eq. 4) and 
this constitutes the basis of NMR spectroscopy. 
ω0 = γ  (Β0-Βi) (eq. 4)
For practical reasons, the use of chemical shifts (δ, expressed in parts per million, ppm)
has been established and extensively used instead of Larmor frequencies,
ω-ωref
ωref(    ) 106δ =
where ω is a Larmor frequency for a given nucleus, and ωref is the Larmor frequency of 
a nucleus in a reference compound, such as tetramethylsilane (TMS). 
Nuclei found close to one another, exert an influence on each other's effective magnetic 
field and this effect shows up in the NMR spectrum when they are nonequivalent. If the 
distance between nonequivalent nuclei is less than or equal to three bond lengths, this 
effect, called spin-spin or J-coupling, is observable. 
3.8.1 Spectral assignment of oligosaccharides 
TOtal Correlation SpectroscopY (TOCSY) experiments are bidimensional, 
homonuclear experiments used to detect spins that are either directly or indirectly 
coupled to each other through a chain of J-couplings, i.e. belonging to the same spin-
system (Bax and Davis, 1985). Practically, cross-peaks of the coupled protons are 
observed. In the case of oligosaccharides, each sugar residue is an isolated spin-system, 
and TOCSY experiments would allow for the differentiation and identification of all the 
protons of a specific sugar residue. Such ability is achieved by inserting a repetitive 
series of pulses that cause isotropic mixing during the mixing period. Longer mixing 
times cause a polarisation spread-out through an increasing number of bonds. 
For their part, Nuclear Overhauser Enhacement (NOE) and Rotating-frame Overhauser 
Enhancement (ROE) spectroscopies allow for the establishment of inter-residue 
 (eq. 5)           
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connectivities (Carver, 1991; Woods, 1995). Here, magnetisation is transferred through 
space in dipole-dipole interactions and the nuclear Overhauser cross-relaxation, 
observed between spatially-vicinal spins, is used to establish the correlations. In the 
case of oligosaccharides (MW below 2 kDa), their rotational correlation time falls into a 
range that turns NOE undetectable. Rotation of the equilibrium magnetisation onto the x
axis and inhibition of precession by spin-locking enables the establishment of 
correlations for small molecules (ROESY). 
Finally, heteronuclear experiments are useful for achieving the splitting of signals that 
are overlapping in the 1H dimension, not unusual in carbohydrates due to their poor 
spectral dispersion (δ=3.5-5 ppm). The most commonly used is the 1H-13C 
Heteronuclear Single-Quantum Coherence (HSQC), providing a 2D mapping of pairs of 
directly bound C-H nuclei. NMR spectral elucidation may often be aided by 
assignments already reported in the literature or stored in databases, such as the 
Biological Magnetic Resonance Data Bank (BMRB) (Ulrich et al., 2008) or, the 
computationally simulated, CASPER (Jansson et al., 2006). 
For the spectral assignment of the oligosaccharides (OS) derived from NTHi, the 
isolated LOS of NTHi375ΔompP5 or Rd strain was first hydrolysed in 1% acetic acid in 
milliQ® water (v/v) at 100 °C for 3 h with frequent vortexing. This afforded an 
insoluble lipid A and core OS fractions in the supernatant. Upon completion of the 
hydrolysis, an equal volume of milliQ® water was added to the hydrolysate which was 
then stored for 36 h at 4 °C and later centrifuged at 8,000g at 4 °C. The recovered 
supernatant was lyophilized and further used for the NMR experiments. The process 
was repeated for different LOS preparations.
All NMR spectra were acquired at 310 K (37 °C) on a 600 MHz Bruker Avance 
spectrometer equipped with a cryoprobe and processed with TopSpin 3.0 software 
(Bruker). NMR samples were prepared in 99.9% deuterium oxide (D2O) buffer 
containing 5 mM phosphate and 200 mM NaCl at pD 7.2 (uncorrected value). The 1H 
and 13C NMR spectra of the OS were assigned using a combination of TOCSY 
(dipsi2phpr), 1H-13C HSQC (hsqcedetgp) and ROESY (roesyphpr) of standard pulse 
sequences, as indicated. TOCSY experiments were performed with 20 and 70 ms 
mixing times, and the ROESY spin-lock module was of 300 ms. Chemical shifts and 
coupling constants are reported in section 4.1.6.1. The 1H chemical shifts were 
69
referenced to the residual water signal using the equation δ (ppm) = 5.051 − 0.011 × Te
(°C), (Gottlieb et al., 1997). 
3.8.2 Saturation transfer difference 
During the last decade, saturation transfer difference (STD) spectroscopy (Mayer and 
Meyer, 2001) has been extensively used for the evaluation of ligand binding to 
biomolecules. It is a ligand-based method that involves the comparison of two 1H-NMR 
spectra of the same sample solution, acquired either with (on-resonance spectrum) or 
without (off-resonance spectrum) protein saturation. 
The off-resonance spectrum, equivalent to a reference 1H-NMR spectrum of the 
complex, is obtained by irradiating at regions devoid of both ligand and receptor 
resonances, i.e. at 100 ppm. On the other hand, the on-resonance experiment involves 
selective irradiation of a subset of the protein protons by a train of pulses, directed 
towards frequencies devoid of ligand signals. Typically the irradiation frequency is 
either set between -1 and 1 ppm targeting the aliphatic side-chain protons (Ile, Val, 
Leu), or in the aromatic region (6-8 ppm). The magnetisation propagates via 1H-1H 
cross-relaxation pathways from the irradiated protons to the rest of the protein, and from 
the protein to any ligands in direct contact with it. A decrease should be thus observed 
in the intensity of the saturated proton signals (belonging to both the receptor and the 
bound ligand; the closest they are to the binding site, the stronger their signal decreases. 
The rest of signals are not 
affected. The difference 
between the off-resonance and 
the on-resonance spectra yields 
a saturation spectrum in which 
the saturated nuclei signals are 
observed and allow for ligand 
identification or epitope-
mapping. Application of 
protein spin-lock or solvent 
suppression modules is also 
possible. 
Fig. 3.29 The basis of Saturation Transfer Difference-NMR.
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In this Thesis, STD experiments were performed for an OS/protein molar ratio of 
approximately 30:1. Protein concentration was determined using UV absorbance at 280 
nm and an extinction coefficient E0.1% of 3 and 1.4, for VAA and RCA. Selective 
saturation of the protein was achieved by using a train of 40 Gaussian-shaped pulses of 
50-ms each, separated by a 1 ms delay (approx. saturation time of 2 s). The residual 
HDO signal was suppressed by hard-pulse gradient tailored excitation (WATERGATE) 
and background protein resonance signals were subtracted. An off-resonance frequency 
of δ = 100 ppm and on-resonance frequency of either δ = -0.5 or 7 ppm were applied, 
targeting a spectrum region where no signals are observed for the ligand. For the 
epitope mapping analysis, a quantitative analysis of the STD signals was carried out, the 
resulting STD percentages being given in Tables 4.5 and 4.6 in section 4.1.6.3.2. 
3.9 Bacteria binding and functional assays in solution 
Assays with live NTHi bacteria were performed at the laboratory of Dr. Junkal 
Garmendia in biosafety level 2 installations. 
3.9.1 Galectin binding to bacteria at exponential growth phase 
Bacteria were grown on chocolate-agar plates as described in section 3.1. One hundred 
and 150 μl of NTHi culture in exponential growth phase was centrifuged for 10 min at 
18,000×g and 4 ºC. Pellets were washed with PBS, resuspended in 50 μl PBS 
containing the galectin of interest in the absence or presence of 50 mM lactose, and 
incubated for 45 min at 37 ºC and 5% CO2. Control inoculate suspensions in the 
absence of galectins were also prepared. Suspensions were then centrifuged for 5 min at 
6,000×g, and the supernatants were mixed with SDS-PAGE loading buffer (section 
3.11.1). Pellets were washed once in PBS, centrifuged, supernatant was withdrawn and 
the pellet resuspended directly in loading buffer. All samples (supernatants and pellets) 
were heated for 5 min at 100 ºC, and loaded in gels containing 12% total acrylamide.
Gels were stained with Coomasie Blue and scanned with a GS-800™ Calibrated 
Densitometer (BioRad). Images were analysed with Quantity One® 1-D analysis 
software (BioRad) for identifying and quantifying the bands corresponding to galectins.
3.9.2 Bacterial susceptibility assay  
NTHi susceptibility to galectins was determined as previously described (Llobet et al., 
2011; Morey et al., 2013) with slight modifications. Bacteria were inoculated in sBHI 
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medium, grown as described in section 3.1, and harvested (2,600×g for 20 min at 20 ºC) 
when the exponential growth phase was reached (OD600 = 0.3). The pellet was washed 
with PBS and subsequently resuspended in PBS at OD600 = 0.15 (corresponding to 
approximately 108 cfu/ml, and serial dilutions in PBS were prepared up to 10-3 dilution. 
To 25 μl of galectin solution in either PBS or PBSβ, 5 μl of bacterial 10-3 dilution was 
added and mixed by soft pipetting. The mixture was incubated at 37 ºC and the whole 
30 μl was plated on sBHI-agar at appropriate time intervals (0, 15, 30, 45, 60 and 90 
min). PBSβ was included in control preparations (absence of galectins) to evaluate 
potential effects of β-mercaptoethanol on the bacterial viability. Colony counts were 
determined and the results were expressed as percentage of the colony count of bacteria 
not exposed to galectins. All measurements were performed with duplicate samples in at 
least three independent experiments.
3.9.3 Epithelial adhesion/invasion assay  
A549 human alveolar basal epithelial carcinoma cells (immortalised type II 
pneumocytes, ATCC CCL-185) were maintained in Roswell Park Memorial Institute  
tissue culture medium (RPMI-1640, Sigma) supplemented with 10 mM HEPES 
(Biowest), 10% heat-inactivated foetal bovine serum (FBS, Sigma) and a combination 
of antibacterial/antifungal drugs (100 IU/ml penicillin, 0.25 μg/ml amphotericin B, and 
0.1 mg/ml streptomycin sulphate, Sigma) in 25 cm2 tissue culture flasks at 37 ºC in a 
humidified 5% CO2-containing atmosphere, as previously described (Morey et al., 2011). Cells were seeded in 24-well plates to reach 4×105 cells/well and serum-starved 
for 16 h before infection by replacement of medium with supplemented RPMI-1640 
lacking FBS. A confluence of 90% was reached at the time of bacterial infection. 
For NTHi infection (Fig. 3.30), bacteria grown for 16 h (stationary phase) were 
recovered from a chocolate-agar plate with 1 ml PBS, and the bacterial suspension was 
adjusted to OD600 = 1 (input, corresponding to ~109 cfu/ml). For the cell-adhesion assay, 
A459 cells were infected in 500 μl Earle's Balanced Salt Solution (EBSS, Life 
Technologies) for 30 min at 37 ºC and 5% CO2 with 50 μl of input to get a multiplicity 
of infection (MOI) of 100:1 (100 bacteria per cell). Experiments were performed in 
triplicate, in the absence or presence of human galectins at 5 μΜ, after exhaustive 
dialysis against PBS/PBSβ. Three experimental modes were followed: direct infection in 
galectin-containing EBSS, infection after 60 min preincubation of bacteria with 
galectins, and infection after 60 min preincubation of cells with galectins. After 30 min,
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cells were washed thrice with PBS and subsequently lysed with 300 µl of PBS 
containing 0.025% w/v saponin (Sigma), for 10 min at 20 ºC. Upon cell lysis, the output
was recovered and serially diluted. One hundred μl of 10-4 and 10-3 dilutions were
plated on sBHI-agar and the number of cfu counted. Bacterial adhesion to the epithelial 
Fig. 3.30 Epithelial NTHi adhesion and invasion assays in presence/absence of galectins. For the 
adhesion assays, three experimental modes were followed as described in the text. Upon serial dilution 
and plating of the output, adhesion and invasion were represented as percentage of c.f.u. per well, taking 
the input as 100%.
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cells was represented as the percentage of cfu per well, taking the input as 100%. 
For the bacterial cell-invasion assay (Fig. 3.30), A459 cells were infected for 2 h as 
described above with 100 μl of input (MOI 200:1), in the absence or presence of 
galectins. This is the time considered necessary for bacterial internalisation upon 
adhesion. Then, cells were washed 5 times with PBS and incubated for another 30 min 
with RPMI-1640 containing 10 mM HEPES, 10% FBS, and 200 μg/ml gentamicin 
(Sigma) to kill extracellular bacteria. Cells were then washed thrice with PBS and lysed 
as described above. The output was serially diluted and 100 μl of 10-2 and 10-1 dilutions 
were plated on sBHI-agar. Results were represented again as the percentage of 
recovered cfu per well.
3.9.4 Galectin binding visualisation by confocal microscopy 
NTHi375 bacteria were harvested at stationary phase and fixed with paraformaldehyde, 
washed and their nucleic acids were stained with SYTO® 13, all as described in section 
3.1. For lectin-binding, bacteria suspensions (OD600=0.5) were incubated for 60 min at 
37 °C, in presence or absence of biotinylated hGal-1 or his-tagged galectins (hGal-3, 
hGal-4 and hGal-8) at 10 μM. Meanwhile, a mouse anti-his Ab and a secondary, 
biotinylated anti-mouse Ab were precomplexed in solution at 1 and 3 μg/ml 
respectively. Following galectin incubation, preparations were centrifuged and washed 
thrice with PBS, then incubated for 45 min at 37 °C with the antibody complex (for 
hGal-3, -4 and -8) or PBS (for hGal-1-biotin). After washing, they were incubated with 
1 μg/ml streptavidin-AlexaFluor® 647 for 30 min, washed and tested in the microscope. 
Images were collected with a Leica TCS SP5 Acousto Optical Beam Splitter confocal 
microscope (Mannheim, Germany) with 20X and 63X oil immersion optics. Laser lines 
at 488nm and 561nm for excitation of SYTO® 13 and AlexaFluor® 647 were provided 
by an Ar laser (100 Mw) and a DiodeP Solid State laser (10 Mw). Detection ranges 
were set to eliminate crosstalk between fluorophores. 
3.10 Affinity chromatography 
The isolation and purification of lectins by affinity chromatography exploits the unique 
property of these proteins of binding saccharides specifically and reversibly. The lectin 
to be purified is passed through a column containing an insoluble matrix to which a 
specific ligand has been covalently attached (Cuatrecasas, 1970; Vretblad, 1976). 
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Proteins not exhibiting appreciable affinity for the ligand elute through the column, 
whereas those bound to the functionalised matrix can be later dissociated by 
competitive elution with an appropriate hapten sugar. In this Thesis, affinity 
chromatography has been used to compare functionality among different batches of 
ConA and recombinant human galectins, as well as for the purification of their active 
fractions.
Affinity chromatography was carried out in 5-ml columns containing either commercial 
mannan-agarose (Sigma) or fetuin-Sepharose 4B prepared as follows. Cyanogen 
bromide (CNBr)-activated Sepharose 4B (GE Healthcare) was initially suspended at 
0.5% (w/v) in 0.1 M HCl and incubated for 1 h at 20 ºC with sporadic shaking, to 
eliminate possible imidocarbonate groups that could interfere during the 
chromatographic procedure (Tercero and Díaz-Mauriño, 1988). The gel was next 
separated by filtration and washed first with abundant milli-Q water and afterwards with 
a small volume of 0.1 M NaHCO3, pH 8.3, 1 M  NaCl. The gel was immediately mixed 
with an equal volume of a fetuin solution (5-10 mg/ml) in the same buffer, and the 
suspension was incubated overnight at 4 ºC, under soft spinning. After incubation, the 
gel was separated from the supernatant by filtration and washed with 5 volumes of the 
bicarbonate buffer. The fetuin-Sepharose matrix was resuspended in 1 M ethanolamine, 
pH 9, in order to de-activate any remaining active cyanide groups, and incubated for 2 h 
at 20 ºC, under soft spinning. Finally, the gel was washed with PBS. The amount of 
immobilised fetuin (2.5-4.5 mg/ml) was calculated from the difference between the 
initial quantity of protein added and the amount of fetuin determined in the supernatant 
and washes by measuring the absorbance at 280 nm (E1cm0.1% = 0.494).
The mannan-agarose and fetuin-Sepharose 4B columns were equilibrated at room 
temperature with PBS or PBSβ, and a 100 µl sample of the lectin (1 mg/ml) in the same 
buffer was injected. Elution was monitored by measuring absorbance at 280 nm with a 
UV Uvicord S2 (LKB) detector and the signal was recorded using a Shimadzu C-R3A 
integrator. The lectin retained in the column was finally eluted with running buffer 
containing 0.1-0.2 M competing sugar. Flow rate was fixed at 0.25 ml/min using a 
peristaltic LKB Pump P1 (Pharmacia).
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3.11 Colorimetric methods 
3.11.1 Determination of protein concentration 
Protein concentration was determined colorimetrically in 96-well polystyrene microtiter 
plates (Costar) following the Bradford method (Bradford, 1976). This method is based 
on the binding of the dye Coomasie Blue G-250 (red colour in the free-state, maximum 
absorption at 465 nm) to the proteins, with the formation of a blue-coloured protein-dye 
complex of high extinction coefficient (maximum absorption at 595 nm). The binding 
occurs rapidly (it takes approximately 2 min) and the blue complex remains dispersed in 
solution and stable for a relatively long time (approximately 1 h). The assay is highly 
reproducible in most cases, no interference of cations or sugars is expected, and it can 
be run in the presence of most buffers by including appropriate controls. 
Protein solutions containing 2 to 8 µg of protein in a 120 µl volume were pipetted in 
triplicate in the microplate wells, and 80 µl of diluted Bradford Reagent (Bio-Rad®, 1:1
dilution with milli-Q water) was added. The Bradford Reagent contains 100 mg of 
Coomasie Blue G-250 dissolved in a mix of 100 ml phosphoric acid at 85% and 50 ml 
of ethanol at 95%. The plate was shaked and incubated for 10 min at 20 ºC and the 
absorbance was measured at 595 nm, using a Bio-Rad® 3550 plate-reader. Standard 
curves built with triplicate samples of bovine serum albumin at different concentrations 
permitted interpolation of the absorbance values and calculation of the concentration of 
the protein sample. 
3.11.2 Determination of hexose concentration 
Hexose concentration was determined colorimetrically in 96-well polystyrene microtiter 
plates (Costar) following the phenol-sulphuric acid method (Dubois et al., 1951). The 
assay is based on the formation of a coloured, stable phenolic complex (yellow-orange), 
as a result of the reaction between phenol and the carbohydrates after dehydration of 
hydrolysed saccharides to furfural derivatives due to the energetic addition of 
concentrated sulphuric acid, what generates heat. 
Sugar solutions containing 0.5 to 10 µg of sugar in a 25 µl volume were pipetted in 
triplicate into the microplate wells, and 25 µl of 4% phenol in milli-Q water was added 
and mixed thoroughly, followed by the energetic addition of 200 µl of concentrated 
H2SO4. The plate was shaken and incubated for 1 h at 20 ºC and the absorbance was 
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measured at 490 nm, using a Bio-Rad® 3550 plate-reader. Standard curves built with 
triplicate samples of the appropriate sugar at different concentrations permitted 
interpolation of the absorbance values and calculation of the sugar concentration per 
well/sample. 
3.11.3 Quantitation of bacterial lipopolysaccharides by the Purpald® assay 
The molar concentration of LPS and LOS solutions was determined colorimetrically by 
the Purpald® assay (Lee and Tsai, 1999) in 96-well polystyrene microtiter plates 
(Costar). The method employs the oxidation by periodate, at room temperature, of 
unsubstituted terminal vicinal glycol (UTVG) groups present in 2-keto-3-deoxy-D-
manno-octonate (Kdo) and L-glycero-D-manno-heptose (Hep) yielding formaldehyde. 
 Formaldehyde reacts with Purpald® giving a colourless adduct, which is further 
oxidised by periodate to form the end product of purple colour, as shown in Fig. 3.31. 
This assay allows the quantitation of many types of LPS, since they just need to possess 
at least one UTVG. This minimal requisite makes possible the estimation of the molar 
concentration of the NTHi LOS, which cannot be detected by the typical Kdo assay 
(Osborn, 1963) due to substitutions at the C-4 and C-5 positions of Kdo. 
Duplicates of LPS/LOS solutions in milli-Q water at different concentrations, prepared 
by serial dilution, were pipetted in 96-well polystyrene microtiter plates at a volume of 
50 µl. In each well, 50 µl of 32 mM NaIO4 was added, and the plate was incubated for  
Fig. 3.31 Chemistry of the purpald assay for LPS/LOS quantitation. The unsubstituted terminal 
vicinal glycol of the Kdo and heptose residues in LPS molecules is oxidised by periodate, producing 
formaldehyde (n molecules corresponding to those of glycol) that reacts with purpald and yields a 
colorless adduct, further oxidised by periodate to form the end product of purple color.
Adapted from (Lee and Tsai, 1999)
25 min, followed by addition of 50 µl of 136 mM Purpald® (Sigma-Aldrich) in 2 N 
NaOH. After further incubation for 20 min, 50 µl of 64 mM NaIO4 was added per well 
and the plate was incubated for another 20 min. All reactions took place at room 
colourless adduct purple
77
temperature. The foam generated during the last step was eliminated by addition of 20 
µl of 2-propanol. Absorbance was measured at 550 nm, using a SpectraMax® Plus 384 
plate-reader located at Instituto de Química Orgánica General, Centro de Química 
Orgánica “Lora Tamayo” (CSIC, Madrid, Spain). Standard curves of duplicate samples 
of Kdo, Hep, formaldehyde and 5-N-acetyl-neuraminic acid (Neu5Ac) permitted the 
interpolation of the absorbance values and calculation of the LPS/LOS molar 
concentration, based on the theoretical UTVG number per molecule. 
3.12 Polyacrylamide gel electrophoresis (PAGE) 
Polyacrylamide gel electrophoresis (PAGE) is an analytical technique widely used for 
the separation of biological macromolecules with different electrophoretic mobility. The 
mobility is a function of the size, conformation and charge of the biomolecule. These 
parameters can be controlled by addition of anionic detergents (sodium dodecyl 
sulphate (SDS), sodium deoxycholate (DOC), etc.), reducing agents (dithiothreitol or β-
mercaptoethanol) and other factors (heating, addition of urea, etc.). 
3.12.1 Protein polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein polyacrylamide gel electrophoresis in the presence of SDS (SDS-PAGE) was 
carried out following the Laemmli protocol (Laemmli, 1970), using a Mighty Small II 
SE 250 system (Hoefer Scientific Instruments) associated with a source of variable 
voltage and amperage (EPS 500/400, Pharmacia). Proteins covered with SDS have a 
relatively equal negative charge and their electrophoretic mobility depends mainly on 
their size.  
In order to obtain efficient resolution in the range between 12 and 55 kDa, 
polyacrylamide separating gels were prepared at a 15% total acrylamide concentration 
(%T, total concentration of both acrylamide and bisacrylamide). The concentration of 
bisacrylamide (%C, cross-linker) was 3% of the total acrylamide concentration. 
Stacking gels contained 4% T and 3% C. Protein samples were mixed 1:1 with sample 
buffer, containing 0.05 M Tris-HCl, pH 6.8, 10% glycerol (v/v), 10% SDS (w/v) and 
0.1% (w/v) bromophenol blue, and incubated for 3 minutes at 100 °C before loaded into 
the gel. In the case of electrophoresis under reducing conditions, the buffer also 
contained 0.2 M β-mercaptoethanol. The running buffer was Tris-glycine-SDS buffer, 
containing 25 mM Tris, 192 mM glycine and 0.1% SDS (w/v), and the electrophoresis 
was carried out under constant  amperage (25 mA). Afterwards, proteins were stained 
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with Coomassie Brilliant Blue R-250 (Fluka) at 0.25% (w/v) in methanol/acetic 
acid/water (45:5:50 v/v/v). A protein-standard ladder was used for monitoring the 
electrophoretic mobility of the samples in the low molecular weight range (Bio-Rad). It 
contained phosphorylase b (97.4 kDa), BSA (66.2 kDa), ovalbumin (45 kDa), carbonic 
anhydrase (31 kDa), soybean trypsin inhibitor (21.5 kDa) and lysozyme (14.4 kDa). 
In the case of electrophoresis of bacterial pellets (see section 3.9.1) separating gels were 
prepared at 12% total acrylamide concentration, of which 3% was bisacrylamide. 
Stacking gels contained again 4% T and 3% C, while the loading and running buffers 
were prepared as described above. The prestained 12-protein standard ladder used was 
Protein Marker VI, ranging 10-245 kDa (Panreac). These electrophoreses were run at 
the laboratory of Dr. Junkal Garmendia.
3.12.2 Lipopolysaccharide polyacrylamide gel electrophoresis (DOC-PAGE) 
DOC-PAGE has been selected as the method of choice for the analysis and quantitation 
of NTHi LOS, which is comparable in size to the LPS rough form of other Gram-
negative bacteria. A novel discontinuous Tricine-DOC-PAGE protocol was developed 
and optimised. The system consisted in a separating gel containing 16.5% T, 6% C and 
6 M urea, overlaid by a spacer gel containing 10% T and 3% C, and an upper stacking 
gel with an even bigger pore size (4% T, 3% C) for alignment of all LOS species before 
entering the spacer gel. All gels contained a final DOC concentration of 0.15%, below 
the critical micelle concentration of 0.16%. Five-μl samples were mixed 1:1 with 
sample buffer containing 1% DOC (w/v), 0.1 M Tris-HCl, pH 6.8, 20% glycerol and 
0.1% bromophenol blue (w/v), and directly loaded into the gels without any previous 
incubation. Electrophoresis was performed with two distinct buffers for anode and 
cathode; the anode buffer contained 0.2 M Tris-HCl, pH 8.9, whereas the cathode buffer 
contained 0.1 M Tris Base, 0.1 M Tricine and 0.1% SDS (w/v), pH 8.25. As molecular 
weight marker, the S-form of Salmonella enterica s. minnesota (Sigma) was selected.
LPS/LOS bands were detected by silver staining. To this aim, a sensitive protocol 
combining sugar oxidation and gel sensitisation was optimised. In detail, 
polyacrylamide gels were fixed for 45 min in 100 ml of fixation solution containing 
methanol/acetic acid/milli-Q water (40:10:50 v/v/v). Upon completion of the fixation 
procedure, further 50 ml of fixation solution containing 1.05 g of H5IO6 was added, and 
incubation was continued for another 10 min. Then, the gel was thoroughly washed with 
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milli-Q water, 6 times for 5 min each, and the sensitising agent Na2S2O3 was added at a 
concentration of 0.2 g/l. After 1 min with stirring, the gel was washed with milli-Q 
water twice for 1 min, to remove the excess of ions, and then incubated at 4o C for 45 
min with staining reagent, containing 0.1% AgNO3 (w/v) and 0.028% formaldehyde. 
All the described incubation and washing steps were carried out under continuous 
shaking. Following a 30-s wash with milli-Q water, alkaline developer containing 3% 
K2CO3 (w/v), 0.05% formalin and 10 mg/l Na2S2O3 was added. Once LPS bands were 
satisfactorily revealed (usually after 5-10 min) the reaction was stopped by addition of 
5% acetic acid. Finally, gels were thoroughly washed with milli-Q water for at least 30 
min and LPS bands were quantitated by densitometry using the UNSCAN-it-gel v6.1 
software (Silk scientific), after scanning the gels with a Perfection 3200 Photo scanner 
(EPSON). 
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RESULTS
We cannot solve our problems with the same 
thinking we used when we created them. 
Albert Einstein
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4.1 Glycosylation patterns of pathogenic bacteria as self and non-self markers for 
endogenous lectins 
Bacterial surfaces are coated with a variety of carbohydrate-rich structures that usually 
serve to typify strains (Peterson and Quie, 1981; Hsu et al., 2006; Kilcoyne et al., 
2014). The accessibility and density of glycans on the bacterial surface make them key 
targets for recognition by host lectins and/or soluble molecules, for triggering defence 
responses or as mechanism exploited by the pathogen for both immune escape and 
adherence to, and invasion of host cells (Sahly et al., 2008; Davicino et al., 2011; 
Kumar et al., 2011). In this Thesis, a combined designer’ microarray and QCM 
approach was developed for the analysis of carbohydrate-mediated interactions directly 
on the bacterial surface, thus preserving the native environment, distribution and 
vicinity of the glycan targets (Kalograiaki et al., 2016). 
Bacteria microarrays were previously developed in our group using Klebsiella 
pneumoniae as model (Campanero-Rhodes et al., 2015). This is a carbohydrate-rich 
Gram-negative bacterium that displays a polysaccharidic capsule and an O-chain-
containing LPS on its surface.  Here we have examined the usefulness of the bacteria 
microarray approach for the study of other bacteria displaying a different repertoire of 
surface carbohydrate structures. This is the case of nontypeable Haemophilus influenzae
(NTHi), which is a common source of upper respiratory infection, primary causative 
agent of pediatric otitis media, and also associated with chronic obstructive pulmonary 
disease (COPD) exacerbation in adult patients (Agrawal and Murphy, 2011). NTHi is 
not capsulated and displays a much simpler LPS that does not contain repetitive O-
antigen, called LOS (described in section 1.2). LOSs are major virulence factors and are 
characterised by the capacity of incorporating host-“mimicking” epitopes, thereby 
offering pathogens an advantage in their survival and interplay with the host. Several 
other important pathogens of the upper respiratory tract, including Neisseria, Moraxella
and Bordetella spp., also present LOSs with oligosaccharide structures limited to 10 
units (Preston et al., 1996). Thus, NTHi serves as archetype for exploring the 
applicability of bacteria microarrays to a relevant class of human pathogens. In addition, 
novel QCM bacteria-based biosensors were developed, also using NTHi as model. 
The glycosylation patterns of different NTHi strains were examined in the microarray 
set-up using a panel of lectins with diverse carbohydrate-binding specificities. In 
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addition, binding kinetics for representative NTHi-lectin pairs was investigated using 
the newly developed QCM bacteria-based chips. The LOS was shown to be a target for 
some lectins, and in two selected cases the recognized epitopes were defined at atomic 
level using NMR-STD experiments. Moreover, the recognition of NTHi by different 
innate immunity lectins was explored. Finally, a pilot study of the influence of selected 
endogenous lectins on the microbial viability in vitro and on the bacterial potential for 
adhesion and invasion in cell culture, was carried out. 
4.1.1 Preparation and validation of NTHi arrays 
For the initial preparation and validation of NTHi microarrays, the NTHi strain 375 
(hereafter referred to as NTHi375), a clinical isolate from otitis media, was selected. 
This strain is highly transformable (Maughan and Redfield, 2009), its whole genome 
and methylome is available (Mell et al., 2014), and its LOS structure (Fig. 4.1) has been 
determined by mass spectroscopy (Bouchet et al., 2003). More important, a library of 
isogenic mutant strains bearing disruption of single genes involved in LOS biosynthesis, 
therefore expressing sequentially truncated LOS, was available (Morey et al., 2013), 
what should facilitate the identification of epitopes recognised by the tested lectins. 
As illustrated in Fig. 4.1, genes disrupted in the mutant library included opsX, encoding 
a heptosyltransferase adding the first L-glycero-D-manno-heptose to Kdo (Gronow et 
Fig. 4.1 LOS structure proposed for NTHi375 (Bouchet et al., 2003)
Genes of interest are highlighted in light pink, with arrows indicating their point of action. The major 
glycoform (Hex4) bears the Hep inner core and four Hex moieties with Gal II at the non-reducing end. 
Sialylated species, with one or two Neu5Ac residues, represent a total of ~14% (Fox et al., 2006).
Abbreviations: GlcN, glucosamine; PEtn, phosphoethanolamine; Hep, heptose; Glc, glucose; Gal, 
galactose; PCho, phosphorylcholine; OAc, O-acetyl; P, phosphate.
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al., 2005); lgtF and lpsA, encoding glycosyltransferases responsible for adding Glc I 
and II to Hep I and III respectively (Hood et al., 2004); and lic2A, a phase-variation 
regulated gene encoding a glycosyltransferase that adds Gal as part of a lactose epitope. 
Of note, NTHi can capture host-derived 5-acetyl-neuraminic acid (Neu5Ac) from its 
media and incorporate it into its LOS as terminal sugar residue (Bouchet et al., 2003), 
mono- and di-sialylated species having been reported to represent 9% and 5% 
respectively of NTHi375 LOS species (Fox et al., 2006). The siaB gene encodes a 
synthetase that catalyses the formation of CMP-Neu5Ac, the nucleotide sugar donor 
used by NTHi sialyltransferases (Hood et al., 1999). Consequently, the siaB gene-
disrupted mutant does not display sialylated carbohydrate structures. For mutant 
designation, the symbol Δ is used to indicate disruption of the respective gene, e.g.
ΔsiaB.
NTHi375 and selected mutant strains were fluorescently labelled with SYTO-13® and 
printed onto nitrocellulose-coated glass slides as triplicates at four different dilutions. 
Fluorescence signals of printed bacteria were reliably detectable, and showed the 
expected concentration-dependent trend (Fig. 4.2, left panel).  
For validation of the NTHi microarrays, the binding of a rabbit polyclonal anti-NTHi 
serum, raised against a mixture of acetone-killed NTHi strains 375, 398 and 2019 
NTHi375
ΔlgtF
Δlic2A
ΔlpsA
ΔlgtFΔlpsA
ΔopsX
1  2  3  4 1  2  3  4
Bacteria dilution Bacteria fluorescence x 10-3
2.0  2.5 3.0  3.5 4.0  4.5
Fig. 4.2 Binding of rabbit polyclonal anti-NTHi serum to NTHi arrays
Left panel, Slides scanned for SYTO-13® fluorescence: bacteria were printed in triplicate at concentrations 
1 to 4, corresponding to OD600 of 1, 0.6, 0.3 and 0.1, respectively. Middle panel, Slides scanned after 
overlay for AF647 fluorescence. Right panel, normalised binding intensity: wild type NTHi375 (), and 
mutants ΔlgtF (), Δlic2A (), ΔlpsA (), ΔlgtFΔlpsA ( ), and ΔopsX (). Fluorescence signals of 
printed bacteria were normalized to wild type NTHi375, taking into account the labelling efficiency. Data 
shown correspond to the mean of two different experiments and error bars indicate the standard deviation. 
Fluorescence intensity values are expressed in relative fluorescence units (rfu).
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(Morey et al., 2011), was examined. All strains tested were bound by the anti-NTHi 
serum in a dose-dependent manner, proving accessibility of the recognised epitopes 
(Figure 4.2, middle and right panels).  
Worth to mention, truncation of the Hep I ramification of the LOS (ΔlgtF) alone, or 
with simultaneous truncation of the Hep III ramification (ΔlpsA), seemed to favour 
recognition, suggesting an increase in epitope(s) exposure. Although the precise 
epitopes recognized by the anti-NTHi serum are not known, it seems likely that 
recognition of exposed domains of the immunogenic outer membrane proteins P1, P5, 
HMW or Hap could be enhanced in these mutant strains (Winter and Barenkamp, 2003; 
Euba et al., 2015; Tchoupa et al., 2015). Thus, having proved the efficiency of NTHi 
microarrays for detecting binding of soluble molecules, the way was paved to the 
analysis of bacterial surface features, as e.g. availability of carbohydrate epitopes for 
lectin recognition.  
4.1.2 Profiling of accessible glycan chains on the surface of NTHi375
To explore the sugar presence and accessibility on the surface of the printed bacteria, 
we first examined the binding to NTHi375 of a panel of 19 biotinylated lectins of 
known binding specificities (see Table 3.2 for details). Notable differences in the 
binding were found (Fig. 4.3, upper panel), evidencing the unavailability of ligands with 
the appropriate structure/accessibility for meaningful recognition by some of the tested 
lectins, such as e.g. LEL, PSA or HHL. This was supported by the fact that these lectins 
strongly bound to the proper control glycoproteins also printed in the arrays but not to 
non-glycosylated RNase A, thus proving out to be functional. 
For all of the lectins, the specificity of the binding was assessed in parallel assays 
carried out in the presence of the suitable hapten for each lectin (Table 3.2). Again, 
noteworthy differences in the inhibitory potential of the tested sugars were observed 
(Fig. 4.3, upper panel). No inhibition was observed for DSL or LPA, and only low 
inhibition was detected for GSL-IB4, GSL-I, PNA, HPA or GNA. This behaviour could 
derive from a very strong carbohydrate-mediated binding of these lectins to components 
of the bacterial surface, including the peptidoglycan (terminal GlcNAc) (Burroughs et 
al., 1993), but it could also reflect the occurrence of non-carbohydrate-mediated 
interactions. In contrast, the binding of 9 lectins, namely VAA, RCA, MAL-I, SBA, 
WFA, WGA, PSqL, SNA and ConA, was inhibited to a moderate/large extent. As 
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consequence, the pattern of hapten-inhibitable lectin binding (Fig. 4.3, lower panel) 
clearly differed from that of total binding. The results unambiguously revealed the 
presence of carbohydrate structures on the bacterial surface specifically recognised by 
the lectins, hinting at the presence of certain epitopes as described below. 
The noticeable binding of the Gal-specific lectins VAA and RCA evidenced the 
availability of Gal-containing structures, and binding of MAL-I pointed to the presence 
of the lactose epitope (Geisler and Jarvis, 2011), which could also account, at least in 
part, for WFA binding (Kurokawa et al., 1976). Finally, the sialic acid-binding WGA, 
PSqL and SNA revealed the availability of Neu5Ac for lectin binding (Monsigny et al., 
1980; Shibuya et al., 1987; Mo et al., 2000). Of note, both Gal and Neu5Ac residues are 
integral constituents of NTHi375 LOS (Fig. 4.1), which also contains Glc and L,D-
hepto-mannose residues, suggested to serve as docking points for ConA (Goldstein et 
al., 1965; Baenziger, 1985; Jaipuri et al., 2008). Hence, the LOS could be a prevalent 
target for these lectins, prompting us to analyse their binding to our library of mutant 
strains expressing a sequentially truncated LOS.  
Fig. 4.3 Binding of reference lectins to NTHi375
NTHi375 was printed in triplicates at concentrations corresponding to OD600 = 1 and binding of 
biotinylated lectins was assessed by incubation with AF647-streptavidin. Upper panel: Lectin binding to 
the NTHi arrays in the absence (white) and presence (blue) of the respective lectin hapten (Table 3.2). 
Lower panel: hapten-inhibitable binding calculated from data shown in the upper panel. The horizontal 
line marks the threshold for significant specific binding (fluorescence intensity 1 × 103 rfu).
Fluorescence intensity values are expressed in rfu. Data shown correspond to the mean of at least two 
different experiments. Error bars indicate the standard deviation of the mean.
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4.1.3 Glycotyping of NTHi375 mutants: the effect of LOS truncation
Those lectins that exhibited hapten-inhibitable binding to NTHi375, in terms of 
fluorescence intensity, of 1 × 103 rfu or above (denoted by the horizontal line in Fig. 
4.3, lower panel) were selected for extended study. As illustrated in Fig. 4.4, LOS 
truncation had differential consequences on lectin binding. The shortest truncations, as 
those found in ΔsiaB, ΔlgtF and Δlic2A strains, had disparate lectin-specific 
consequences, with both reduced and enhanced binding compared to NTHi375 (Fig. 4.4 
and Table 4.1), whereas deletion of the Hep III ramification (ΔlpsA) resulted in 
decreased binding for many lectins, and the most truncated mutants, lacking the outer 
core (ΔlgtFΔlpsA) or even all core sugars (ΔopsX) showed a moderate to strong drop in 
the binding of most lectins.  
A close view to each mutant background and the lectins’ specificities helped to explain 
the binding patterns here revealed. Starting with NTHi375ΔsiaB, this mutant strain does 
not express the enzyme responsible for the synthesis of the CMP-Neu5Ac donor. 
Consequently, its LOS, as well as any other carbohydrate structure of the bacteria, 
cannot be sialylated. Consistently, the binding of the Neu5Ac-specific lectins WGA, 
PSqL and SNA decreased significantly. The capability of these lectins to recognise 
other sugar epitopes, as e.g. GlcNAc for WGA (Monsigny et al., 1980) or lactose for 
PSqL (Mo et al., 2000) and SNA (Nsimba-Lubaki et al., 1986), could account for their 
remaining binding to the sialylation-defective mutant. Contrariwise, the absence of 
Neu5Ac residues masking Gal or GalNAc groups might explain the significant increase 
Mutant strain
Lectin
ΔsiaB ΔlgtF Δlic2A ΔlpsA ΔlgtFΔlpsA ΔopsX ΔompP5
VAA
RCA
MAL-I 
SBA
WFA
WGA
PSqL
SNA
ConA
> 150 % 150 – 115 115 – 85 85 – 50 50 – 25 < 25 %
Fig. 4.4 Relative binding strength of selected reference lectins to NTHi375 wild type and mutant
strains. Binding of biotinylated lectins to NTHi375 wild type and mutant strains printed onto NC-coated 
glass slides was assessed simultaneously, and the relative binding strength was calculated as percentage 
taking for each lectin the binding to wild type NTHi375 as 100%. Detailed data are given in Table 4.1.
89
in the binding of SBA, RCA and VAA. A similar shielding effect of sialic acid on the 
binding of SBA was repeatedly reported in cell binding and histochemical studies 
(Takahashi, 1992; Abe et al., 1996). Moreover, it is considered that substitutions at 
position 3´ of Gal, as those found in the minor, α(2,3)-sialylated isoform of NTHi375 
LOS, may abolish RCA and VAA binding because this is a key position for Gal 
recognition (Solís et al., 1993; Jiménez et al., 2008). In contrast, MAL-I tolerates 
substitutions at position 3´, sialylation or sulphation even increasing the binding affinity 
(Geisler and Jarvis, 2011), thus explaining that no increase in the binding to ΔsiaB was 
observed for this lectin, a behaviour also exhibited by WFA.  
Besides the LOS, other Gal-containing structures on the bacterial surface could serve as 
lectin docking points. Indeed, the lectin-binding pattern to NTHi375Δlic2A, lacking the 
proximal β-Gal in the Hep III ramification (Gal I, Fig. 4.1), is difficult to rationalise 
without considering recognition of other carbohydrate structures. Thus, although 
binding of VAA to Δlic2A was decreased compared to the wild type strain, no 
significant alteration was observed in the case of RCA, MAL-I or WFA.  
An intricate lectin-binding pattern was also observed for NTHi375ΔlgtF, lacking the 
glycosyltransferase responsible for adding Glc to Hep I. Here, binding of VAA and 
SBA was enhanced, what could be tentatively explained by an increase in accessibility 
of the Hep III extension carrying Gal, a trait also observed for the anti-NTHi serum 
(Fig. 4.2). However, recognition by the other Gal-specific lectins (RCA, MAL-I and 
WFA) was decreased. Of note, ΔlgtF was found to exhibit an altered behaviour 
compared to the wild type strain in terms of resistance to antimicrobial peptides, biofilm 
Table 4.1. Binding of selected reference lectins to NTHi375 mutant strainsa
Lectin
NTHi375 mutants
ΔsiaB ΔlgtF Δlic2A ΔlpsA ΔlgtFΔlpsA ΔopsX ΔompP5
VAA 156 ± 5 165 ± 6 66 ± 6 38 ± 3 36 ± 1 31 ± 1 257 ± 10
RCA 140 ± 15 70 ± 4 105 ± 3 64 ± 5 32 ± 5 75 ± 15 64 ± 7
MAL-I 92 ± 5 80 ± 6 114 ± 8 55 ± 5 70 ± 4 61 ± 4 226 ± 33
SBA 140 ± 10 250 ± 25 132 ± 7 70 ± 8 76 ± 8 52 ± 3 283 ± 7
WFA 102 ± 5 82 ± 5 110 ± 5 92 ± 4 72 ± 4 44 ± 4 108 ± 8
WGA 47 ± 3 28 ± 3 58 ± 9 42 ± 5 22 ± 3 21 ± 3 59 ± 13
PSqL 80 ± 10 70 ± 10 80 ± 5 36 ± 3 41 ± 3 30 ± 4 72 ± 4
SNA 61 ± 4 45 ± 3 100 ± 6 85 ± 10 54 ± 9 52 ± 3 140 ± 10
ConA 170 ± 15 117 ± 7 140 ± 10 95 ± 4 82 ± 7 106 ± 6 272 ± 37
aPercentage of binding taking for each lectin the binding to wild type NTHi375 as 100%. Data shown 
corresponds to mean values calculated from binding intensities of triplicate samples of at least two different 
experiments to bacteria dilutions at OD600 of 1 and 0.6. Standard deviations of the mean are given.
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growth, and epithelial and lung infection (Morey et al., 2013), evidencing that this 
apparently small LOS truncation results in key phenotypic consequences. The reduced 
biofilm formation by ΔlgtF was particularly unexpected, as sialic acid residues, which 
are supposed to be present in the Hep III extension of ΔlgtF, are known to be important 
for biofilm growth (Swords et al., 2004; Jurcisek et al., 2005). Interestingly, ΔlgtF 
exhibited a significantly decreased binding of the Neu5Ac-specific lectins WGA, PsqL 
and SNA, indicating a lower availability of sialic acid residues for lectin recognition. 
Possible explanations could be a major change in the three-dimensional presentation of 
the LOS upon removal of PCho-Glc at Hep I, or a decrease in the sialic acid content of 
the LOS molecule due to dynamic compensatory changes in response to the truncation. 
The binding pattern of ConA was also complex, with enhanced recognition of ΔsiaB, 
Δlic2A and ΔlgtF mutants, and similar or slightly decreased binding to the mutants with 
the shortest LOS versions (ΔlpsA, ΔlgtFΔlpsA and ΔopsX). Increased ConA binding 
following desialylation was previously reported in histochemical studies (Takahashi, 
1992). The PCho substitution at position 6 of the Glc unit at Hep I, as found in the wild 
type strain, might impede recognition of this Glc by ConA (Goldstein et al., 1965). 
Indeed, ΔlgtF truncation seemed to favour recognition. In this mutant, Hep I is 
displayed as terminal moiety and may serve as possible docking point (Jaipuri et al., 
2008), therefore explaining the increased binding. Hep III, however, being acetylated 
and also substituted by PEtn, is not a likely target and, accordingly, binding to the ΔlpsA
was comparable to that observed for the wild type strain. Furthermore, the small 
differences in binding to the ΔlgtFΔlpsA and ΔopsX strains compared to wild type 
NTHi375 suggest that other surface carbohydrate structures, besides the LOS, must be 
recognised. 
Overall, the noticeable effect of deletion of the outer core (ΔlgtFΔlpsA) or all core 
sugars (ΔopsX) on the binding of most lectins supported the notion that the LOS could 
serve as lectin target. This idea was further nourished by the results obtained for the 
binding of the selected lectins to an isogenic NTHi375 mutant lacking P5, an outer 
membrane immunogenic protein that favours adhesion to mucosae (Miyamoto and 
Bakaletz, 1996) or mucin structures (Reddy et al., 1996). In accordance, the ΔompP5
NTHi375 mutant was found to present impaired adhesion to epithelial cells and 
subsequent invasion (Euba et al., 2015). Previous blotting analysis with the anti-PCho 
monoclonal antibody TEPC-15 had revealed more intense marks for ΔompP5 over wild 
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type NTHi375 colonies (personal communication of Dr. Junkal Garmendia), hinting at a 
higher PCho content in this mutant and, therefore, LOS expression, as PCho is a 
constituent of NTHi375 LOS (Bouchet et al., 2003). And indeed, the amount of LOS 
isolated from ΔompP5 was significantly higher than that obtained from wild type 
NTHi375 (see section 4.1.5.1). As illustrated in Fig. 4.4 and detailed in Table 4.1, a 
moderate drop in the binding was observed for RCA, WGA and PSqL upon disruption 
of the ompP5 gene, and no significant effect on WFA was found. However, the binding 
of SNA, and to a larger extent of VAA, MAL-I, SBA, and ConA to the ΔompP5 mutant 
was substantially increased compared to wild type NTHi375. 
4.1.4 QCM bacteria-based biosensors: monitoring lectin binding kinetics directly 
on the bacterial surface
To confirm lectin recognition and strain-specific binding trends using a complementary 
approach, a novel application of the QCM technology was developed. RCA, WGA and 
ConA were selected as representative lectins with Gal, sialic acid/GlcNAc, and 
Man/Glc binding specificities, respectively. Wild type NTHi375 and the ΔlgtFΔlpsA
mutant were selected as reference strains, the latter showing in general the weakest 
binding signals for the tested lectins (Table 4.1). This new QCM approach was expected 
to provide additional insights into the interactions occurring at the bacterial surface, 
including information on binding kinetics, as successfully done previously for lectin 
binding to the eukaryotic cell surface (Pei et al., 2012; Peiris et al., 2012; Li et al., 
2013; Li et al., 2015). The concept and development of QCM bacteria-based chips is 
described in detail in section 3.6.1. Based on the fairly comparable binding of ConA to 
NTHi375 and the ΔlgtFΔlpsA mutant in the microarray assays (Table 4.1), this lectin 
was selected as bacteria capturer.  
ConA covalently immobilised on activated LNB-carboxyl QCM chips via amine 
coupling was previously found to be operative for ex situ capture of cancer cells through 
recognition of cell surface carbohydrates (Li et al., 2013), supporting the applicability 
of our setup. Bacteria cells were thus captured onto the surface of ConA-derivatised 
QCM chips and fixed in formaldehyde, so that they become an integrated part of the 
sensor chip. Fixation is key to allow the use of efficient regeneration solutions for 
completely removing bound lectins between successive binding assays. Regeneration of 
non-fixed mammalian cell chips following lectin-binding assays using a high 
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concentration of a competitive sugar had been reported (Li et al., 2013; Li et al., 2015). 
Still, the use of this cell chip was limited to a few injection cycles. Furthermore, cell 
outflow might occur if the sugar can also compete with the capturing-lectin–cell 
interaction. In contrast, the formaldehyde-fixed ConA-bacteria chips here developed 
could be completely regenerated using a pulse injection of 10 mM glycine, pH 1.2, 0.5 
M NaCl, were stable for more than 50 injection cycles, and could be stored at 4 ºC for 
further use (Kalograiaki et al., 2016). 
Bacteria coverage of the chip surface before and after the binding assays (Fig. 4.5, a and 
b) was assessed by DAPI staining of nucleic acids and fluorescence microscopy, 
showing a widespread capture of cells 
over the entire surface and proving 
retention of the bacteria after injection 
and regeneration cycles. Furthermore, 
lectin binding to the immobilized 
bacteria was visualised by fluorescence 
microscopy following ex situ incubation 
with FITC-ConA, evidencing the 
availability of ligands for ConA on the 
bacterial surface all over the chip (Fig. 
4.5, c). 
Having confirmed the efficiency of ConA-derivatised chips for bacteria capturing, the 
stability of the formaldehyde-fixed ConA-bacteria chips and their applicability for lectin 
binding studies, we examined the interaction of RCA, WGA and ConA with NTHi375 
and ΔlgtFΔlpsA chips. After stabilisation of the resonant frequency under continuous 
flow of running buffer, lectins were injected in a range of increasing concentrations. 
Examples of the recorded sensograms are shown in Fig. 4.6. 
Strain- and lectin-specific responses were clearly observed. A first parameter deserving 
attention was the maximum frequency shift induced by injection of each lectin, –Δf 
(Table 4.2). The amplitude of the response was proportional to the amount of lectin 
bound to the chip at the end of the injection, as well as to the molecular mass of the 
respective lectin. Since all three lectins were tested on the same surfaces (i.e., against 
Fig. 4.5 Fluorescence microscopy evaluation of 
the wild type 375 chip. Bacteria coverage of the 
chip surface was evaluated before (a) and after (b) 30 
lectin-binding and regeneration cycles by ex situ
DAPI staining and visualization using fluorescence 
microscopy; (c) FITC-ConA binding to the bacteria 
chips after the lectin binding assays.
(a) (b)  (c)
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the same amount of bacteria on the chip), the frequency shift can be used to compare 
lectin binding to each chip after normalisation for the lectin molecular mass.  
As detailed in Table 4.2, WGA and especially RCA bound to the NTHi375 chips to a 
significantly greater extent than ConA. Of note, the observed trend was analogous to 
that found for the hapten-inhibitable binding in the microarray assays (Fig. 4.3, lower 
panel). Interestingly, ConA binding to the QCM chips was completely abolished when 
Fig. 4.6 Representative sensograms illustrating the binding of RCA, WGA, and ConA to NTHi375 
and ΔlgtFΔlpsA. Lectins were injected at the following concentrations: 0.3, 0.6, 1.25, 2.5 and 5 μg/ml for 
RCA; 6.25, 12.5, 25, 50 and 100 μg/ml for WGA; and 10, 60, 90, 100 and 150 μg/ml for ConA. The black 
lines in the sensogram represent experimental data, and the red lines the fits obtained using 1:1 (RCA) or 
1:2 (ConA and WGA) models. In the competition experiments (bottom panels), the binding of ConA at 
concentrations of 100 and 150 µg/ml was examined after pre-incubation of the lectin with
0.2 M α-Me-Man for 1 h before injection.
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 the lectin was pre-incubated with 0.2 M α-Me-Man before injection (Fig. 4.6), proving 
that the monitored interactions were carbohydrate-dependent. Binding of ConA to the 
NTHi375 arrays, however, was only inhibited to a small extent in the presence of this 
hapten, suggesting that after the primary carbohydrate-mediated interaction detected in 
the dynamic QCM analysis, further interactions are established at the longer contact 
times of the static microarray binding assays. 
Compared to NTHi375, the binding of RCA and WGA to ΔlgtFΔlpsA chips was 
noticeably smaller (41% and 33%, respectively, of the binding to the wild type strain), 
whereas for ConA a small increase (33%) in the –Δf values was observed (Table 4.2). 
Therefore, the lower –Δf induced by injection of RCA and WGA over the mutant chips 
should be ascribed to a different availability on the bacterial surface of carbohydrate 
structures recognised by each lectin rather than to a lower bacteria content. What is 
more, the observed trend was again analogous to that found in the microarray binding 
Table 4.2 QCM analysis of the binding of RCA, WGA and ConA to NTHi375 wild type and
ΔlgtFΔlpsA strains
Parameter
RCA WGA ConA
NTHi375 ΔlgtFΔlpsA NTHi375 ΔlgtFΔlpsA NTHi375 ΔlgtFΔlpsA
–Δf (Hz) 47 ± 1.5 19.5 ± 1.5 12 ± 1 4.01 ± 0.02 3.14 ± 0.02 4.45 ± 0.07
Normalised
–Δf (Hz kDa-1) 0.39 0.16 0.33 0.11 0.03 0.04
ka1 (M-1 s-1)
1.75 ± 0.01
× 105
1.19 ± 0.01
× 105
2.15 ± 0.06
× 104
4.2 ± 0.1
× 104
2.01 ± 0.05
× 104
2.8 ± 0.4
× 104
kd1 (s-1)
8.76 ± 0.02
× 10-7
6.29 ± 0.05
× 10-5
8.99 ± 0.01
× 10-4
1.63 ± 0.01
× 10-3
2.2 ± 0.1
× 10-4
3.4 ± 0.1
× 10-3
KD1 (M)
5.0 ± 0.1
× 10-12
5.29 ± 0.01
× 10-10
4.2 ± 0.1
× 10-8
3.88 ± 0.01
× 10-8
1.1 ± 0.7
× 10-8
1.2 ± 0.2
× 10-7
ka2 (M-1 s-1) — — 4.6 ± 0.1× 104
1.5 ± 0.15
× 104
5.25 ± 0.4
× 104
4.6 ± 0.2
× 104
kd2 (s-1) — — 3.88 ± 0.01× 10-2
4.62 ± 0.01
× 10-2
2.1 ± 0.1
× 10-2
4.7 ± 0.15
× 10-2
KD2 (M) — — 8.4 ± 0.2× 10-7
3.1 ± 0.3
× 10-6
4.0 ± 0.01
× 10-7
1.0 ± 0.1
× 10-6
The association rate (ka), dissociation rate (kd) and dissociation constant (KD) are derived from the fitting of the 
experimental data to 1:1 (RCA) or 1:2 (WGA and ConA) models. Frequency shifts were recorded upon injection 
of 5 μg/ml of RCA, 100 μg/ml of WGA or 150 μg/ml of ConA. Molar concentrations were calculated 
considering molecular masses of 120 kDa for RCA, 36 kDa for WGA, and 104 kDa for ConA. Normalised –Δf
values were calculated by dividing –Δf by the molecular mass of each lectin. Standard deviations of mean values 
are given.
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assays, with ConA being the less affected by the outer core truncation and WGA the 
most (Fig. 4.6 and Table 4.2). At any rate, frequency shifts achieved were higher than 
0.9 Hz (also see Fig. 4.6, WGA), defined as the lowest –Δf detection limit for Attana 
QCM-chips bearing crystals of 10 MHz-nominal frequency and circular electrodes 
(Anderson et al., 2007). This permitted the safe calculation of kinetic parameters (ka and 
kd).  
For calculation of the kinetic parameters (ka and kd), the experimental data were fitted 
using 1:1 or 1:2 binding models. The first model was found suitable for fitting the 
binding profiles of RCA (Fig. 4.6 and Table 4.2). Its binding kinetics to the wild type 
strain was characterised by a relatively fast association rate (in the range of 105 M-1 s-1) 
and an extremely slow dissociation rate, in the order of 10-7 s-1. This kd indicates the 
formation of an extremely stable complex that does not dissociate over the time frame 
of the experiment, leading to a very high binding affinity, in the picomolar range. Worth 
to be mentioned, dissociation rates in the range of 10-7 s-1 or slower require extremely 
long measurement times to observe a significant shift in the dissociation phase, making 
these strong binding events difficult to quantitate. In comparison, the association rate to 
ΔlgtFΔlpsA (Table 4.2) was similar, but dissociation was 100-fold faster, resulting in a 
proportionally lower binding affinity.  
On the other hand, a 1:2 model was required for fitting the experimental data obtained 
for WGA and ConA (Fig. 4.6), what could indicate different accessibilities of the bound 
target due to specific micro-environments, uneven clustering of the target on the 
bacterial surface, locally favouring multivalent interactions, or even binding to different 
targets with dissimilar binding affinities. The rather broad nominal binding-specificity 
of these two lectins, which are able to recognise different monosaccharides (sialic acid 
and GlcNAc for WGA; Glc, Man and manno-Hep for ConA) makes the existence of 
multiple targets highly likely. 
The difference in affinity between the two sets of binding sites on the surface of both 
NTHi375 and ΔlgtFΔlpsA primarily arose from a faster dissociation rate from the low-
affinity sites, with kd values on the order of 10-2 s-1, whereas the ka values for both low- 
and high-affinity sites were in the range of 104 M-1 s-1 (Table 4.2). However dissociation 
rates for the high-affinity sites were faster for ΔlgtFΔlpsA compared to the wild type 
strain, resulting in a lower binding affinity of both WGA and ConA towards the mutant. 
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The KDs calculated from the kinetic parameters were around 10-6 M for the low-affinity 
sites of WGA and ConA, and ranged from 10-7 to 10-8 M for the high-affinity sites, 
while for RCA KD values in the order of 10-10-10-12 M were obtained. Although these 
affinities are noticeably higher than those exhibited by these lectins when binding to 
purified glycan structures, they are comparable to those reported for the binding to cell 
surfaces. As example, KD values in the 10-7-10-9 M range were determined by QCM for 
the binding of RCA, WGA, ConA and other lectins to a diversity of cancer cells (Peiris
et al., 2012; Li et al., 2013; Li et al., 2015). It seems reasonable to presume that the 
complex mixture and density of epitopes displayed on the cell surfaces may favour the 
establishment of high-affinity interactions. In contrast, KD values in the 10-4 to 10-5 M 
range were also determined for the binding of HPA and Ulex europaeus agglutinin I to 
certain cancer cells (Peiris et al., 2012), evidencing that high-affinity interactions are 
lectin- and cell-specific. Similarly, the binding affinities here determined for the binding 
of RCA, WGA, and ConA to NTHi375 and ΔlgtFΔlpsA were lectin- and strain-specific, 
the three lectins exhibiting a higher affinity for the wild type strain than for the mutant 
(Table 4.2).  
Overall, the results of the QCM analysis fully agreed with the binding trends observed 
in the microarray analysis, supporting the utility of the microarray-based approach to 
assess accessibility for lectin recognition of carbohydrate structures on the surface of 
NTHi.  
4.1.5 Evaluation of lectin binding to the isolated NTHi375 LOS 
Prompted by the results of the bacteria-based microarray and QCM analyses, hinting at 
the LOS as likely target for many of the tested lectins, we examined the binding of the 
lectins to the isolated LOS using microarray and NMR approaches.  
4.1.5.1 LOS quantitation and validation of LOS microarrays 
As mentioned before (section 4.1.3), NTHi375ΔompP5 was suspected to overexpress 
LOS based on a higher reactivity of this mutant towards the anti-PCho antibody TEPC-
15. Therefore, the LOSs of NTHi375 wild type and ΔompP5 mutant strains were 
extracted (described in section 3.2) and quantified by a combination of the Purpald 
assay (Fig. 4.7, a) and densitometry of LOS bands upon DOC-PAGE electrophoresis 
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and silver staining (Fig. 4.7, b), following an optimised protocol. S. minnesota smooth 
and Rb LOSs were used as reference.  
Although batch-to-batch variations in the relative yields of the isolated LOS were 
observed, the estimated quantity of LOS extracted from the ΔompP5 mutant was always 
significantly higher than that extracted from a wild type NTHi375 culture of equal 
biomass. As ΔompP5 is an isogenic mutant of NTHi375 that keeps unaltered the 
enzymatic machinery involved in LOS biosynthesis, their LOSs are expected to be 
structurally identical. Consequently, the higher yield in LOS extraction from ΔompP5
cannot derive from a differential partition index in the extraction media due to structural 
divergences, directly pointing to a higher LOS expression in this mutant compared to 
wild type NTHi375. Thus, 
apparently, deletion of this major 
outer membrane protein results in 
LOS overexpression, probably due 
to compensatory changes in the 
bacterial surface.  
LOSs extracted from wild type and 
ΔompP5 NTHi375 were printed in 
manual microarrays along the S. 
minnesota Rb LOS as control, and 
the utility of the arrays for 
detecting recognition by LOS-
Fig. 4.7 Quantitation of the LOS isolated from NTHi375 wild type and ΔompP5 mutant strains. (a)
Colorimetric quantitation by the Purpald assay. LOS dilutions from the stock solution are indicated (in 
duplicates). (b) Electrophoretic profiles of the isolated LOSs; Sample loaded: (i) 1 μg, (only shown the 
two lower Mw bands); (ii) 1 μg, single band; (iii) 0.7 μg; (iv) 2 μl stock; (v) 1 μl stock; (vi) 2 μl (dil 1:10); 
(vii) 2 μl (dil 1:20); (viii) 2 μl (dil 1:30). 
Fig. 4.8 Anti-lipid A binding to manually printed LOS 
microarrays. Each LOS was printed in decreasing 
concentrations as sextupliclates. Concentrations refer to  
the dilution of the stock solution. 
(b)(a) 
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binding molecules was examined by testing the binding of a polyclonal antibody against 
E. coli O157-lipid A (Lee et al., 2004), of common structure with NTHi-lipid A 
(Helander et al., 1988; Risberg et al., 1999; Garmendia et al., 2014). Salmonella-lipid A 
also shares structural features (Qureshi et al., 1985) with NTHi-lipid A – both contain 
(14:0) myristate chains (frequently hydroxylated at position 3’) and are phosphorylated 
at position 4’ of the non-reducing GlcN. 
As shown in Fig. 4.8, arrayed NTHi LOSs were recognized efficiently by the antibody. 
Moreover, fluorescence signals observed for the ΔompP5 LOS were stronger, in line 
with the quantitation results (Fig. 4.7).  
4.1.5.2 Lectin binding to LOS microarrays 
As already mentioned, the LOS of ΔompP5 should be structurally identical to that of the 
wild type strain. Therefore, since the amount of LOS isolated from wild type NTHi375 
was very limited, the ΔompP5 LOS was used to investigate the binding of the panel of 
selected lectins. Microarray data (Fig. 4.9) indicated direct LOS binding of weak to very 
strong intensity for WGA, ConA, and VAA. In all cases, the binding was carbohydrate-
mediated, as it was inhibited in the presence of the appropriate hapten. The weak 
binding observed for WGA could be attributed to the recognition of the minor sialylated 
LOS glycoforms, what would be supported by the significant drop in WGA-binding to 
the entire bacteria upon disruption of the siaB gene. The N-acyl GlcN residues of lipid 
A, which are expected to be more accessible in the isolated LOS than on the intact 
bacterial surface, might also serve 
as docking points. The binding of 
ConA indicates that Glc and/or 
manno-Hep residues within the 
LOS can be recognized by this
lectin. Regarding VAA, recognition 
of the terminal α-Gal moiety,
present in the major LOS 
glycoform as part of a globotriose 
in the Hep III extension, could 
account for the strong binding of 
this lectin.
Fig. 4.9 Recognition of ΔompP5 LOS by reference 
lectins. The LOS was printed at a concentration of 1 mg/ml
and the binding of the lectins was tested in the absence 
(blue) or presence (orange) of their competitive hapten.
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Of note, no binding of RCA to the LOS microarrays was detected. Indeed, although 
VAA and RCA exhibited noticeable binding to NTHi375, evidencing the availability of 
galactose-containing structures on the bacterial surface, LOS truncation had disparate 
consequences on the binding of the two lectins (Fig. 4.4). In particular, binding of VAA 
to the Δlic2A mutant, lacking Gal in the LOS, was importantly decreased compared to 
the wild type strain, while this truncation had no significant effect on RCA binding. 
Furthermore, the binding of VAA to the ΔompP5 mutant, here found to overexpress the 
LOS, was substantially increased compared to the wild type strain, whereas a drop in 
the binding was observed for RCA (Fig. 4.4 and Table 4.1). Altogether, the results 
strongly indicate that VAA and RCA recognise different ligands on the bacterial 
surface. At this point it is important to mention that both VAA and RCA are galactose-
specific (AB)2-type agglutinins that show a high structural homology but also exhibit 
different fine-oligosaccharide binding specificities. In particular, VAA is able to bind 
both α- and β-galactosides (Lee et al., 1992), whereas RCA shows a clear preference for 
terminal β-Gal (Podder et al., 1974).
The binding of ConA to the LOS microarrays was also fully consistent with the 
increased binding of this lectin to the ΔompP5 mutant compared to wild type NTHi375. 
However, for the rest of lectins, there was no correlation between their binding to LOS 
microarrays and to the entire ΔompP5 bacteria. First, although WGA was capable to 
bind weakly to the isolated LOS, its binding to ΔompP5 was smaller than to wild type 
NTHi375, what could be due to a reduced accessibility to the recognized epitope 
resulting from LOS overexpression. On the other hand, although the binding of MAL-I, 
SBA, and SNA to the ΔompP5 mutant was substantially increased compared to wild 
type NTHi375, no binding to the LOS microarrays was detected for these lectins, 
suggesting that they could recognise other carbohydrate structures on the bacterial 
surface. Still, the possibility that the specific presentation of the LOS upon 
immobilisation in the microarrays might substantially differ from that on the entire 
bacteria and preclude lectin recognition cannot be excluded. Overall, the results stressed 
the importance of examining recognition directly at the bacterial surface, where the 
native environment, density and accessibility of the recognised epitopes are preserved. 
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4.1.6 Comparative analysis of the binding of VAA and RCA to NTHi Rd KW20 
and its transformed Rd hmw1strain12 strain
Altogether, the results above reported strongly indicate that the major ligand(s) 
recognized by VAA and RCA on the bacterial surface are different. Besides the LOS, 
other Gal-containing structures exposed on the surface of NTHi could serve as lectin 
docking points. A relevant candidate is the high molecular weight glycoprotein HMW1, 
which is glycosylated at multiple asparagine residues with N-linked simple glucose and 
galactose moieties or with disaccharide units, the latter only present at sites with 
glucose first linked to asparagine (Grass et al., 2010). In order to evaluate HMW1 as 
possible docking site for VAA and/or RCA, we extended our study to a capsule-
deficient NTHi laboratory strain, Rd KW20 (hereafter to as Rd), which lacks the hmw1
operon (and its paralog hmw2). Direct comparison of lectin binding to NTHi375 and Rd 
strains is not appropriate, since the two strains have a distinct genetic background 
(Hood et al., 2001; Cody et al., 2003). We thus took advantage of the availability of Rd 
hmw1strain12, a transformed Rd strain carrying the hmw1 operon of NTHi strain 12 (also 
known as R2846). This was the prototypic HMW-positive strain in which the 
glycoprotein was originally identified, isolated and sequenced (Barenkamp and 
Leininger, 1992), and most extensively characterised. The HMW1strain12 adhesin shares 
a homology of 93% with that of NTHi375. The binding of VAA and RCA to Rd and Rd 
hmw1strain12 was comparatively examined, starting with the bacteria microarray analysis 
(Fig. 4.10). 
Fig. 4.10 Binding of VAA and RCA to Rd and Rd hmw1strain12 . Different dilutions of Rd (□) and Rd 
hmw1strain12 (■) were immobilised on NC-coated microarray slides, and the binding of the two lectins was 
tested as described before. Normalised fluorescence intensity values are expressed in rfu. Data shown 
correspond to the mean of at least four independent experiments. Error bars indicate the standard 
deviation of the mean.
VAA RCA
101
Binding of VAA to the transformed Rd hmw1strain12 strain was noticeably higher than to 
Rd, what indicates that the HMW1 glycoprotein may also serve as ligand for this lectin 
(Fig. 4.10). In striking contrast, the binding of RCA was significantly lower, suggesting 
that the Gal moieties “decorating” HMW1strain12 are not docking sites for RCA and, 
what is more, that the expression of HMW1 at the bacterial surface even decreases the 
availability of ligands for RCA recognition.  
Following our combined microarray and QCM approach for exploring lectin 
recognition on the bacterial surface, we next performed binding assays of VAA and 
RCA to Rd and Rdhmw1strain12 QCM chips. In all cases, data could be fitted to a one-
class-of-sites model. The parameters obtained for the binding of RCA to Rd and 
Rdhmw1strain12 were similar (Table 4.3). As observed for NTHi375 (Table 4.2), the RCA 
binding kinetics were characterised by relatively fast association rates and extremely 
slow dissociation rates, leading to binding affinities in the picomolar range. For VAA, 
the parameters obtained for the binding to both strains were also similar (Table 4.3), 
with association rates comparable to those observed for RCA. However, dissociation 
rates were significantly faster for VAA, resulting in a lower binding affinity towards 
both Rd and Rdhmw1strain12. 
Noteworthy, the LOS of the Rd strain (Fig. 4.11) is structurally very similar to that of 
NTHi375 (Fig. 4.1). Its major glycoform, representing nearly 60% of LOS forms, 
presents a terminal Lac moiety anchored to Hep III, whereas two additional glycoforms 
bear a terminal αGal(1,4)-linked to Lac, as found in the NTHi375 LOS, or a further 
elongation by addition of β(1,3)-linked GalNAc (Fig. 4.11) (Risberg et al., 1999; Hood
Table 4.3 QCM analysis of the binding of VAA and RCA to Rd and Rd hmw1strain12
Parameter
VAA RCA
Rd Rd hmw1strain12 Rd Rd hmw1strain12
ka (M-1 s-1)
6.71 ± 0.01
× 105
4.42 ± 0.01
× 105
6.47 ± 0.01
× 105
2.7 ± 0.1
× 105
kd (s-1)
4.37 ± 0.02
× 10-4
3.39 ± 0.07
× 10-4
9.55 ± 0.03
× 10-7
2.9 ± 0.5
× 10-7
KD (M)
6.5 ± 0.03
× 10-10
7.67 ± 0.17
× 10-10
1.48 ± 0.01
× 10-12
1.02 ± 0.01
× 10-12
aKinetic values are derived from fitting of the experimental data to 1:1 model for both lectins. Frequency 
shifts were recorded upon injection of 2.5 μg/ml of VAA or RCA. Molar concentrations were calculated 
considering molecular masses of 114 kDa for VAA and 120 kDa for RCA. Standard deviations of mean 
values are given.
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et al., 2001). Thus, the Rd LOS could constitute a ligand for both VAA and RCA. 
Therefore, considering the disparate binding behaviour of VAA and RCA to the isolated 
NTHi375 LOS, as well as the lower binding affinity of VAA towards the Rd strains 
compared to RCA, evidenced by the QCM analysis, a direct comparison of the binding 
of the two lectins to the Rd LOS appeared essential. 
To this aim, the LOS of strain Rd was extracted and quantified, Rd LOS microrrays 
were prepared as described for NTHi375 LOS (section 4.1.5.1), and binding assays with 
RCA and VAA were carried out. Strong and lactose-inhibitable binding of RCA to the 
Rd LOS was observed (Fig. 4.12), proving that the terminal Lac moiety present in the 
major Rd LOS glycoform can serve as docking point for this lectin. In striking contrast, 
only weak binding was observed for VAA. This result was particularly unexpected, as
the major glycoform of the NTHi375 
LOS, to which VAA was found to 
bind very strongly, represents ~19% 
of the Rd LOS. Hence, in order to 
confirm these results and also to get 
further insights into the NTHi375/Rd
LOS epitopes recognized by RCA 
and VAA, a saturation transfer 
difference (STD) NMR analysis of 
LOS binding by the two lectins was 
carried out.
Fig. 4.11 LOS structure proposed for NTHi Rd strain. The major glycoform (Hex3) bears the Hep 
inner core and three Hexp moieties with Gal I at the non-reducing end, representing 59% of total species. 
Minor glycoforms (Hex4 & Hex5) were also detected by ESI/MS and their occurrence was assigned as 
noted (Risberg et al., 1999). Abbreviations generally stand as for Fig. 4.1 for coherence, while GalNAc 
refers to galactosamine.
Fig. 4.12 Binding of VAA and RCA to microarray-
printed Rd LOS. The binding of 74 μg/ml VAA (blue) 
and 8 μg/ml RCA (cyan) was tested in the absence or 
presence of 100 mM lactose (white). Binding intensities 
correspond to the mean of triplicate data and the error 
bars indicate the standard deviation.
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4.1.7 STD NMR analysis of the binding of VAA and RCA to the NTHi375ΔompP5
and Rd LOSs
STD NMR is a sensitive method to study weak to medium interactions (KD in the μM 
range), like those frequently found between glycans and lectins. Moreover, it is very
accurate for identifying the atoms of a ligand in close contact with the receptor in a 
process called ‟ligand epitope mapping” (Mayer and Meyer, 2001). To this aim, 
assignment of the NMR resonances of the ligand is required. Therefore, in order to 
perform an STD NMR analysis of the binding of VAA and RCA to the LOS isolated 
from strains NTHi375ΔompP5 and Rd, we first approached the structural elucidation of 
these LOSs.
4.1.7.1 NMR structural characterisation of NTHi375ΔompP5 and Rd LOSs. 
The 1H-NMR spectra of the isolated LOSs in D2O showed only broad undefined signals 
possibly due to lipid-mediated aggregation or even micelle formation, as previously 
reported for Rd LOS (Risberg et al., 1999). In order to overcome this problem, the LOS 
preparations were hydrolyzed with acetic acid under mild conditions affecting the acid-
labile Kdo‒lipid A linkage, thereby yielding insoluble lipid A and soluble core 
oligosaccharides (OSs) derived from the various LOS glycoforms. The hydrolysis 
resulted in considerable improvement in signal resolution and intensity, giving rise to 
Fig. 4.13 1H-NMR spectrum of the OSs derived from NTHi375ΔompP5 LOS. Acquired in deuterated 
PBS at 310 K with water-signal suppression. The black arrow indicates signals corresponding to the PCho 
methyl protons. The blue arrow indicates those corresponding to the anomeric protons of α-sugars.
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well-defined resonances particularly evident in the anomeric proton region (4.4-5.7 
ppm) of the spectrum, as shown in Fig. 4.13 for ΔompP5 LOS. A notable feature of the
spectra was the intense singlet at 3.25 ppm, attributed to the PCho methyl protons (Fig. 
4.13).
A collection of 1H-13C HSQC, TOCSY and ROESY experiments (Figs. 4.14, 4.15 and 
Annex II) helped to the resolution of signals overlapping in the 1H dimension, and 
enabled the assignment of chemical shifts and coupling constants of the anomeric 
protons (reported in Table 4.4 and Annex II). 
Numerous resonances were visible in the Hep anomeric region of the spectra (Fig. 4.14, 
inset). Indeed, mild acid hydrolysis may result in partial cleavage of PEtn from the Hep 
moieties, elimination of the phosphate group from position 4 of Kdo (Carof et al., 
1987), and formation of several anhydro-forms of this sugar , altogether accounting for 
the heterogeneity of anomeric signals for the Hep moieties (Schweda et al., 1993; 
Risberg et al., 1999).
Focussing on NTHi375ΔompP5 OSs, for which detailed NMR data had not been 
reported so far, anomeric resonances were observed in the 1H-NMR spectrum at δ = 
Fig. 4.14 Section of the multiplicity-edited 1H-13C HSQC spectrum of core oligosaccharides derived from 
NTHi375ΔompP5 LOS. Peak assignment is denoted for the terminal trisaccharide moiety (Hex4 glycoform) protons
and the anomeric proton of Glc I. CH2 are shown in petrol; CH and CH3 in black. Chemical shifts and coupling 
constants of the anomeric protons are reported in Table 4.4. The insert corresponds to the αGal and Hep anomeric 
proton region, δ from 5 to 6 ppm.
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5.03-5.14 and 5.60-5.68 ppm (Fig.  4.13, Table 4.4) corresponding to the three Hep 
residues of the inner core. Coupling constants were not resolved for all of them, but 
their identities were further confirmed by the occurrence of ROE cross-peaks between 
the respective H1-H2 intra-residue resonance pairs (Table 4.5). In addition, intense 
transglycosidic ROE contacts between the proton pairs Hep III H1/Hep II H2 and Hep 
II H1/Hep I H3 (Table 4.5) were in agreement with the sequence of the inner-core 
trisaccharide being L-α-D-Hep-(1,2)-L-α-D-Hep-(1,3)-L-α-D-Hep-(1→), as previously 
described by NMR and mass spectroscopy for this and other Hi strains (Phillips et al., 
1992; Borrelli et al., 1995; Masoud et al., 1997; Risberg et al., 1999; Fox et al., 2006) .
Regarding Hex residues, the relatively large J1,2-values of the anomeric resonances 
(Table 4.4) observed at δ = 4.52 ( J = 8.2 Hz), 4.53 ( J = 7.5 Hz) and 4.68 ( J = 7.5 Hz) 
in the TOCSY spectrum, indicated that the corresponding residues have β-configuration. 
The anomeric signal at 4.47 ppm (J not resolved) was ascribed to the terminal β-linked 
galactosyl moiety of a Hex3 glycoform. A ROE cross-peak between H1 of Gal I and the 
overlapping signals of H3/H4/H5 of Glc II confirmed this notion (Fig. 4.15). In contrast, 
the anomeric signal at 4.97 ppm exhibited a small Jl,2 coupling (3.7 Hz), consistent  with 
an α-linked saccharide. This signal was assigned to the terminal α-Galp (Gal II) of a
Fig. 4.15 Detail of ROESY spectrum of NTHi375ΔompP5-derived OSs.
ROE connectivities for the globotriose component of the Hex4 glycoform. The spectrum was acquired 
with 300 ms spin lock mixing time.
Table 4.4 1H-13C NMR chemical shifts for core oligosaccharides derived from OS glycoforms of NTHi375ΔompP5
Isoform Residue Sugar unit 3JH,H†
H1
(C1)
H2
(C2)
H3
(C3)
H4
(C4)
H5
(C5)
H6A
(C6) H6B
H7A
(C7) H7B
all Hep I 3,4)-l-α-D-Hepp-(1 N/R 5.09-5.14
(99.5-99.9)
4.05-4.06
(69.2)
3.70
(78.9) 
4.25*
(78.1) 
N/D 4.14*
(64.5)
N/D N/D N/D
all Hep II 2)-l-α-D-Hepp-(1 3.8 5.60-5.68
(99.2)
4.32
(78.8)
4.02
N/D
3.68
(72.8)
N/D N/D N/D 3.75
(65.0)
3.92
(61.2)
all Hep III 2)-l-α-D-Hepp-(1 N/R 5.10-5.13 
(99.7)
4.19; 4.21*
(78.2) 
4.02
N/D
N/D N/D N/D N/D N/D N/D
all Glc I β-D-Glcp-(1 8.2 4.52
(103.3)
3.38
(73.8)
3.48
(76.2)
3.55
(74.8)
3.60*
(74.9) 
4.14
(64.5)
4.26
(64.5)
all Glc II 4)-β-D-Glcp-(1 7.5 4.68
(101.8)
3.38
(72.7)
3.69
(74.3)
3.69
(78.8)
3.69
(74.6) 
3.84
(60.5) 
4.00
(60.5) 
Hex3 Gal I β-D-Galp-(1 N/R 4.47
(103.1)
3.55
(74.8)
3.68
(73.3) 
3.94
(68.7)
3.75
(75.5)
3.74
(62.8)
N/D
Hex4 Gal I 4)-β-D-Galp-(1 7.5 4.53(103.3)
3.59
(70.7)
3.76
(72.3)
4.06
(77.6) 
3.80*
(75.5)
3.86
(60.5) 
3.92
(60.5) 
Hex4 Gal II α-D-Galp-(1 3.7 4.97(102.1) 
3.84
(68.7)
3.90
(69.3)
4.04
(69.2)
4.35*
(71.0)
3.72
(60.8)
all PEtn
4.15
(62.1)
3.24
(40.8) 
all PCho
4.38
(59.6) 
3.69
(66.2)
Hex3 bears Galβ(1,4)Glcβ(1,2) at Hep III, while Hex4 bears Galα(1,4)Galβ(1,4)Glcβ(1,2) at this position. 3JH,H values for anomeric 1H resonances (H1) are given. 
Except where indicated, chemical shifts are the same (± 0.02 ppm) for the conserved inner core residues, shared by both glycoforms. N/R: not resolved, N/D: not 
defined. *Tentatively assigned from ROESY spectra. †Calculated from TOCSY spectra.
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Hex4 glycoform. The presence of the globotriose moiety at Hep III was confirmed by 
the ROE connectivities between H1 of Gal II and H4/H6 of Gal I (Fig. 4.15 and Table 
4.5). 
Table 4.5 Proton ROE data for NTHi375ΔompP5-derived OSs
Anomeric
proton
Observed proton ROE
Intra-residue Inter-residue 
5.09-5.14
(Hep I)
4.05 (H2) –
a Similar intra-residue distance 
of ~2.5 Å from the anomeric 
proton;
b 1H-signals corresponding to 
H3, H4 and H5 of Glc II were 
overlapping (~3.69 ppm), 
resulting in a broadened ROE 
cross-peak (also see Fig. 4.15). 
5.60-5.68
(Hep II)
4.32 (H2) 3.70 (Hep I H3); 4.19; 4.21 (Hep III H2)
5.10-5.13
(Hep III)
4.19; 4.21 (H2) 5.60-5.68 (Hep II H1); 4.32 (Hep II H2);
4.68 (Glc II H1)
4.52
(Glc I)
3.48 (H3) a and 
3.60 (H5)a
4.25 (Hep I H4); 4.14 (H6A)
4.68
(Glc II)
3.69 (H3/H5)b 5.10-5.13 (Hep III H1); 4.23 (H2)
4.53
(Gal I)
3.76 (H3) and 
3.80 (H5)
3.69 (Glc II H4)b
4.97
(Gal II)
3.84 (H2) and
3.90 (H3)
4.06 (Gal I H4); 3.86 (H6A); 3.92 (H6B)
Based on the relative 1H-13C HSQC intensities of the anomeric signals of terminal Galp
in the Hex3 and Hex4 glycoforms (Gal I and II respectively), Hex3 was roughly 
estimated to represent a population of ~22% of total OSs. NTHi375 LOS was 
previously described to be predominantly constituted by Hex4 glycoforms, together 
with mono- and di-sialylated Hex3 species representing 9% and 5% of the LOS, as 
determined by electrospray-ionisation mass spectrometry (Fox et al, 2006). No OS-
bound Neu5Ac was detected in our NMR analysis. At first place, the small difference in 
population reported for total sialylated species compared to that estimated here for Hex3 
could be attributed to the different detection methods used in each case. Besides, it 
seems highly likely that the conditions used for cleavage of the Kdo-lipid A linkage 
could also result in hydrolysis of Neu5Ac residues, yielding the Hex3 glycoform here 
observed. Indeed, the 1H-NMR spectra of Neu5Ac before and after treatment at our acid 
hydrolysis conditions (section 3.8.1) differed substantially, the appearance of new peaks 
pointing to further hydrolysis of the Neu5Ac moiety besides the cleavage of the α(2,3)-
glycosidic bond (Annex II). Thus, the Hex3 OS would correspond to desialylated 
species.
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A similar set of NMR analyses was carried out for the Rd OSs (Annex II). The results 
obtained were comparable to those previously reported for this strain (Risberg et al., 
1999) confirming the presence of three main glycoforms bearing terminal βGal (Hex3), 
αGal (Hex4), or βGalNAc (Hex5) at the Hep III branch (see Fig. 4.11).
4.1.7.2 The LOS epitopes recognized by VAA and RCA are lectin- and OS-specific
Following OSs assignment, we proceeded to the study of their recognition by the 
lectins. As no significant binding was detected for RCA in the NTHi375ΔompP5 LOS
microarrays (Fig. 4.9), the STD analysis was carried out only for VAA in this case.
Aromatic irradiation (7 ppm) provided sufficient protein saturation (82%), while 
aliphatic radiation (-0.5 ppm) was less efficient, with protein saturation barely reaching 
70%. Control experiments of the NTHi375ΔompP5-derived OSs were performed in the 
absence of VAA in order to ensure that its protons did not suffer non-specific saturation 
upon irradiation. 
Under the experimental conditions followed (1:30 VAA:ligand ratio), the highest 
absolute STD signal observed, corresponding to Gal II H4, was 1.8% compared to the
Fig. 4.16 STD spectra of the VAA- NTHi375ΔompP5 OS complex.
STD NMR spectrum obtained upon irradiation at 7 and -0.5 ppm. A lower saturation of the receptor 
during aliphatic irradiation yielded a poorer saturation transfer to the ligand, compared to aromatic 
irradiation.  Both spectra indicate the ligand protons that interact stronger with VAA, following an 
identical profile. The resonance corresponding to H4 of the terminal α-Gal-moiety gave the most intense 
STD signal. This and other STD signals are highlighted in the top spectrum. The bottom spectrum 
corresponds to the off-resonance spectrum of a 1:30 VAA:NTHi375ΔompP5 OS mixture irradiated at 100
ppm after protein signal subtraction.  
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Table 4.6 STD intensities of Gal II and Gal I in the Hex4 glycoform of NTHi375ΔompP5 OS
Gal II [α-D-Galp-(1→] Gal I [→4)-β-D-Galp-(1→]
1
H STD
Normaliseda
STD
1
H STD
Normaliseda
STD
H1 4.97 N/Db N/Db 4.53 NDb NDb
H2 3.84 0.95% 56% 3.59 1% 56% 
H3 3.90 1.5% 83% 3.76 0.9% 50%
H4 4.04 1.8% 100% 4.06 0.9% 50% 
H5 4.35 1.75% 95% 3.80 0.9% 50%
H6
A-B 3.72 1.2% 67% 3.86; 3.92 1.2% 67%
a Normalised values were calculated taking  the signal of  Gal II H4 as 100%; b shift close to 
residual HDO signal, unreliable STD quantitation.
off-resonance spectrum after protein background signal subtraction (Fig. 4.16 and 
Tables 4.4 and 4.6). This STD signal was normalised to 100%. For each proton whose 
signal intensity could be individually measured, its STD value was obtained and 
normalised to the most intense signal (Table 4.6). Unfortunately, the use of a pulse 
sequence with water suppression (WATERGATE) affected the resonances around 4.7 
ppm, so no STD values could be reported for the anomeric protons of the two Gal 
moieties potentially involved in binding. In addition, for Gal II the H6A and H6B signals 
overlapped (Table 4.4), so only a mean STD value could be determined in this case
(Table 4.6). The lower protein saturation achieved during irradiation at -0.5 ppm 
resulted in lower saturation transfer for Gal II, the H4 signal being affected only by 
1.3%. However, the spectral profile was identical to that observed upon aromatic
irradiation (Fig. 4.16), confirming the proximity of the defined protons to the protein.
Major contacts engaged the α-terminal Gal residue of the major Hex4 glycoform, while 
saturation transfer to protons of the inner β-Gal was also observed. Since Gal II H4, H5 
and H3 received maximal saturation (Fig. 4.17) it can be deduced that these are the 
Fig. 4.17 STD-based epitope mapping for VAA binding to the globotriose moiety of 
NTHi375ΔompP5 OS. Percentages upon normalisation to the most intense signal, ascribed to H4 of the 
terminal α-Gal (Gal II).
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protons closer to the protein. The crystallographic structures of VAA-Gal (PDB: 1PUM, 
1OQL) and VAA-Lac (PDB: 1PUU) complexes show that in the binding site operative 
at the VAA concentrations used for the STD-NMR experiments (Jiménez et al., 2005; 
Jiménez et al., 2006) the phenolic ring of a Tyr residue (Tyr249) participates in CH-π
stacking with the Galp ring, a frequent feature in lectin binding sites (Asensio et al., 
2013), engaging protons H3, H4 and H5 (Fig. 18) (Fernández-Alonso et al., 2005). 
Thus, considering the proximity of these protons to Tyr249, which was probably 
directly irradiated, high saturation transfer to the three of them was expected. In 
addition, the hydroxyl groups at positions 3 and 4, the latter defining the Gal 
stereochemistry, are involved in strong hydrogen bonds with the protein (Fig. 4.18).
On the other hand, although HO-6 is not involved in the binding (Jiménez et al 2008), 
the H6 protons can be also oriented towards the Tyr side chain, so that saturation 
transfer to these protons appears possible. Worth to mention, STD values for α-methyl-
galactoside H6 in presence of VAA were the highest upon receptor saturation for 0.5 s, 
yet around 75% for longer saturation intervals (El Biari, 2014). Saturation of approx. 2 s 
was pursued throughout the STD experiments here presented. Finally, a STD signal was 
also observed for Gal II H2, with intensity comparable to that observed for the Gal I 
protons. The HO group at position 2 has been proposed to be involved at neutral pH in a 
water-mediated interaction with the protein (Jiménez et al., 2008), indicating that this 
position is still accommodated within the contact area. The STD signals observed for 
Gal I protons hint at possible medium-distance contacts of this unit with the protein. Of 
note, a previous study of the binding of the Galα(1,4)Gal disaccharide to VAA also 
revealed STD signals for the reducing Gal residue (Miller et al., 2011), supporting the 
results here reported.
Fig. 4.18 Stacking interaction and key hydrogen bonds observed in the crystal structure of the 
VAA-Gal complex. Positions in the Gal moiety are numbered and the key hydrogen bonds established 
by the hydroxyl groups at positions 3 and 4 are represented by dotted lines.
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Worth mentioning, a watchful look to the STD spectrum of VAA‒NTHi375ΔompP5
OS (Fig. 4.16) suggests that more protons may suffer saturation transfer and be involved 
in binding, including those belonging to the terminal β-Gal of the Hex3 glycoform, in 
agreement with the lactose epitope also serving as ligand for VAA (Jiménez et al 2008). 
Yet, a quantitative analysis and normalisation of these signals could be erratic and was
not therefore attempted, especially considering that the Hex3 glycoform only appears as 
the result of hydrolysis of the sialylated LOS species and is not naturally present in the 
NTHi375ΔompP5 LOS. Indeed, the absence of a terminal Lac epitope explains the lack 
of binding of RCA to this LOS in the microarray binding assays, since this lectin 
exhibits a strong preference for β-linked over α-linked Gal (Podder et al., 1974; 
Baenziger and Fiete, 1979; Wu et al., 1993).
In contrast, strong binding of RCA to the Rd LOS was observed (Fig. 4.12). As already 
mentioned, the major glycoform of the Rd LOS presents terminal βGal(1,4)Glc (Fig. 
4.11), which could serve as docking point for RCA. To confirm this postulation, the 
binding of RCA to the Rd-derived OSs was examined (Fig. 4.19). STD for β-Gal (Gal I) 
H4 corresponded to 2% of the initial off-resonance signal. Other affected protons 
included H2 (normalized STD value of 98%), H3 (85%) and H6A-B (60%) of this 
residue, followed by the overlapping H3/H4 and H5 of the proximal Glc II moiety 
(mean value of 40%), Table 4.7 and Fig. 4.19. All these signals were fully consistent 
with the differential contribution of the HO groups at these positions to the binding of 
lactose to RCA, as determined by chemical mapping analysis (Rivera-Sagredo et al., 
1992; Solís et al., 1993). The particularly high contribution of Gal I H2, could be 
attributed to the establishment of a direct hydrogen bond with lectin residues, as a 
Table 4.7 STD intensities of Gal I and Glc II in the Hex3 glycoform of the Rd OS.
Gal I [ β-D-Galp-(1→] Glc II [→4)-β-D-Glcp-(1→]
1
H STD
Normaliseda
STD
1
H STD
Normaliseda
STD
H1 4.47 N/Db N/Db 4.67 N/Db NDb
H2 3.55 1.95% 98% 3.38 0.55% 28%
H3 3.68 1.7% 85%
3.69c 0.8% 40%H4 3.94 2% 100%
H5 3.74 0.6% 30%
H6
A-B 3.78; N/D 1.2% 60% 3.85; 3.99 0.7%;0.5% 35%; 25%
a Normalised values were calculated taking the signal of Gal I H4 as 100%; b shift close to 
residual HDO signal, unreliable STD quantitation. c signal overlapping, the mean STD value is given.
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donor, as previously suggested (Bhattacharyya and Brewer, 1988). No meaningful 
signals for other sugar protons were observed, also in agreement with the reported RCA 
binding specificity (Podder et al., 1974; Baenziger and Fiete, 1979; Wu et al., 1993), 
including its inability to accommodate GalNAc residues at the binding site. Thus, 
recognition of the Hex3 glycoform accounts for the binding of RCA to the Rd LOS. 
A similar analysis of VAA binding yielded similar STD signals (Fig. 4.20). Again, the 
terminal β-Gal H4 proton (3.94 ppm) gave the strongest signal with an absolute STD
value of 2%. Saturation transfer was also effective to the H3, H5, and H6 of Gal I.
Although the poor signal-to-noise ratio precluded a detailed quantitative analysis, the 
results evidenced that VAA is also able to recognize the Hex3 glycoform, here 
representing ~60% of total OSs (Risberg et al., 1999). The absence of meaningful 
signals for αGal was intriguing, as the Hex4 glycoform, serving as ligand for VAA in 
the NTHi375ΔompP5 LOS, accounts for nearly 20% of the Rd OSs. Interestingly, 
colony immunoblotting had previously revealed weak or even undetectable binding of 
the Galα(1,4)Gal-specific monoclonal antibody 4C4 (High et al., 1993) to this strain 
Fig. 4.19 STD and reference spectra of the RCA-OS NTHi Rd complex.
(a) STD NMR spectrum revealing the directly interacting OS protons. The resonance corresponding to the H4 of 
the terminal β-Gal I, gave the most intense STD signal. Other significant STDs are denoted by arrows and 
reported in Table 4.7. (b) Section of an off-resonance spectrum of a mixture of RCA and OS from 
NTHi375ΔompP5 in a 1:30 ratio, after protein signal subtraction. RCA was irradiated at 100 ppm.
STD (128x scaled)
Off-resonance
(a) 
(b) 
H4
H3H5
H2
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(Virji et al., 1990), what could indicate a very different presentation of this epitope in 
the Rd LOS that is neither appropriate for VAA binding.
Fig. 4.20 STD and reference spectra of the VAA-OS NTHi Rd complex.
(a) STD NMR spectrum revealing the directly interacting OS protons. The resonance corresponding to the H4 of 
the terminal β-Gal I, gave the most intense STD signal. Other significant STDs are denoted by arrows.
(b) Section of an off-resonance spectrum of a mixture of VAA and OS from NTHi375ΔompP5 in a 1:30 ratio, 
after protein signal subtraction. VAA was irradiated at 7 ppm.
4.1.8 Profiling of accessible glycans on NTHi clinical isolates and recognition by 
endogenous lectins
A hallmark of NTHi is its inter-strain genomic and phenotypic heterogeneity (Martí-
Lliteras et al., 2011; De Chiara et al., 2014). The LOS outer core is highly variable due 
to the presence/absence and phase variation of genes responsible for initiating 
extensions from the three inner core Hep residues (Hood et al., 2004), leading to 
variable outcomes as on pathogen colonisation, persistence, or acute infection (Schweda
et al., 2007). Prompted by the demonstrated utility of NTHi microarrays for profiling 
accessible glycans on the bacterial surface, we next compared the lectin-binding  
patterns of six different NTHi clinical isolates. We selected four genotypically distinct 
clinical isolates of two frequent pathological origins, otitis media (strains 375 and 86-
028NP) and COPD (strains 398 and 1566). These strains had been previously genome 
sequenced (Table 3.2) and found to present heterogeneous genomic contents. In  
STD (128x scaled)
Off-resonance
(a) 
(b) 
H4 H3
H5
H6
114
addition, we selected two NTHi 
isolates from paediatric healthy 
carriers (strains 131 and 133), 
which exhibited different pulse 
field gel electrophoresis (PFGE) 
profiles (personal communication 
of Dr. Junkal Garmendia). As 
illustrated in Fig. 4.21 and Table 
4.8, the “lectin fingerprint” 
obtained for each isolate was 
different. 
A clear-cut dissection and 
assignment of the glycoepitopes recognised by the lectin panel is not feasible, 
particularly considering that detailed information on the LOS structure for all NTHi 
strains is not available. Still, the lectin-binding fingerprints of strains 131 and 133 
deserve to be highlighted as they yielded the strongest signals for key lectins. 
 PSqL gave strong signals for both isolates, binding to 133 giving the most intense 
signal among all strain–lectin pairs tested (Table 4.8). A high content of sialic acid-
bearing ligands could be tentatively connected with a role in allowing the microbe to 
masquerade as “self” and thereby to either elude or subvert host immune responses 
(Chang and Nizet, 2014), at the same time contributing to biofilm formation and 
persistence (Swords et al., 2004). Binding signals observed for RCA also revealed a 
Lectin 375 86-028 NP 398 1566 P131 P133
VAA
RCA
MAL-I 
SBA
WFA
WGA
PSqL
SNA
ConA
1 – 2.5×103 2.5 – 5 5 – 10 10 – 20 > 20×103
Fig. 4.21 Clinical isolates were printed in the arrays, and the 
binding of selected lectins was examined. The colour code 
reflects the fluorescence intensity of AF647-streptavidin 
signals (in rfu) used for detecting the biotinylated lectin 
binding to OD600 = 1 of printed bacteria in the microarrays. 
Detailed data are given in Table 4.8. 
Table 4.8 Binding of selected reference lectins to NTHi clinical isolatesa
Lectin
Otitis media COPD Healthy carriers
375 86-028NP 398 1566 P131   P133 
VAA 4250 ± 150 5050 ± 60 1730 ± 20 1850 ± 150 2100 ± 100 2300 ± 300
RCA 5100 ± 700 5500 ± 400 8700 ± 700 6800 ± 700 10400 ± 400 25500 ± 900
MAL-I 2800 ± 150 2870 ± 80 2900 ± 200 1290 ± 75 2900 ± 150 2950 ± 200
SBA 2000 ± 100 2400 ± 400 2250 ± 450 1700 ± 550 1900 ± 50 2500 ± 900
WFA 2450 ± 100 3100 ± 150 3850 ± 300 2700 ± 450 3200 ± 500 4500 ± 750
WGA 3300 ± 250 5450 ± 200 4000 ± 300 1100 ± 150 1700 ± 150 5600 ± 300
PSqL 3700 ± 200 2900 ± 200 13000 ± 600 5600 ± 300 9000 ± 800 28000 ± 4800
SNA 5050 ± 200 6050 ± 300 3850 ± 200 1870 ± 80 6150 ± 450 2200 ± 250
ConA 5090 ± 90 4300 ± 150 3000 ± 150 3900 ± 200 11100 ± 200 5200 ± 150
aData shown corresponds to mean values of the fluorescence intensity of AF647-streptavidin signals (in arbitrary 
units) at the highest concentration of bacteria tested (OD600 = 1), calculated from the intensities obtained for triplicate 
samples of two different experiments. Standard deviations of the mean are given.
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high availability of ligands for this lectin. In contrast, binding of VAA was noticeably 
smaller, again evidencing that RCA and VAA recognise different Gal-containing 
ligands.  
Of note, the two isolates from otitis media presented a greater abundance of VAA 
ligands compared to the rest of isolates. LOS capping by α-Gal has been previously 
found to contribute to evasion of acquired immunity, also being advantageous in 
inflammatory states (Weiser and Pan, 1998). However, in the case of COPD isolates 
only weak binding of VAA was detected, suggesting a low availability of the 
digalactose Galα(1,4)Gal epitope. These results were in line with blotting assays of 
bacterial lysates showing no reactivity of strains 398 and 1566 towards the 
Galα(1,4)βGal-specific 4C4 monoclonal antibody, although these strains carry the 
phase-variable gene lic2A in frame (Martí-Lliteras et al., 2011). Noteworthy, NTHi1566 
in particular also gave the smallest binding signals for other lectins, pointing to the 
unavailability of other epitopes. 
At any rate, the microarray lectin-binding assays evidenced the availability on the 
bacterial surface of Man/Glc, Gal and Neu5Ac residues that might serve as docking 
points for lectins of the innate immune system. To confirm this hypothesis, we took 
advantage of our microarray platform to analyse the binding to the isolates of SP-D, 
hGal-8, and Siglec-14, as representative lectins with the required nominal binding 
specificities (see Table 1.2).  
SP-D is a calcium-dependent lectin of the collectin family involved in surfactant 
homeostasis and pulmonary immunity (Waters et al., 2009; Seaton et al., 2010). 
Collectins recognize pathogen-associated molecular patterns of a variety of 
microorganisms, most of them exhibiting mannose-like binding specificity (Gupta and 
Surolia, 2007). Galectins have also been shown to participate in defence against 
microbial pathogens, through regulation of innate and adaptive immunity (Rabinovich
et al., 2012). In addition, they interact directly with pathogens leading to either 
enhancement or blockage of microbial infection, or to microbicide activity (Baum et al., 
2014; Chen et al., 2014). In particular, a direct microbicidal effect of hGal-8 on 
NTHi2019 was demonstrated (Stowell et al., 2014). A variety of interactions with 
bacterial, viral and protozoan pathogens have been described for Siglecs too, which also 
have important innate and adaptive immune functions (Chang and Nizet, 2014; 
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Macauley et al., 2014). Binding of NTHi2019 to Siglec-14, expressed on neutrophils 
and monocytes, was found to enhance inflammation, triggering COPD exacerbation 
(Angata et al., 2013). Of note, compared to NTHi375, the NTHi2019 LOS has, as 
distinctive structural features, the presence of Galβ(1,4)Glcβ(1,4) linked to the proximal 
Hep I and of Galβ(1,4)Glcβ(1,4)Glcα(1,3), and truncated versions thereof, linked to the 
middle Hep II (Phillips et al., 1992). This poses the question of the extrapolability of 
Siglec-14 and, especially, hGal-8 binding to NTHi375 as well as to other NTHi strains. 
Analysis of the binding to the array-printed NTHi clinical isolates revealed a dose-
dependent and strain-specific recognition by the three lectins (Fig. 4.22), providing the 
first experimental evidence for direct binding of SP-D to NTHi, and also demonstrating 
the binding of hGal-8 and Siglec-14 to NTHi strains other than NTHi2019 (Kalograiaki
et al., 2016). Although the different binding-detection protocols used for the three 
lectins (please see Fig. 3.12) make inappropriate an inter-lectin comparison of binding 
intensities, the strain-specific binding patterns observed for each lectin can be 
confidently compared. Once again, the smallest binding signals were observed for  
Fig. 4.22 Binding of innate immune lectins to NTHi clinical isolates. Bacteria strains were printed as 
triplicates at four dilutions (1-4, corresponding to OD600 of 1, 0.6, 0.3 and 0.1, respectively). Slides were 
overlaid with either SP-D, hGal-8 or Siglec-14, and binding was detected by incubation with AF647-
streptavidin as final step. Dotted lines represent the observed binding trends, distinct for each lectin.
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 NTHi1566. For the other isolates tested, lectin-specific trends were observed (Fig. 
4.21) indicating that the availability of the respective epitopes varies from strain to 
strain.  
 Interestingly, only in the case of SP-D the binding to strain 1566 was comparable to 
that detected for NTHi375. SP-D exhibits a broad binding-specificity with maltose 
(Glcα(1,4)Glc), glucosides and mannosides with a preference for α-anomers (Persson et 
al., 1990) , as well as L,D-manno-Hep (Wang et al., 2008; Clark et al., 2016) being
recognised ligands. As illustrated in Fig. 4.1, the NTHi LOS contains an Hep
trisaccharide inner core, which is conserved in several bacterial species (Hood et al., 
2004) and could serve as docking point for SP-D. Therefore, prompted by the observed 
strain-selective binding of SP-D to all NTHi clinical isolates, we explored the 
recognition by this lectin of the library of NTHi375 mutants displaying sequentially 
truncated LOS, with Hep residues cloaked or exposed to different degrees.
4.1.9 Recognition of NTHi375 mutants and isolated LOSs by SP-D 
SP-D binding to microarray-printed NTHi375ΔsiaB, ΔlgtF, ΔlgtF/ΔlpsA and ΔompP5 
strains was significantly enhanced compared to the wild type strain, while deletion of 
the Hep III extension led to a moderate binding increase (Fig. 4.23). Hence, 
increasedexposure of the LOS inner core gave rise to a boost in SP-D binding (Fig. 
Mutant RelativeSP-D binding
ΔsiaB 200 ± 20
ΔlgtF 170 ± 11
Δlic2A 160 ± 12
ΔlpsA 129 ± 6
ΔlgtF/lpsA 180 ± 11
ΔopsX 150 ± 10
ΔompP5 210 ± 10
Fig. 4.23 Binding of SP-D to the panel of NTHi375 mutants.
(a) Representative  binding of 6 μg/ml SP-D to immobilised bacteria (triplicates of OD600 values 1 
and 0.6) in the absence (orange) or presence of 0.2 M maltose (yellow). Data shown correspond to 
the mean of three data points obtained in the same microarray slide, upon normalisation for bacterial 
staining with SYTO® 13. Error bars indicate the standard deviation of the mean. (b) Relative binding 
strength calculated as percentage taking binding to wild type NTHi375 as 100%, upon normalisation 
for staining with SYTO® 13. The colour code (light to dark) denotes the relative binding increase. 
Data correspond to at least two independent experiments.  Standard error values are given.
(a) (b) 
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4.23, b). Indeed, it has been reported that SP-D prefers rough LPS over smooth LPS as 
ligand (Kuan et al., 1992; Ofek et al., 2001), probably because of a higher accessibility 
to the inner core Hep (Wang et al., 2008). 
The specificity of the binding was assessed using different competitors (Table 4.9). 
First, the binding to all strains was partially inhibited (30-56%) in the presence of 0.05 
M L,D-manno-Hep and to a higher extent (up to 70-77%) in the presence of 0.2 M 
maltose (Fig. 4.23, a). In contrast, Kdo was not a competitor when used at 
concentrations of up to 50 mM (not shown), in agreement with previous observations 
(Wang et al., 2008; Reinhardt et al., 2016).  In addition, since Ca2+ is essential for SP-
D’s lectin-binding activity (Shrive et al., 2003; Kishore et al., 2006), the effect of 
EDTA was also tested, inhibition reaching 80-89% of the binding in the presence of 
Ca2+. Altogether, the results evidenced that SP-D binding to the NTHi strains was 
carbohydrate-mediated. 
Binding to ΔopsX (exposing an unsubstituted Kdo moiety) was slightly lower compared 
to ΔlgtF. This finding was in good agreement with a weaker SP-D binding to a deep 
rough Re-LPS E. coli mutant bearing a terminal α(2,4)-linked di-Kdo moiety, compared 
to its Rd form substituted in position 5 with 4-phosphoryl-L,D-manno-Hep, akin to 
NTHiΔlgtF (Wang et al., 2008), revealing a preference for terminal Hep over Kdo. 
More important, the efficient binding to NTHi375ΔsiaB and ΔompP5 implies that, if the 
Table 4.9 Inhibition of SP-D binding to NTHi375 wild type and mutant
strains by different competitive haptensa
Strain
Inhibitor
Maltose Manno-Hep EDTA
NTHi375 76 ± 5 32 ± 5 88 ± 5
ΔsiaB 72 ± 4 41 ± 3 81 ± 4
ΔlgtF 69 ± 2 39 ± 9 80 ± 3
Δlic2A 75 ± 5 30 ± 3 85 ± 4
ΔlpsA 71 ± 3 51 ± 3 81 ± 5
ΔlgtF/lpsA 77 ± 4 56 ± 4 89 ± 5
ΔopsX 76 ± 3 35 ± 2 84 ± 3
ΔompP5 70 ± 3 41 ± 3 87 ± 3
aSP-D binding was tested at 6 μg/ml. Hapten concentrations were 0.2 M 
maltose, 0.05 M manno-Hep, and 0.01 M EDTA. Data correspond to the 
mean of at least two competition experiments. Standard error values are 
given.
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inner core of the NTHi375 LOS is a docking point for SP-D on the bacterial surface, 
this lectin should be able to recognise internal manno-Hep, as previously suggested 
(Wang et al., 2008; Reinhardt et al., 2016). To further clarify this issue, a direct 
comparison of SP-D binding to the LOSs isolated from the ΔompP5, ΔlpsA and ΔlgtF
mutants was carried out.  
To this aim, the LOS of the ΔlgtF and ΔlpsA mutants was extracted and quantified as 
described above (section 4.1.5.1). A higher extraction yield was again observed 
compared to wild type NTHi375 LOS (Fig. 4.24), what in this case could result from a 
differential partition index in the extraction media due to structural differences. 
Interestingly, a second weak band was detected for the ΔlgtF-derived LOS (highlighted 
by an arrow in Fig. 4.24), which apparently corresponds to a shorter isoform with 
mobility close to that of the ΔlpsA LOS. Of note, this mutant strain was found to be 
reactive to the anti-PCho antibody TEPC-15, suggesting that in the absence of Glc I at 
Hep I, PCho could be added to Glc II, linked to Hep III (Morey et al., 2013). Thus, a 
tentative explanation for the appearance of this second band could be that PCho 
conjugation to Glc II in a small population of the ΔlgtF LOS could be a source of 
spatial hindering, preventing further branch extension. 
Fig. 4.24 Quantitation of the LOS isolated from NTHi375 ΔlgtF and ΔlpsA mutant strains.
(a) Colorimetric quantitation by the Purpald assay. LOS dilutions from the stock solution are indicated 
(in duplicates). (b) Electrophoretic profiles of the isolated LOSs,  sample loaded: (i) 1 μg, (only shown 
the two lower Mw bands); (ii) 1 μg, single band; (iii) 0.7 μg; (iv) 3 μl stock; (v) 1 μl (dil 1:200); (vi) 0.6 
μl  (dil 1:200); (vii) 1 μl (dil 1:200); (viii) 0.6 μl (dil 1:200). The arrow indicates the presence of a 
second weak band in the LOS of ΔlgtF (v).
Quantified ΔlgtF and ΔlpsA LOSs were incorporated in the microarrays at equal 
concentrations, along with ΔompP5 and S. minnesota Rb LOS as references. The arrays 
were validated by confirming binding of the polyclonal anti-Salmonella-lipid A 
antibody, as described in section 4.1.5.1. A slight tendency to an increase in the binding 
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intensity with LOS truncation was observed (Fig. 4.25, a), what could be attributed to a 
higher lipid A accessibility. Of note, no binding of mouse polyclonal anti-Salmonella 
typhimurium antibody to the printed NTHi LOSs was detected, supporting the 
specificity of the recognition by the anti-lipid A antibody (not shown). The binding of 
SP-D to ΔompP5, ΔlgtF and ΔlpsA LOSs printed in the arrays was then examined in the 
absence and presence of 0.2 M maltose or 0.05 M L,D-manno-Hep. 
Efficient binding to the LOS isolated from ΔompP5 was detected (Fig. 4.25, b). 
Moreover, the binding was comparable to that to ΔlgtF and ΔlpsA LOS at the same 
printed concentrations, evidencing that exposure of terminal Hep I or Hep III is not 
necessary for recognition. In all cases, the binding was inhibited almost completely in 
the presence of competitive haptens (Fig. 4.25, b), proving that it was entirely 
carbohydrate-mediated, without the involvement of hydrophobic protein-lipid 
interactions. Thus, incomplete inhibition by the tested haptens of SP-D binding to the 
whole bacteria could attest for the existence of alternative high-affinity docking points 
for the lectin, or alternatively reflect the establishment of secondary carbohydrate–
independent interactions. 
4.1.10 Recognition of NTHi375 mutants and isolated LOSs by galectins 
Galectins constitute an attractive lectin family involved in multiple processes related to 
health and disease. Their CRDs are highly conserved, with a common sequence 
signature that determines their specificity for β-galactosides (Annex IV). However, 
Fig. 4.25 Binding of anti-lipid A antibody and SP-D to LOS microarrays. The LOSs were immobilised at
decreasing concentrations as triplicates, and the binding of anti-lipid A (left panel), and SP-D was examined (right 
panel). For SP-D, the binding was tested in the absence (blue) or presence of 0.2 M maltose (grey) or 0.05 M L,D-
manno-Hep (white). Error bars stand for standard deviation of the mean.
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small variations in the sequence and architecture of the carbohydrate-binding site lead to 
distinct fine oligosaccharide-binding specificity, particularly towards Galβ(1,4)GlcNAc- 
Galβ(1,3)GlcNAc- or Galβ(1,3)GalNAc-containing oligosaccharides and sialylated 
species thereof. What is more, their structural organisation defines three groups, i.e. 
proto, chimera and tandem-repeat type (Fig. 4.26, a), with distinct capacities to bind 
ligand clusters (cis-crosslinking) and/or act as bridges (trans-crosslinking) (Fig. 4.26, 
b). Galectins are present in all tissues, but certain mucosal epithelia (e.g. Gal-4 in 
intestine or Gal-8 in larynx), show a particularly high expression, what appears to be 
associated to crucial physiological roles, including pathogen recognition and clearance. 
The linker peptide connecting the two different CRDs of tandem-repeat galectins (Fig. 
4.26, a), which is composed of a minimum of 20 amino acids, is susceptible to 
proteolysis (Oda et al., 1993), and has been proposed to govern the CRDs’ proximity, 
relative orientation and crosslinking capacity (Earl et al., 2011).
Fig. 4.26 Galectin classification and physiological roles. (a) Classification is based on CRD 
organisation (Hirabayashi and Kasai, 1993). (b) Among their functional roles, galectins bind in a cis or 
trans manner to Gal-containing ligands on bacterial surfaces, with different outcomes. Adapted from 
(Liu and Rabinovich, 2005).
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Microarray screening of six different NTHi clinical isolates (section 4.1.8) revealed 
binding of hGal-8 to all tested strains, and evidenced for the first time the availability of 
docking sites for this galectin on the surface of NTHi strains other than NTHi2019 
(Kalograiaki et al., 2016). In order to explore whether other members of the galectin 
family are also capable to recognise the Gal-bearing NTHi glycosylation patterns 
(section 4.1.3), and if possible dissect the specific sugar epitopes involved in the 
recognition, we have examined the binding of a panel of 6 human galectins including 
members of the three structural subgroups to array-printed NTHi375. All the tested 
galectins were available in biotin-labelled form, thereby enabling inter-lectin 
comparison of their binding intensities. 
Binding of proto-type hGal-1 and hGal-2 at the maximum concentration tested (2 µM) 
was negligible (Fig. 4.27). Direct binding to live bacteria at exponential growth phase 
(described in section 3.9.1) was not visible either (data not shown), confirming the 
microarray results. Therefore, hGal-1 was used as negative control in all subsequent 
experiments. 
In contrast, the CRD of hGal-3 (designated as hGal-3tr, “tr” accounting for truncated) 
bound to array-printed NTHi375, revealing the presence of docking sites for this lectin 
Fig. 4.27 Binding of biotinylated galectins to NTHi375 microarrays. 
Binding of galectins in PBSβ to NTHi375 printed as triplicates at OD600 = 1 and 0.6, was tested in the 
absence (blue) or presence of 0.1 M Lac (cyan). Galectin concentrations were set as follows: hGal-1 and -
2: 2 μΜ, hGal-3tr: 1 μΜ, hGal-4: 0.25 μΜ, hGal-8 and -9: 0.5 μΜ. Data shown correspond to the mean of 
at least three independent experiments, upon normalisation of the amount of printed bacteria based on 
SYTO® 13 fluorescence signals and bacteria labelling efficiency. Error bars indicate the standard 
deviation of the mean.
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on the pathogen surface, and the binding was significantly reduced in the presence of 
Lac, indicating carbohydrate-mediated recognition (Fig. 4.27). 
On the other hand, binding of hGal-4 was less efficiently inhibited in presence of either 
0.1 M Lac (Fig. 4.27), or 0.1 M LacNAc (~55% inhibition, not shown), the latter 
previously reported to be slightly better inhibitor for both hGal-4 CRDs (Buzamet, 
2012). This might be due to the establishment of high-avidity interactions resulting from 
ligand clustering, and/or to non-carbohydrate-mediated secondary interactions of e.g.
electrostatic or hydrophobic nature. In contrast, hGal-8 and hGal-9, the other two 
tandem-repeat galectins tested, bound to NTHi375 in a carbohydrate-specific manner 
(Fig. 4.27). 
Having detected binding of the chimera and tandem-repeat type galectins, we next 
explored in more detail possible factors involved in the recognition, starting with the 
impact of the presence of the non-lectin N-terminal region of hGal-3 on the behaviour 
of this lectin. 
4.1.10.1 NTHi375 recognition by hGal-3 
SDS-PAGE analysis of bacterial lysates following incubation with non-labelled hGal-3 
of NTHi375 suspensions in exponential growth phase showed the presence of a protein 
band with the electrophoretic mobility of the full length protein (Fig. 4.28, a), pointing 
to direct binding of hGal-3 to live bacteria. Densitometric quantitation of the band 
revealed a 50% decrease in intensity when the incubation was performed in the presence 
of 50 mM Lac, indicative of carbohydrate-mediated binding. Moreover, as observed by 
confocal microscopy, full length hGal-3 was able to agglutinate fixed bacterial cells 
(Fig. 4.28, b), what necessarily implies oligomerisation. Indeed, N-terminal tail-
mediated pentamerization of hGal-3 in the presence of multivalent ligands has been 
reported (Ahmad et al., 2004).  
No effect of full length hGal-3 on NTHi adhesion to A549 cells was observed in in vitro
assays (see section 3.9.3) posing the question of the physiological role of the hGal-
3NTHi interaction. Interestingly, hGal-3 also binds to the surface of Neisseria 
meningitidis (Quattroni et al., 2012), a frequent colonizer of the human respiratory tract. 
The binding requires intact LPS molecules and is coupled to an increase in adhesion to 
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Fig. 4.28 Binding of hGal-3 to NTHi375. (a) Representative electrophoretic profiles of NTHi375 lysates 
in 12% polyacrylamide gels under reducing conditions. For the binding assay, 150 μl of a bacteria
suspension (OD600 = 1) in PBSβ was used. (i) MW markers; (ii) 5 μg of non-labelled hGal-3; bacterial 
pellet lysates: (iii) control in the absence of galectin; (iv) bacteria incubated with 10 μM non-labelled 
hGal-3. (b) Binding of 10 μM His-tagged hGal-3 (central panel) to NTHi375 stained with SYTO® 13 (left
panel) was detected by incubation with 1 μg/ml AF647-labelled streptavidin as final step (see 3.9.4). The 
right panel corresponds to the merge of SYTO® 13 and AF647 fluorescence signals.
monocytes and macrophages, apparently without contributing to phagocytosis, but not 
to epithelial cells. In contrast, hGal-3 has been found to significantly increase 
phagocytosis of Klebsiella pneumoniae (strain Kp52145) by human macrophages 
(unpublished results), thus indicating that the outcome of hGal-3 binding is bacterium 
specific. As K. pneumoniae LPS is also a ligand for rat Gal-3 (Mey et al., 1996), the 
possibility that the NTHi LOS could serve as docking site for the lectin was considered. 
However, taking the binding to wild type NTHi375 as 100%, the relative binding 
strength in the bacteria arrays to entire NTHi375ΔompP5 was 98  5% and 108  6% 
for full-length hGal-3 and its separate CRD, respectively, indicating that LOS 
overexpression in the ΔompP5 mutant does not result in increased binding. 
Furthermore, no binding of either hGal-3 or hGal-3tr to array-printed NTHi375ΔompP5
LOS was observed. Altogether, the results argue against the possibility that the 
NTHi375 LOS behaves as ligand for hGal-3.
4.1.10.2 NTHi375 recognition by tandem-repeat galectins hGal-4, hGal-8, and 
hGal-9 
Binding assays to the surface of bacteria at exponential growth phase, performed as 
described above for hGal-3, revealed the presence of protein bands with the 
electrophoretic mobility of full length hGal-4 (Fig. 4.29, a) and hGal-8 (Fig. 4.29, b). 
The intensity of the hGal-8 band decreased 20-30% in the presence of 50 mM Lac, 
indicating that binding to live bacteria is, at least in part, carbohydrate-mediated. 
(a) (b)
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However, no inhibition at all was observed for hGal-4 under the assayed conditions, 
here pointing to the establishment of non-carbohydrate-mediated interactions. 
Regarding hGal-9, the appearance of protein bands at the position expected for a 
separate CRD evidenced degradation most probably due to linker proteolysis (Fig. 4.29, 
c), a phenomenon frequently observed for tandem-repeat-type galectins. Still, the lectin 
proved to be functional, as a protein band at the position of full length hGal-9 was 
clearly visible in the bacterial lysates following incubation with this galectin, and the 
intensity of the band decreased 50-55% in the presence of 50 mM Lac.  
Fig. 4.29 Direct binding of tandem-repeat hGal-4, hGal-8 and hGal-9 to live NTHi375.  
Representative electrophoretic profiles in 12% polyacrylamide gels under reducing conditions of 
NTHi375 lysates after incubation of bacteria suspensions (OD600 = 1) in PBSβ with 10 μM non-labelled 
hGal-4 (a), hGal-8 (b), or hGal-9 (c), in the absence (lanes iv) and presence of 50 mM Lac (lanes v). (i) 
MW markers; (ii) 5 μg of non-labelled galectin; (iii) NTHi375 control pellet lysate.
In contrast to hGal-3, the binding of the three tandem-repeat galectins increased 
considerably as result of LOS overexpression, with relative binding strengths to array-
printed NTHi375ΔompP5 of 250  20% for hGal-4 and -9, and 170  10% for hGal-8 
with respect to wild type NTHi375. Thus, in this case the LOS appears a likely 
candidate to act as ligand for these lectins. Therefore, the binding of hGal-4, -8 and -9 to 
the panel of mutants presenting sequentially truncated LOSs was next examined (Fig. 
4.30). The three galectins exhibited reduced binding to the ΔsiaB mutant whereas 
silencing of lgtF, the gene coding for the glycosyltransferase responsible for adding Glc 
to Hep I, had no significant effect or even increased binding, a behaviour also observed 
for the anti-NTHi serum (section 4.1.1) and the plant lectins VAA, SBA and ConA 
(section 4.1.3). Truncations affecting the extension at Hep III (i.e. Δlic2A, ΔlpsA, and 
ΔlgtFΔlpsA) or even all core sugars (ΔopsX) had only small consequences on NTHi
recognition by hGal-4 and hGal-9. However, they did weaken significantly the binding 
of hGal-8, for the ΔopsX mutant the relative binding strength being reduced up to 37 
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1% with respect to wild type NTHi375. Thus, the Hep III extension could serve as 
docking point for hGal-8. 
A distinguishing feature of tandem-repeat galectins is the presence of two different 
CRDs within the same molecule, enabling these lectins to recognize different sets of 
ligands. In order to get information on the relative contribution of the N- and C-terminal 
CRDs to NTHi375 binding, we took advantage of the availability of the separate 
domains of hGal-4 and hGal-8 (designated as hGal-4/8 N and C), which have been 
shown to exhibit clearly distinct fine-tuned specificities (Huflejt and Leffler, 2003; 
Carlsson et al., 2007). 
Fig. 4.30 Relative binding strength of hGal-4, hGal-8, and hGal-9 to NTHi375 mutant strains.  
Binding of 0.5 μM hGal-4 (cyan), hGal-8 (yellow) and hGal-9 (magenta) in PBSβ to NTHi375 wild type 
and mutant strains, printed as triplicates of OD600 values 1 and 0.6, was assessed simultaneously, and the 
relative binding strength was calculated as percentage taking binding to wild type NTHi375 as 100%. 
Data shown correspond to the mean of at least three independent experiments and error bars indicate the 
standard error.
127
Using the same strategy followed for the full-length galectins, we first examined the 
binding of the domains to live NTHi375 in exponential growth phase. As detailed in 
Table 4.10, no significant binding of hGal-4N was detected. In addition, the intensity of  
Table 4.10 Binding of hGal-4 and -8 CRDs to NTHi375 at exponential
growth phase.
CRD
Optical density (× 10-2)a
Control pellet Pellet + galectin Pellet + galectin
+ 50 mM Lac
hGal-4N 6 ± 1 7 ± 1 6 ± 1
hGal-4C 8 ± 1 26 ± 4 28 ± 5
hGal-8N 6 ± 1 36 ± 4 19 ± 3
hGal-8C 6 ± 1 11 ± 1 9 ± 2
Measured by densitometric quantitation of the CRD protein bands upon SDS-
PAGE analysis of bacterial lysates following incubation of NTHi375 
suspensions in exponential growth phase with 10 μM of the respective CRD, 
in the absence or presence of 50 mM Lac. The intensity of the control pellet 
corresponds to the background at the equivalent electrophoretic mobility. 
aIntensity value for the center of the band (3x3). Data correspond to the mean 
of at least two different experiments and standard error values are given.
the hGal-4C and hGal-8C bands appearing in NTHi375 lysates following incubation 
with these two proteins did not decrease in the presence of 50 mM Lac. Only for hGal-
8N, a noticeable inhibition of the binding in the presence of the hapten was observed, 
here evidencing carbohydrate-mediated recognition.  
To get further insights into the possible ligands recognized by the hGal-4 and -8 
separate CRDs, their binding to the panel of NTHi375 mutants was next examined 
using the bacteria microarray set-up (Fig. 4.31). The first remarkable observation is that 
binding of hGal-4C but not of hGal-4N was detected, in full agreement with the assays 
using live bacteria. Recognition by the C-domain was strongly favoured for the 
ΔompP5 mutant. However, truncation of the LOS had dissimilar consequences 
depending on the mutant, the binding to the shortest ΔopsX variant being comparable to 
that of the wild type strain.  
Regarding hGal-8, although binding of both CRDs was observed, the consequences of 
LOS overexpression and truncation were entirely opposite. Thus, for hGal-8C no 
increase in the binding was found for the ΔompP5 mutant compared to wild type 
NTHi375 and LOS truncation at certain levels even favoured recognition. In striking 
contrast, recognition by the N-domain was strongly favoured for the ΔompP5 mutant, as 
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similarly observed for hGal-4C, and truncation of the LOS extension at Hep III resulted 
in decreased binding (Fig. 4.31), suggesting that this branch could serve as docking 
point for hGal-8N. Only silencing of siaB had a similar impact on the two hGal-8 
CRDs, with a noticeable drop in binding. Altogether, the results evidence that the N- 
and C-terminal CRDs of hGal-8 recognize different ligands on the NTHi375 surface.  
Indeed, different roles have been proposed for the two domains of tandem-repeat 
galectins when interacting with Gram-negative bacteria, one CRD serving for 
carbohydrate recognition and the other contributing to a loss of membrane integrity, 
leading to bacteria cleavage (Stowell et al., 2010), susceptibility of NTHi2019 to hGal-8 
having been reported (Stowell et al., 2014). Thus, the contrasting behaviour of the hGal-
8N and C- CRDs in the microarray binding assays could be reflecting these different 
roles. 
Based on the important increase in the binding of hGal-4C and hGal-8N to NTHi375 as 
a result of LOS overexpression, and on the impact of LOS truncation, the LOS appears 
to act as ligand for these CRDs. Therefore, their binding to array-printed LOSs was 
examined in comparison with the full-length galectins (Fig. 4.32). An important 
observation is that the behaviour of hGal-4 and hGal-8 paralleled that of their respective 
C- and N-domains, indicating that these CRDs are mainly responsible for the binding of 
the full-length proteins to the tested LOSs.  
For hGal-8, a stronger binding to ΔlgtF over ΔompP5 LOS was observed, but truncation 
of the LOS extension at Hep III in ΔlpsA dramatically reduced recognition (Fig. 4.32), 
Mutant strain
Lectin
ΔsiaB ΔlgtF Δlic2A ΔlpsA ΔlgtFΔlpsA ΔopsX ΔompP5
hGal-4N NO BINDING
hGal-4C 81 ± 5 76 ± 4 78 ± 6 49 ± 4 60 ± 6 92 ± 5 250 ± 17
hGal-8N 58 ± 6 89 ± 4 60 ± 5 41 ± 7 58 ± 8 68 ± 6 210 ± 6
hGal-8C 67 ± 3 150 ± 12 102 ± 10 131 ± 9 140 ± 10 99 ± 6 89 ± 66
> 150 % 150 – 115 115 – 85 85 – 50 50 – 25 < 25 %
Fig. 4.31 Relative binding strength of hGal-4 and -8 separate CRDs to NTHi375 microarrays. 
Binding of 0.5-5 μM CRDs in PBSβ to immobilised NTHi375 wild type and mutant strains, printed as 
triplicates at OD600 values 1 and 0.6, was assessed simultaneously, and the relative binding strength was 
calculated as percentage taking binding to wild type NTHi375 as 100%. Data shown correspond to the 
mean of at least 2 independent experiments and the standard error is indicated. 
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evidencing that this branch behaves as ligand for hGal-8N. Moreover, in the presence of 
0.1 M Lac a substantial inhibition of the binding to ΔompP5 (70-80%) and ΔlgtF (90-
92%) LOS was observed for both the full-length protein and N-domain, inhibition 
reaching values of up to 97% in the presence of 0.01 M 3´-sialyl-lactose, known to be a 
superior ligand for hGal-8N (Ruiz et al., 2014).
Fig. 4.32 Binding of hGal-4 and hGal-8 to NTHi375 LOSs. The LOSs were immobilised as triplicates 
at decreasing concentrations and the binding of 0.5 μM hGal-4 (magenta), hGal-4C (light magenta), hGal-
8 (cyan) or hGal-8N (light cyan) in PBSDTT was examined. Competition experiments were run with the 
full-length galectins in the presence of 0.1 M Lac (white). Only the two highest concentrations of printed
LOSs are shown. Error bars stand for the standard deviation of the mean.
An entirely different picture was obtained for hGal-4 (Fig. 4.32). Here, a noticeably 
higher binding to both ΔlgtF and ΔlpsA LOSs over the ΔompP5 LOS was detected. 
However, in all cases inhibition was hardly observed in the presence of Lac (Fig. 4.32), 
LacNAc, or its 3´/6´-sulphated derivatives (not shown). Contrarily, the binding was 
completely abolished by high ionic strength (1 M NaCl), indicating the involvement of 
electrostatic interactions. What is more, hGal-4 strongly bound to the isolated lipid A of 
NTHi375, binding being partially inhibited (~30%) in presence of 1’/6’-phospho-
GlcNAc, and to a greater extent (60-90%, depending on lipid A concentration) by 1 M 
NaCl (not shown). Taken together, the results argue for ionic, non-carbohydrate-
mediated interactions being the main forces driving NTHi375LOS recognition by hGal-
4. A further distinctive feature of hGal-4 was a significant increase in binding to both 
NTHi375 LOS and lipid A when the lectin was assayed in the absence of reducing 
agents (DTT or β-ΜΕ). Indeed, confocal microscopy demonstrated a dramatic increase 
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in bacteria agglutination under non-reducing conditions (Fig. 4.33). The rationale 
behind this behaviour will be the subject of future studies. 
At any rate, no effect of hGal-4 on the colony formation capacity of NTHi375, or on its 
adhesion to or invasion of pulmonary epithelium (cell line A549) was observed either in 
the absence or presence of reducing agents. 
Fig. 4.33 Effect of red-ox conditions on hGal-4 binding to NTHi375.
(a, b) hGal-4 binding (10 μM, red) to NTHi375 stained with SYTO® 13 (green) in the presence of 1 mM 
DTT. (c, d) hGal-4 binding (10 μM) in absence of reducing agent. In all cases, experiments were run in 
duplicates, pictures representing different preparations.
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4.2 Exploring glycosylation profiles of extracellular vesicles 
Our understanding of the mechanisms of intercellular communication and transport 
increased with the discovery that sub-micrometric membranous particles can act as 
carriers for “message exchange” (György et al., 2011b; Mittelbrunn and Sánchez-
Madrid, 2012). Extracellular vesicles (EV), encompassing exosomes (EXO), 
microvesicles (MV), and apoptotic bodies, are bilayer-enclosed assemblies originated 
from most mammalian cell types (Raposo and Stoorvogel, 2013), and isolated from 
conditioned cell culture media or biological fluids (blood, urine, breast milk, etc.) 
(Boukouris and Mathivanan, 2015). 
A clear-cut dissection of EVs’ composition and functional roles in health and disease is 
currently hampered by the diversity of approaches used for their characterisation, 
making the establishment of common guidelines essential (Lötvall et al., 2014). 
Isolation methodologies usually used, primarily based on differential centrifugation or 
density gradient separation, also complicate obtaining pure EV fractions. Consequently, 
the composition of EV preparations greatly varies depending on the protocol used. In 
addition, information on their long-term stability is limited (Kalra et al., 2013; 
Zonneveld et al., 2014). 
Physical characterisation of EV preparations at least requires observation of size, 
structure and morphology, while their concentration is expressed in terms of particle 
number, mass or, gradually more frequently, their biomolecular cargo (Rupert et al., 
2017). Aiming at retrieving data from proteomic, lipidomic and transcriptomic analyses 
(Choi et al., 2013), several web-based databases have been launched, as e.g.
Vesiclepedia (Kalra et al., 2012), EVpedia (Kim et al., 2013), and ExoCarta (Simpson
et al., 2012). The latter is a key resource for exosomal cargo (Keerthikumar et al., 
2016), unfortunately only offering comprehensive data for this EV subpopulation. 
 Still, descriptive studies on the dynamic glycan profile of distinct subpopulations from 
different sources are currently missing. In this context, only a limited number of reports 
have been published (Krishnamoorthy et al., 2009; Gomes et al., 2015), along with 
several studies suggesting a role in the MV internalisation by target cells (Escrevente et 
al., 2011), or focussing on glycan-mediated sorting of cargo into MV (Batista et al., 
2011; Liang et al., 2014), and on the search of cancer biomarkers (Melo et al., 2015).  
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Therefore, in this Thesis, we have aimed at developing a widely applicable analytical 
methodology for glyco-profiling distinct EXO and MV populations. The THP-1 human 
acute monocytic lymphoma cell line was selected as EV source. Characterisation of 
these populations have included determination of total protein cargo and lipid content, 
particle concentration by resistive pulse sensing (RPS), and morphology observation by 
transmission electron microscopy (TEM). Then, following immobilisation as 
microarray probes, recognition of EVs by our panel of lectins with diverse 
carbohydrate-specificities was examined. In addition, lectin-derivatised QCM chips 
were developed to enable “fishing” and detection of EXO in flow. Finally, binding 
kinetics for representative EVlectin pairs was investigated using EV-based QCM 
chips. 
4.2.1 Characterisation of THP-1-derived EXO and MV populations 
Quantitation and normalisation of EV preparations, an essential step prior to 
downstream assays, can be approached by determination of their total protein content. 
However, its use as single reference is devalued by the likely presence in the 
preparations of protein complexes and/or aggregate contaminants, which are ubiquitous 
in body fluids and culture media (György et al., 2011a). The “total” lipid determination 
using sulfuric acid and vanillin complement protein cargo measurements, and protein-
to-lipid ratios have recently proved to be suitable for distinguishing among EV 
subpopulations (Osteikoetxea et al., 2015). 
In this Thesis, the protein-to-lipid ratio and RPS measurements (section 3.3.2) were 
used for determination of EV concentration (Table 4.10). For all the preparations tested, 
EXO gave rather uniform size measurements of 90-110 nm (mean), whereas MV were 
highly heterogeneous, with a calculated mean of 220-270 nm and the occurrence of 
larger particles (Fig. 4.34, a). For selected preparations, TEM pictures were obtained 
(Fig. 4.34, b, for experimental details see section 3.3.3). Data for all preparations are 
given in Table 4.11. 
Membrane lipid order has also been reported to be a distinctive feature of different EV 
subpopulations (Osteikoetxea et al., 2015). An indirect yet easy way to infer the fluidity 
of membranes is to use polarity sensitive probes whose emission spectra change with 
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Table 4.11 Protein cargo, protein/lipid ratio and particle quantitation measurements for THP-1-
derived EV preparations
EXO MV
Protein
(μg/ml)
Lipid
(μg/ml)
Protein-
to-lipid
RPS
(U/ml)
Protein
(μg/ml)
Lipid
(μg/ml)
Protein
to-lipid
RPS
(U/ml)
THP-1a 0.2 0.85 0.2 9.1  1011 4.1 6.8 0.6 2.6  1011
THP-1b 13.05 59.7 0.2 5.2  1013 4.2 2.3 1.8* 1.4  1011
THP-1c 0.9 1.00 0.9* ND 0.9 0.8 1.2* ND
THP-1d 4.8 17.5 0.27 3.1  1012 3.1 5.7 0.5 ND
EVs were isolated from a THP-1 cell culture (in suspension) and purified as described in section 3.2. Lipid 
concentration was determined at the laboratory of Prof. E. Buzas (Semmelweis University, Budapest). RPS 
values correspond to stock preparations. The asterisk indicates protein contamination as confirmed by TEM (see 
Fig. 4.34, b). ND, not determined.
Fig. 4.34 Characterisation of the size and morphology of THP-1-derived EV.
(a) Representative RPS histograms for EXO (red) and MV (blue) of preparation THP-1. At least 500 
measurements were recorded for serial dilutions of EV preparations in PBS and particle concentrations 
calculated from each dilution for the stock preparation were merged into a single histogram for each 
subpopulation. Major peaks correspond to the mean size of particles and are representative of particle 
concentration (also see Table 4.11). (b) TEM images of EV preparations derived from THP-1 culture of 
advanced confluency and overnight vesiculation in serum depleted media (section 3.3.1). Vesicles were fixed 
in paraformaldehyde, post-fixed with OsO4, and the resin block was stained with uranyl-acetate (section 
3.3.3). The asterisks spot protein contamination.
the polarity of the environment (Parasassi et al., 1998). A ratiometric determination of 
general polarisation (GP) values was carried out by fluorescence spectroscopy, upon 
staining with the polarity-sensitive lipid probe di-4-ANEPPDHQ (section 3.3.4). The 
GP value was calculated from the difference in fluorescence intensity at 570 nm and 
630 nm (Fig. 4.35), resulting in values between −1 and +1, the higher the GP value the 
higher the lipid order (i.e. low liquid disorder and more packed membrane structure),. 
THP-1-derived EXO displayed GP values of 0.37-0.39, reflecting a remarkably higher 
*
*
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lipid order than MV, which displayed GP values of 0.07-0.1 (based on measurements on 
three different preparations of each subpopulation). These values were comparable to 
those previously reported (Osteikoetxea et al., 2015).  
Fig. 4.35 Ratiometric determination of 
EV membrane lipid order by 
fluorescence spectroscopy.
Representative emission spectra of THP-
1-derived EXO (red) and MV (blue) 
preparations stained with di-4-
ANEPPDHQ, upon excitation at 488 nm. 
Intensities corresponding to membrane 
ordered (570 nm) or disordered (630 nm) 
regions were used for ratiometric 
determination, as described in section 
3.3.4.
4.2.2 Preparation and validation of EV microarrays 
EV were printed onto nitrocellulose-coated glass slides as triplicates at increasing 
dilutions. Only preparations with a meaningful EV concentration and confirmed 
absence of protein contamination, as derived from the protein-to-lipid ratio and TEM 
measurements, were used. EV could not be fluorescently labelled following the 
approach previously described for bacteria (using thenucleic acid stain SYTO-13®) due 
to their random and rather low content in nucleic acids, yielding signals far below the 
detection limit of the microarray scanner. On the other hand, the lipid-packing indicator 
di-4-ANEPPDHQ emits in the “red” region upon excitation, thus interfering with our 
detection system based on the use of AlexaFluor®647. Therefore, for validation of the 
developed EV-microarrays the binding of specific anti-tetraspanin antibodies and lipid-
binding molecules (annexin V) was examined. Tetraspanins (CD63, CD9, etc.) have 
been proposed as exosomal markers due to their enrichment in this vesicle 
subpopulation, from 7- to 124-fold compared to the parental cells (Andreu and Yáñez-
Mó, 2014). They are also found on the plasma membrane of certain cell-types hinting at 
their presence also on MV. In addition, annexin V conjugates are conventionally used 
for MV detection, as they bind phosphatidylserine, which is “flipped” and exposed on 
the plasma membrane during vesiculation (Dachary-Prigent et al., 1993). 
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Both array-printed THP-1-derived EXO 
and MV populations were reliably 
detected by anti-CD63 antibody, the 
binding showing the expected 
concentration-dependent trend (Fig. 
4.36). Surprisingly, moderate binding 
signals to printed supernatants from 
EXO ultracentrifugation were detected, 
pointing to the presence of small size 
vesicles that may be lost using the 
conventional centrifugation protocol, as 
similarly noticed in recent studies on 
urinary extracellular vesicles (Musante
et al., 2017). Tested in parallel, annexin 
V-FITC did not bind THP-1-derived MV 
even upon buffer supplementation with 
10 mM Ca2+, in line with previous 
observations (Ismail et al., 2013). 
However, it selectively recognised 
blood-derived MV, what could result from the use of human blood without prior platelet 
depletion as starting source for EV isolation (Thiagarajan and Tait, 1990). 
In any case, both anti-CD63 antibody and annexin V bound to the immobilised vesicles 
in a dose-dependent manner, proving accessibility of vesicle surface epitopes and 
opening the way to EV glycoprofiling. 
4.2.3 Profiling of EV glycosignatures 
Screening of our panel of 19 biotinylated lectins of known binding specificities (see 
Table 3.2 for details) revealed noticeable differences in binding depending on the EV 
subpopulation (Fig 4.37). For all of the lectins, the specificity of the recognition was 
assessed in parallel assays carried out in the presence of their respective inhibitory 
hapten.  
Except for HPA and DSL, moderate to strong binding to THP-1-derived EXO and/or 
MV were observed for all the lectins, the Gal-specific VAA, RCA, and MAL-I 
Fig. 4.36 Validation of EV microarrays. NC-
printed THP-1- (triangles) and blood-derived 
(circles) EXO (red) and MV (blue) were incubated 
with anti-CD63 at 1:1000 dilution and binding was 
detected by use of a secondary biotinylated antibody 
and streptavidin-AF647 (circles for Alternatively, 
they were incubated with Annexin V-FITC (1:100) 
in Ca2+-containing buffer (diamonds). Open circles 
correspond to THP-1-derived EXO supernatants at 
the same dilution used for EV.. Data shown 
correspond to the mean of two different experiments 
and error bars indicate the standard deviation.
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agglutinins giving intense signals for both EV subpopulations. In general, similar lectin-
binding trends were observed, with the following significant exceptions. First, divergent 
binding intensities to EXO and MV were found when comparing PNA (exhibiting 
preference for Galβ(1,3)GalNAc) and WFA (specific for GalNAcα(1,3/6)Gal), and the 
same was found for HHL (preferentially recognizing Manα(1,3/6)Man) vs PSA (which 
shows a broad binding specificity towards Man, Glc, and GlcNAc), revealing a different 
availability of the recognized epitopes on the EV surfaces. Second, WGA (selective for 
GlcNAc and Neu5Ac) binding signals for MV almost doubled those for EXO, while the 
opposite was found for PSqL (specific for Neu5Acα(2,6)Galβ(1,4)GlcNAc/Glc). And 
third, a strikingly EV-selective behaviour of GNA (recognizing terminal 
Manα(1,3)Man) was observed, this lectin giving the strongest binding signals for EXO  
 populations and only very moderate signals for MV. The intense binding of ConA 
(Man/Glc specific) to EXO further supported a higher abundance of Man-containing 
structures on the EXO surface. Of note, GNA and ConA binding was only partially 
inhibited in the presence of 0.1 M α-Me-Man (Fig. 4.37), whereas 10 mg/ml mannan 
from S. cerevisae was able to reduce binding below 15% (not shown), indicating the 
establishment of high avidity GNA/ConA‒EXO interactions. 
Fig. 4.37 Binding of reference lectins to THP-1-derived EXO and MV
EXO (upper panel) and MV (lower panel) preparations were printed in triplicate at 0.1-3  1010 U/ml and 
the binding of biotinylated lectins in the absence (red/blue) and presence (white) of the respective lectin 
hapten (Table 3.2).was assessed by incubation with AF647-streptavidin. Data shown correspond to the 
mean of at least two experiments, each performed with different EV preparations. Error bars indicate the 
standard deviation of the mean.
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 In the case of blood-derived EV, strong binding signals for several lectins were also 
detected, although no clear binding trends were observed (not shown). This behavior 
could be due to the diversity of cells contributing to EV occurring in blood. Still, GNA 
exhibited a clear preference for EXO populations, arguing in favour of a highly-specific 
EXO glycosignature.  
Altogether, the results unveil differential glycosylation patterns for these two vesicle 
subpopulations that could be exploited for designing new isolation protocols based on 
lectin affinity chromatography. 
4.2.4 QCM-assisted detection of THP-1-derived EV under continuous flow 
Based on the microarray results suggesting specific recognition of THP-1 EXO 
populations by GNA, in-flow detection by a QCM biosensor was targeted. To this end, 
GNA-derivatised chips were prepared as detailed in section 3.6.1. GNA immobilisation 
through amine coupling yielded frequency shifts somewhat smaller than those observed 
for ConA (50 vs 70 Hz, mean values respectively), pointing to a poorer surface 
coverage. Nevertheless, the chips proved to be efficient EXO capturers. 
 For THP-1-derived EXO, remarkable frequency shifts were recorded, and the sensor 
response reached the steady state in a reasonable time upon injection (100 s) (Fig. 4.38). 
In contrast, THP-1-derived MV did not bind to the immobilised lectin, confirming the 
microarray results. The experiments were carried out with two different THP-1 EV 
preparations, showing good reproducibility, within the expected error limits for the 
estimated particle concentration (not shown). 
Fig. 4.38 Vesicle capture in flow by GNA-derivatised QCM chips.
1:10 dilutions in PBS of THP-1-derived EXO (red) and MV (blue) were injected at 20 μl/min and 22 ºC 
over a GNA-derivatised QCM chip (section 3.6.1). Samples were injected in duplicate, the mean sensor 
response being here presented.
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Sample scarcity precluded a full kinetic analysis of the interaction, and equilibrium 
analysis for KD calculation based on a single injection was not attempted, since the 
bound fraction may differ depending on the injected concentration and volume (Hunter 
and Cochran, 2016). Instead, since GNA was a confirmed capturer for EXO, we focused 
on the development of EXO-based sensor chips for the kinetic analysis of EXO-lectin 
interactions. 
4.2.5 QCM EXO-based biosensors: monitoring lectin-binding kinetics directly at 
the vesicle surface 
The concept and development of QCM EXO-based chips is described in detail in 
section 3.6.1, grounded on our previous observations with bacteria-based chips 
(Kalograiaki et al., 2016). EXO chips enabled real-time monitoring of the binding of 
selected lectins to the vesicle surface and, importantly, allowed the reliable calculation 
of rate constants without the need for reaching equilibrium. Efficient regeneration by a 
single injection of glycine pH 2.5 was also an important advance, preserving the vesicle 
surface while avoiding the use of buffers with ionic strength beyond the physiological 
values. To be mentioned, following EXO capture, chips were fixed with formaldehyde 
so that the vesicles become an integrated part of the sensor chip thereby allowing the 
use of efficient regeneration solutions for completely removing bound lectins between 
successive binding assays.   
Based on the microarray results revealing a distinctive behaviour of ConA, GNA, and 
PNA towards EXO vs MV, the interaction of these three lectins was examined. 
Examples of the sensograms obtained upon injection of the lectins in a range of 
increasing concentrations are shown in Fig. 4.39, unveiling lectin-specific responses. 
Comparison of the maximum frequency shift induced by injection of each lectin, after 
normalisation for the molecular mass, was consistent with a higher amount of GNA 
bound to the chip compared to ConA and PNA (Table 4.12), in full agreement with the 
binding trend observed in the microarray assays. For calculation of the kinetic 
parameters, experimental data were fitted using 1:1 or 1:2 binding models (Fig. 4.39). 
The first model was found suitable for fitting the binding profiles of ConA and PNA 
despite the signal noise. The dissociation rates for the two lectins were similar, but 
association was 10-fold faster for ConA, resulting in a proportionally higher binding 
affinity (Table 4.12). On the other hand, a 1:2 model was required for fitting the 
experimental data obtained for GNA, the difference in affinity between the two sets of 
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binding sites on the EXO surface primarily arising from a noticeably faster dissociation 
rate from the low-affinity sites. Overall, the dissociation constants calculated from the 
kinetic parameters differ in a 15-fold factor the maximum, being in the low micro-
/submicromolar range (Table 4.12). 
Fig. 4.39 Representative sensograms illustrating the binding of ConA, GNA and PNA to THP-1-
derived EXO. Lectins were injected at the following concentrations: (a) 10.6, 35, 70, 104 and 175 μg/ml 
for ConA; (b) 34, 52, 86, 104 and 156 μg/ml for GNA; (c) 73, 181, 220 and 330 μg/ml for PNA. The 
black lines in the sensogram represent experimental data, and the red lines the fits obtained using 1:1 
(ConA and PNA) or 1:2 (GNA) models.
Table 4.12 Analysis of the binding of the three lectins to EXO-derivatised QCM sensor 
chips.
ka
(M-1 s-1)
kd
(s-1)
KD
(M)
–Δf
(Hz)
Normalised
–Δf
(Hz/kDa)
ConA
1.81 ± 0.03
× 104
2.5 ± 0.1
× 10-3
1.4 ± 0.1
× 10-7 2.2 0.02
GNA
5.08 ± 0.05
× 103
6.1 ± 0.7
× 104
1.53 ± 0.01
× 10-3 
5.76 ± 0.07
× 10-2
3.01 ± 0.04
× 10-7 
9.4 ± 0.7
× 10-7
2.4 0.05
PNA
1.8 ± 0.1
× 103
3.7 ± 0.8
× 10-3
2.06 ± 0.7
× 10-6 1.7 0.02
The association rate (ka), dissociation rate (kd) and dissociation constant (KD) are derived from the 
fitting of the experimental data to 1:1 (ConA and PNA) or 1:2 (GNA) models. Frequency shifts (Δf) 
were recorded upon injection of 104 μg/ml of ConA, 104 μg/ml of GNA or 220 μg/ml of PNA. Molar 
concentrations were calculated considering molecular masses of 104 kDa for ConA, 52 kDa for GNA, 
and 110 kDa for PNA, and normalised –Δf values were calculated by dividing –Δf by the molecular 
mass of each lectin. Standard deviations of mean values are given.
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4.3 Evaluation of the functionality of bacterial adhesins and microarray-assisted 
screening of anti-adhesive compounds 
In the era of increasing antibiotic resistance, antivirulence has emerged as an alternative 
chemotherapeutic strategy, prompting the discovery of new bactericide or bacteriostatic 
molecules, as well as potential anti-adhesives (Escaich, 2008). Bacteria have evolved 
refined machineries aimed at actively invading target cells for replication and 
circumventing host immunity (Pizarro-Cerdá and Cossart, 2006; Kline et al., 2009). 
Bacterial adhesion is one of the very first steps of the infective process and is often 
mediated by carbohydrate–protein interactions, as in the archetypal  case of the E.coli
mannose-specific adhesin, FimH (Mulvey, 2002). 
As the interaction between a single sugar moiety and lectins is typically characterised 
by low intrinsic affinity, urinary tract infectious E.coli (strain UTI89) bears multiple 
copies of FimH, enabling the establishment of multivalent interactions with arrays of 
mannosylated uroplakin Ia present in the urothelium (Zhou et al., 2001), thereby 
increasing binding avidity and guaranteeing a strong adherence. The cluster glycoside 
effect may result in an increase in avidity of several orders of magnitude (Lundquist and 
Toone, 2002), what is particularly important for lectins showing low binding affinities 
towards monovalent ligands (Reichardt et al., 2013). Therefore, FimH multivalent 
ligands based on a variety of synthetic scaffolds (Chabre and Roy, 2013), as e.g. 
glycofullerenes, glycodendrimers, or nanodiamonds, have been synthesised  and 
assessed as anti-adhesives using different approaches, such as SPR, ELISA, 
heamagglutination, or bladder cell assays (Heidecke and Lindhorst, 2007; Gouin et al., 
2009; Durka et al., 2011; Barras et al., 2013).  
A novel microarray application in the field of preventive, anti-adhesive therapies is here 
presented. Microarrays were designed and developed for evaluation of the functionality 
of FimH in paraformaldehyde-fixed bacteria as well as in bacteria at different growth 
phases. A competitive binding assay was established, encompassing immobilisation of 
model multivalent ligands and the use of ConA for platform validation. Different 
mannose-bearing multivalent compounds were tested as inhibitors of ConA binding to 
the arrays, and SPR and ITC analyses of the interaction served to confirm the 
microarray-derived results. The validated microarray set-up was finally used for the 
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evaluation of glycofullerenes as inhibitors of bacterial adhesion to the array-printed 
ligands. 
4.3.1 Establishment of an efficient microarray set-up for evaluation of the 
functionality of E. coli FimH adhesin
The applicability of the established bacteria microarrays for detecting functional FimH 
on the surface of E. coli UTI89 was first examined. Fixed and SYTO® 13-labelled 
bacteria were printed  in both manual and robotic arrays and the binding  of biotin-
labelled α-heptyl-mannoside (MAF285, Fig. 3.13) at increasing concentrations was 
tested (up to 0.1 mM). No significant binding was detected, what could be in principle 
explained by a low affinity of FimH towards this monovalent ligand. Tested in parallel, 
moderate fluorescence signals were observed for the binding of this ligand to printed 
ConA (Fig. 4.40, a), although efficient inhibition (>75%) was not achieved for the 
higher ConA concentrations in the presence of α-Me-Man concentrations up to 0.2 M 
(Fig. 4.40, b). This observation suggested that non-carbohydrate-mediated interactions 
may occur upon NC-immobilisation. Similarly, bacteria printing could negatively have 
affected the functionality of FimH, conformational changes counting for its inability to 
bind the heptosyl-ligand (Rabe et al., 2011).
Therefore, a different microarray approach was next designed (Fig. 4.40, c). Mannan 
from S. cerevisae along with S. cerevisae cells and RNase B, a glycoprotein bearing a 
single high-mannose glycosylation site, were manually printed on NC-coated slides. 
Indeed, the mannose-binding activity of E. coli adhesins was previously studied using 
yeast agglutination assays (Ofek and Beachey, 1978), also including determination of 
the inhibitory activity of mannose-based compounds (Firon et al., 1983). Strong ConA 
Fig. 4.40 Towards the establishment of an efficient microarray set-up for assessing FimH functionality.   
(a) Binding of 0.1 mM MAF285 to ConA, immobilised in quadruplicates at decreasing concentrations.
(b) Competition experiment in the presence of 0.2 M α-Me-Man. (c) Binding of 0.4 μM biotinylated ConA to 
immobilised mannan (i), or unstained S. cerevisae cells (ii) at decreasing concentrations (duplicates shown). (d)
Respective competition experiments in the presence of 0.1 M α-Me-Man. (e) NC-slide incubation with SYTO 
62®-stained UTI89 (OD600=0.5). All experiments were carried out in HBS, pH 7.4.
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binding to these arrays was observed, and it was inhibited in the presence of 0.1 M α-Me-
Man (Fig. 4.40, d) confirming carbohydrate-dependent recognition. However, upon 
incubation with fixed SYTO® 62-stained UTI89, a thin film of bacteria was deposited 
over the whole NC membrane, even when continuous shaking was applied (Fig. 4.40, 
e). The consequent high background noise in the laser-scanned images precluded a 
quantitative or even qualitative assessment. Therefore this set-up was also discarded.
As alternative to NC-coated slides, the use of succinimide-activated hydrogel surfaces 
(H-slides) was then examined. Printing of neoglycoprotein ligands on hydrogel slides to 
enable bacterial capture had previously afforded quantifiable results, with low non-
specific binding or surface adsorption (Adak et al., 2013). Based on this precedent, 
mannan-poly-L-lysine (see section 3.5.1) and RNase B were immobilised on H-slides. 
Cy3®, which was successfully used for tracing probes upon arraying on NC-coated 
slides, was not useful in this case, since it is washed off during the deactivation and 
blocking steps (see 3.5.4.2.2). Thus, validation of the microarray set-up was carried out 
by examining the binding of ConA, as reliable binder of mannose-containing ligands. 
The expected concentration-dependent trend was observed for ConA binding, 
evidencing that both mannan–poly-L-lysine and RNase B probes were efficiently 
immobilised in H-slides (Fig. 4.41, a). Moreover, the binding signals were stronger than 
those observed for NC-slides prepared using the same probe dilutions, pointing to 
higher immobilisation efficiency and/or favoured presentation in the hydrogel matrix 
Fig. 4.41 ConA binding to mannan–poly-L-lysine and RNase B immobilized on NC and H 
microarray surfaces. (a)The probes were robotically printed in triplicates at decreasing concentrations 
and the binding of biotin-labelled ConA (0.4 μΜ) was monitored. White spots indicate detector 
saturation and correspond to mean rfu values >60,000. (b) Stability assessment of printed H-slides. 
Mannan–poly-L-lysine was printed as sextuplicates, and the binding of ConA (0.1 μM) was monitored 
immediately upon deactivation and blocking (t = 0), and after 6- or 12-month storage at -20 ºC. All 
experiments were carried out in HBS, pH 7.4.
(a) (b)
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for ConA binding over the NC arrays. Of note, comparable ConA binding to freshly 
prepared H-slides or after 6- or 12 month storage at -20 ºC was observed (Fig. 4.41, b), 
demonstrating that a set of simultaneously printed slides can be used for comparative 
testing of different lectin/bacteria targets for at least 1 year.  
Having proved the applicability of the established H-arrays for lectin-binding assays, 
we next examined the binding of fixed SYTO® 62-stained UTI89 (harvested at the 
stationary growth phase) at different dilutions of OD600 up to 1. Bacteria deposits and 
film formation were not observed in this case. However, binding to the printed probes 
was neither observed (Fig. 4.42, a). A possible explanation was that FimH could be 
damaged by paraformaldehyde fixation, which might result in secondary structure 
“lock-in” or cross-linking aggregation (Hopwood, 1969; Mason and O'Leary, 1991). 
Down-regulation of FimH expression during the stationary phase of UTI89 could also 
account for the lack of binding.  
Comparative binding experiments with live non-fixed bacteria in stationary and 
exponential growth phases revealed that both factors are decisive (Fig. 4.42). Thus, an 
aliquot of the bacterial culture was withdrawn during the logarithmic growth phase 
(OD600 = 0.3-0.5), and the rest was allowed to reach the stationary phase (OD600 above 
1) before being harvested and stained. Live, non-fixed UTI89 in the exponential growth 
phase strongly bound to both RNase B and mannan–poly-L-lysine in a probe 
Fig. 4.42 Binding of UTI89 to mannan–poly-L-lysine printed on H-slides. The binding of SYTO 62®-
stained UTI89 (OD600 = 1 in HBS, pH 7.4) to decreasing concentrations of mannan–poly-L-lysine, printed 
as sextuplicates, was tested. (a) Stationary phase fixed bacteria (b) Stationary phase non-fixed (live) 
bacteria (c) Exponential growth phase not-fixed (live) bacteria. (d) Inhibition of exponential growth phase 
bacteria binding in presence of 0.1 M α-Me-Man. (e) Mannan concentration dependence of the binding to 
the arrays of UTI89 in exponential growth phase. All experiments were carried out in HBS, pH 7.4.
(e)
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concentration-dependent manner (Fig. 4.42, c,e), and the binding was successfully 
inhibited in the presence of 0.1 M α-Me-Man (Fig. 4.42, d), evidencing carbohydrate-
mediated recognition. In striking contrast, live bacteria in the stationary growth phase 
only gave weak binding signals (Fig. 4.42, b), and paraformaldehyde-fixation 
completely abolished binding (Fig. 4.42, a).  
Indeed, expression of type 1 fimbriae in E. coli is subject to phase-dependent control, 
and transcription of fimA, the gene encoding the fimbrial subunit protein is repressed as 
cells enter the stationary phase (Dove et al., 1997). Thus, the established microarray set-
up can be used to discriminate between fimbriate and afimbriate states by assessing 
FimH-mediated binding.  
4.3.2 Microarray-assisted screening of anti-adhesive compounds 
The efficient mannose-specific binding of live UTI89 to the mannan microarrays could 
also serve as platform for the evaluation of compounds as inhibitors of FimH-mediated 
bacterial adhesion. To explore the applicability of the approach, we again used ConA as 
model lectin, also allowing validation by other techniques of the microarray-derived 
results.
4.3.2.1 Testing of silica-core glyconanoparticles as inhibitors of ConA 
Despite their widespread use for drug targeting (Zhou et al., 2015), sensing or 
fluorescent detection (Hao et al., 2016), the study of the interaction of lectins with silica 
nanoparticles (SNPs) covered with sugars started relatively recently (Wang et al., 2011; 
Wang et al., 2013; Kong et al., 2015). In this Thesis, α-Me-Man- and α-Me-diMan- 
[Manα(1,3)Man-α-OMe] derivatised SNPs were synthesised as described in section 3.4, 
and evaluated for their binding capacity to ConA. Photo-initiated coupling of the 
underivatised sugars on PFPA-activated NPs, yielded GNPs carrying 14 and 4.3 μmol 
of α-Me-Man and α-Me-diMan-NPs, respectively, per g of particle, as quantified by the 
phenol/sulfuric acid method using bare NPs as blank. The quantity of immobilised α-
Me-Man on the SNP-surface was comparable to that previously reported for Man- and 
Gal-conjugated SNPs (Kong et al., 2015). 
The activity of the GNPs as inhibitors of 0.4 μΜ ConA binding to mannan–poly-L-
lysine  and RNase Bin the Slide H set-up was first examined. However, no inhibition 
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was observed at any printed mannan/RNase B concentration, even when using GNPs 
concentrations up to 9 mg/ml. Thus, the binding avidity of ConA for immobilised, 
clustered ligands was noticeably superior to its affinity for the tested GNPs. Therefore, 
an alternative set-up was arranged, involving binding of unlabelled ConA to the mannan 
arrays followed by incubation with biotinylated heptyl mannoside (MAF285, see Fig. 
3.13) in the absence or presence of GNPs. Because incubation with heptyl mannoside 
alone could result in inhibition of ConA binding to some extent, extensive control 
experiments were run in order to establish the most appropriate working concentrations 
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Fig. 4.43 Inhibition of heptyl mannoside-binding to ConA by GNPs. (a) ConA was anchored on mannan–poly-L-
lysine printed as sextuplicates at different concentrations on hydrogel slides, and the binding of 0.1 mM MAF285 to 
ConA was next tested in the absence (–) and presence of α-Me-Man-, α-Me-diMan, or Gal-NPs and underivatised NPs 
(SNPs-PFPA). (b) Fluorescence intensity of MAF285 bound to ConA, anchored on 6 mg/ml (orange) or 3 mg/ml 
(purple) mannan–poly-L-lysine, in the presence of increasing concentrations of α-Me-Man- (triangles) or α-Me-
diMan-NPs (circles). Data correspond to the mean fluorescence intensity of sextuplicates and the error bars to the 
standard deviation to the mean. (c) Inhibition percentage of MAF285 binding to ConA anchored on 6 mg/ml mannan–
poly-L-lysine. Symbols are as in (b). Data points represent the mean of at least two independent experiments and error 
bars correspond to standard error values.  All experiments were performed in HBS, pH 7.4.
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for both the lectin and MAF285. Using 0.8 μM ConA and 0.1 mM MAF285, 
fluorescence signals for MAF285 binding to ConA were in the linear range, enabling 
the evaluation of GNPs in competition experiments (Fig. 4.43). Both α-Me-Man- and α-
Me-diMan-NPs were effective inhibitors of MAF285 binding to ConA, whereas neither 
Gal-NPs nor bare PFPA-derivatised NPs competed with MAF285 (Fig. 4.43, a), 
demonstrating the specificity of the inhibitory activity of the Man-derivatised NPs.
The inhibitory potential of α-Me-Man-NPs was slightly but consistently higher than that 
observed for α-Me-diMan-NPs (Fig. 4.43, b-c), what could be due to the smaller sugar 
content of the latter. Fifty per cent inhibition was observed around 3-6 mg/ml of GNP, 
which in terms of molar concentration of sugar corresponded to 4.2-8.4 × 10-5 M of α-
Me-Man and 1.3-2.6 × 10-5 M of α-Me-diMan, respectively. In order to assess how 
these sugar concentrations compare with the binding affinity of ConA for the respective 
free sugars in solution, the association constants were determined by ITC.  
Data obtained from the calorimetric 
titration of ConA with both saccharides 
could be fitted to a one-set-of-sites 
model, Fig. 4.44. The thermodynamic 
parameters derived from the analysis 
are given in Table 4.13. The 
stoichiometric values (N) suggested 
that only 80% of lectin subunits in the 
batch used for the analysis efficiently 
bound mannose. Both interactions 
were enthalpically driven, with an 
unfavourable entropic contribution, as 
usually observed for lectin‒sugar 
interactions. The enthalpy change 
associated to the binding of the 
monosaccharide was lower than for the 
disaccharide, in line with previous 
reports (Williams et al., 1992).  
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Fig. 4.44 Calorimetric titration of ConA with α-Me-
Man (■) and α-Me-diMan (●) at 25 °C. ConA was 
loaded in the calorimeter cell at 270-300 μM in HBS, 
pH 7.4, and each ligand was injected in a stepwise 
fashion. Continuous lines correspond to data fit to a
one-set-of-sites model.
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More significantly, the binding affinity of ConA for α-Me-Man was 3.4-fold lower than 
for α-Me-diMan. Thus, the difference in affinity fully accounts for the comparable 
inhibitory activity of α-Me-Man- and α-Me-diMan-NPs on MAF285 binding to ConA 
in the microarray competition assays, despite the 3.2-fold difference in sugar content. 
Table 4.13 Thermodynamic parameters for the binding of α-Me-Man and α-Me-diMan to 
ConA at 25 ºC
Compound N Ka (M-1) ΔH
(cal·mol-1)
ΔS
(cal·mol-1·degree-1)
α-Me-Man 0.772 ± 0.004 (8.77 ± 0.09) × 103 -7985 ± 55 -8.74
α-Me-diMan 0.759 ± 0.002 (3.02 ± 0.04) × 103 -9370 ± 40 -10.9
On the other hand, assuming that the binding affinity of ConA for MAF285 is 
comparable to that measured for α-Me-Man, dissociation constants of 2.2-4.5 × 10-5 M 
and 0.7-1.4 x 10-5 M can be estimated for the α-Me-Man- and α-Me-diMan GNPs, 
respectively, which represent 2.5-5.2- and 2.4-4.7-fold enhancements in inhibitory 
activity of the GNPs over the free ligands. Still, these enhancements were not sufficient 
for achieving efficient inhibitory activity on the binding of ConA to immobilised 
ligands such as mannan–poly-L-lysine or RNase B. For detailed calculation of the 
dissociation constants here describe please see Annex V. 
A random orientation of sugars when clicked on PFPA, the density or/and proximity of 
the silica core could be a possible explanation for the lack of a more significant 
clustering effect (Weber et al., 2014) that could favour ConA recognition. Indeed, 
appropriate presentations should result in affinity enhancements of more than one order 
of magnitude in the case of monovalent ligands (Weber et al., 2014). Thus, future work 
should address the optimisation of the photo-initiated coupling mechanism for 
functionalisation of PFPA-SNPs. At any rate, since the silica-based GNPs did not prove 
to be suitable candidates as efficient inhibitors of FimH-mediated bacterial adhesion, we 
next tested different glycofullerenes as alternative multivalent compounds with well-
characterised sugar-derivatisation, again using ConA for initial evaluation. 
4.3.2.2 Testing of glycofullerenes as inhibitors of ConA 
Four fullerene hexakis-adducts, synthesised at the laboratory of Prof. Stéphane Vincent 
(University of Namur/FUNDP, Belgium), were evaluated (Fig. 4.45), three of them 
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carrying 12 peripheral α-Man residues grafted onto the C60 core by different spacers 
(compounds 1-3), and the fourth one bearing 12 peripheral Gal moieties (compound 4), 
to be used as negative control. Glycofullerenes were obtained by a ‟click” reaction 
between monovalent azido-sugars and the trimethylsilyl-protected polyalkyne fullerene 
scaffold, Fig. 4.45 (Iehl and Nierengarten, 2009; Nierengarten and Nierengarten, 2014), 
and their structure was confirmed by 1H and 13C NMR, infrared and mass spectroscopy 
(Abellán Flos, 2015). 
Fig. 4.45 Synthesis and illustration of the tested fullerene hexakis-adducts, bearing 12 peripheral 
hexose moieties. “Clicking” of monovalent azido-sugars (Rn-N3) on the trimethylsilyl (TMS)-protected 
polyalkyne fullerene scaffold was assisted by tetrabutylammonium fluoride (TBAF) in presence of 
CuSO4/NaAsc (0.1/0.3 eq) in THF/DMSO/H2O (3:3:1), 72 h at room temperature.
The heptosyl-mannose residue (compound 3), acknowledged to be an excellent ligand 
for FimH, was included to enable comparisons with existing literature (Bouckaert et al., 
2005; Compain et al., 2010; Nierengarten et al., 2010; Durka et al., 2011), although its 
high hydrophobicity and poor water-solubility was reported to be disadvantageous. 
Therefore, flexible polyethyleneglycol (PEG) spacers of distinct length were employed 
for glycofullerenes 1, 2, and 4. 
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4.3.2.2.1 Microarray assay 
Glycofullerenes 1, 2, and 4 were first tested as inhibitors of the binding of biotinylated 
ConA (0.4 μΜ) to mannan–poly-L-lysine and RNase B printed on H-slides, using 
fullerene concentrations up to 0.1 mM. Fullerene 3 was not tested in this set-up due to 
its poor solubility and limited availability. As the derived fluorescence signals for 
ConA-binding reached plateau for mannan concentrations above 0.3 mg/ml (also see 
Fig. 4.2, a), but were in linear range for all four tested concentrations for RNase B, the 
latter was selected for the evaluation of the inhibitory potential of the glycofullerenes.
A dose-dependent inhibition by mannofullerenes 1 and 2 was observed (Fig. 4.46), 
whereas the galactofullerene had no effect, in agreement with ConA’s carbohydrate-
binding specificity. Sigmoidal fitting yielded inhibition curves from which IC50 values 
in the submicromolar range were estimated (Fig. 4.46 and Table 4.14). Interestingly, the 
IC50 value obtained for mannofullerene 2 was slightly below that obtained for 
mannofullerene 1, suggesting that the longer and flexible PEG linker may provide 
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Fig. 4.46 Inhibition of ConA binding to RNase B 
by mannofullerenes 1 and 2. The binding of 
biotinylated ConA (0.4 μΜ) to RNase B printed at 1 
mg/ml on H-slides was tested in the absence and 
presence of increasing concentrations of 
mannofullerenes 1 (green) or 2 (blue) in HBS, pH 
7.4. For calculation of IC50 values, the results were 
fitted to a sigmoidal curve.
Table 4.14 Inhibitory capacity of the compounds tested on ConA binding to RNase B
Compound IC50 (M)
Relative inhibitory potential
Relative potencya Normalised potencyb
Mannofullerene 1 (6.41 ± 0.07) × 10-7 713 59.4
Mannofullerene 2 (4.20 ± 0.09) × 10-7 1088 90.7
a-Me-Man (4.6 ± 0.5) × 10-4 1 1
a Relative potency taking the IC50 value obtained for α-Me-Man as unit. b Relative potency normalized per 
Man moiety.
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additional spatial freedom and/or less steric hindrance to the attached mannose moieties, 
thereby facilitating the binding to ConA. 
The inhibitory capacity of both mannofullerenes was compared to that of α-Me-Man, 
which was included as reference in all series of measurements. Of note, the IC50 value 
obtained for the monovalent hapten (457 μM) was similar to those derived from 
enzyme-linked lectin assays in plate format (530-870 μM), also using mannan as the 
immobilised ligand (Roy et al., 1998; Köhn et al., 2004). Thus, a strong multivalency 
effect was observed for the mannofullerenes tested, with an increase of up to 90-fold in 
inhibitory potency when normalised per Man moiety (Table 4.14). In order to confirm 
direct binding of ConA to mannofullerenes 1 and 2, we next performed SPR analyses of 
ConA-fullerene interactions.
4.3.2.2.2 Surface plasmon resonance analyses 
SPR has been widely employed to investigate the different factors contributing to the 
binding enhancement arising from the glycocluster effect, using a variety of 
experimental set-ups (Mann et al., 1998; Hernáiz et al., 2002; Munoz et al., 2013; 
Bayón et al., 2016). In this work, ConA was immobilised at acidic pH on Biacore®
sensor CM5 chips, as described in section 3.6.2, yielding an approximate response of 
2000 RU. The functionality of immobilised ConA was confirmed by injecting 4.3 μM
RNase B) over the chip, what resulted in a 100 RU increase. Mannofullerenes 1 and 2, 
as well as the galactofullerene as negative control, were then systematically tested under 
identical conditions in at least two independent experiments using different chips. Mild 
regeneration conditions were optimised to yield at least 95% of surface regeneration 
with a single injection.
Mannofullerenes 1 and 2 gave positive and concentration dependent signals (Fig. 4.47, 
left), the interaction apparently following pseudo-first order kinetics, whereas injection 
of galactofullerene resulted in no response (Fig. 4.47, right), proving the absence of 
non-specific interactions. Maximal response data were plotted versus the fullerene 
concentration (Fig. 4.48) and, the dissociation constants (KD) were calculated in 
equilibrium following a 1:1 interaction model (see section 3.6.2), yielding satisfactory 
Chi2 values (Table 4.15). 
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Fig. 4.47 Representative sensograms for the binding of mannofullerene 1 and galactofullerene to ConA 
immobilized on CM5 chips. Left panel: mannofullerene 1was injected at 0.25 (red), 0.5 (green), 1 (blue), 2 
(cyan), 3 (magenta), 5 (yellow) 7.5 (dark yellow), and 10 µM (navy) in HBS, pH 7.4, followed by 100 s of 
buffer flow, corresponding to the dissociation phase, and a single 20-s injection of 10 mM glycine-HCl, pH 3.0,
achieve at least 95% regeneration of the surface. Right panel: for galactofullerene, only the two highest 
concentrations, 7.5 (dark yellow) and 10 µM (navy) were tested, resulting in no response. Performed at 22 °C.
Table 4.15 SPR-derived parameters of mannofullerene binding to immobilised ConA  
Mannofullerene KD (M) Rmax (RU) Chi2(RU2)
1 (2.1 ± 0.4) × 10-6 132 ± 5 6.91
2 (1.5 ± 0.1) × 10-5 125 ± 2 1.38
Data processing and analysis were carried out with Biacore X-100 evaluation software applying the one-
set-of-sites model (1:1).
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Fig. 4.48 Maximum resonance shift detected for the binding of mannofullerenes 1 and 2 to ConA 
immobilised on CM5 chips. Mannofullerenes 1(left panel) and 2 (right panel) were injected at different 
concentrations, as described in the legend to Fig. 4.47, and the maximum response was plotted as a function of 
fullerene concentration.
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The obtained KDs were within the sensitivity limits reported for the Biacore® instrument 
used in this study, i.e. 10-3-10-6 M (Hall et al., 1996). Unexpectedly, the KD for 
mannofullerene 1 was one order of magnitude lower than for mannofullerene 2, a trend 
opposite to that observed in the microarray set-up, in which both ConA and the 
mannofullerene are in solution. A similar trend was witnessed before by an SPR 
competition assay applied in the evaluation of the ConA-inhibitory potential of 
mannose-derivatised gold NPs bearing linkers of distinct length (Lin et al., 2003).   
At any rate the longer PEG spacer of mannofullerene 2 apparently disfavours the 
establishment under flow of multivalent contacts with ConA immobilized on the SPR 
chip, whereas it seems to facilitate the binding when the lectin is also in solution 
(microarray assay). To evaluate this hypothesis and in order to determine the 
thermodynamic parameters of the interaction, an ITC analysis was carried out. 
4.3.2.2.3 Isothermal titration calorimetry analysis of ConA-mannofullerene 
binding 
 ConA (at 79-90 μM monomer concentration) was titrated with 0.2 mM solutions of 
glycofullerenes at the temperature used for the microarray and SPR analyses, i.e. 22 ºC. 
Titration with galactofullerene yielded small endothermic ITC signals (Fig. 4.49)
similar to those obtained for compound dilution, as expected for the absence of 
interaction.
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Fig. 4.49 Calorimetric titration of ConA with glycofullerenes.
Representative raw calorimetric data obtained upon 18 automatic injections of mannofullerene 1 (black), into 
the cell containing 90 μM ConA. The blue peaks correspond to the heat of dilution of the mannofullerene 
when injected into the cell filled with buffer.  Red peaks correspond to raw calorimetric data obtained for the 
titration of ConA with galactofullerene. All the titrations were carried out in HBS, pH 7.4, at 22ºC.
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In contrast, significant exothermic signals were obtained upon titration of ConA with 
mannofullerenes 1 and 2 (Fig. 4.49 and 4.50). Titration curves of several independent 
experiments are shown in Fig. 4.50. For calculation of the binding parameters, the 
“ligand-in-cell” analysis option was used, enabling the determination of the number of 
binding sites for ConA per mannofullerene molecule. Mean thermodynamic parameters 
derived from at least three independent experiments are compiled in Table 4.16. 
Interestingly, the number of binding sites for ConA per fullerene varied between 6-8 for 
mannofullerene 1 and 6-9 for mannofullerene 2, depending on the experiment, 
indicating that simultaneous binding of ConA to the 12 mannose residues per molecule 
was not possible, most likely due to steric hindrance effects. It has been reported for the 
ConA tetramer that it presents two sites on each face, the distance between them being 
6.5 nm (Derewenda et al., 1989). Worth mentioning, at pH 7.4 ConA forms bulky 
tetramers (Senear and Teller, 1981) that might obstruct access to neighbour mannose 
residues. In the same context, tetramerisation also qualifies ConA as multivalent  
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Fig. 4.50 Analysis of data derived from calorimetric titration of ConA with mannofullerenes 1 and 2.
Two different preparations of ConA at 79 (red) and 90 μM (black) were used for the titration with 
mannofullerenes 1 (right panel) and 2 (left panel). Circles and squares correspond to experimental data obtained 
for two independent experiments, and the solid lines to the fit of the data using a one-set-of sites model and the 
“ligand-in-cell” analysis option. The mean of functional monomer concentration N, calculated for the used batch 
of ConA , was applied as input for ligand concentration in the fitting of the dodecamannosylated fullerene 
titrations. All experiments were carried out in HBS, pH 7.4, at 22 ºC.
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receptor, thus enabling the formation of cross-linked complexes. Indeed, samples 
recovered from the calorimeter cell upon completion of the experiments were cloudy, 
proving extensive cross-linking at saturation. 
The enthalpy changes (ΔΗ) associated to the binding of both mannofullerenes were 
identical, but the entropic penalty (ΔS) was smaller for mannofullerene 2, resulting in a 
2.9-fold higher association constant, in line with the tendency observed in the 
microarray competition experiment. This observation concerning the length of linker 
was consistent with the reported by others (Chien et al., 2008; Wang et al., 2010) for 
comparable systems and experimental conditions (in-solution evaluation).
In order to assess the effect of glycofullerene’s multivalent presentation of Man residues 
on the binding affinity towards ConA, titrations were also performed using α-Me-Man 
and the Man-derivative serving as precursor of mannofullerene 1 (i.e., the azido-sugar 
containing the PEG spacer of this mannofullerene, designated as compound 1a) (Fig. 
4.51). The thermodynamic parameters obtained for the binding of α-Me-Man to the 
specific ConA preparation used in this case (Table 4.16) were very similar to those 
reported in Table 4.I, thus validating the results of the two sets of ITC experiments.  The 
Ka was found to be 16-45-fold lower than that measured for the mannofullerenes, in line 
with the relative potency trend observed in the microarray competition assays. 
Table 4.16 Thermodynamic parameters for the binding of ConA to mannofullerenes 1 and 2 
and to α-Me-Man and the monovalent Man-derivative bearing the spacer of mannofullerene 1 
(compound 1a)
Compound Na Ka
(M-1)
ΔH
(cal/mol)
ΔS
(cal/mol/degree)
Mannofullerene 1 6.8 ± 0.2 (1.5 ± 0.3) × 105 -(1.01 ± 0.03) × 104 -10.63
Mannofullerene 2 7.4 ± 0.2 (4.3 ± 0.6) × 105 -(1.01 ± 0.03) × 104 -8.88
α-Me-Man 0.862 ± 0.002 (9.48 ± 0.05) × 103 -(7.74 ± 0.03) × 103 -7.99
1a 1.45 ± 0.01 (7.0 ± 0.1) × 103 -(5.21 ± 0.04) × 103 -0.05
1ab 1 (7.0 ± 0.1) × 10
3 -(7.55 ± 0.04) × 103 -7.98
a For mannofullerenes 1 and 2, N represents the number of mannose residues occupied by ConA per 
dodecamannosylated fullerene. For α-Me-Man, N corresponds to the relative number of functional ConA 
monomers calculated for that specific batch of lectin. For compound 1a, N corresponds to the number of 
molecules calculated to be recognised per ConA site. Except for the second set of values given for 1a, Ka, ΔH, 
and ΔS (cal/mol/degree) are calculated per mole of sugar. b Recalculation of thermodynamic parameters per 
mole of ConA monomer. Data for mannofullerenes 1 and 2 correspond to the mean of at least three individual 
experiments.
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The Ka value obtained for compound 1a 
was comparable to that obtained for α-
Me-Man (Table 4.16). However, the
binding stoichiometry approached 1.5 
molecules of 1a per ConA subunit, 
resulting in lower enthalpy and entropy 
changes per mole of sugar. This 
behaviour could be attributed to self-
association or formation of an 
aggregate or other self-assembled 
structure, as recently brought up 
elsewhere (Kong et al., 2016). Indeed, 
the capacity of compounds bearing 
oligo(ethyleneglycol) linkers to form 
self-assembled monolayers has been 
described (Harder et al., 1998). On 
these terms, the minimal (if existent) entropic cost of the ConA interaction with 
compound (1a) would argue for the formation of a higher-order assembly. Recalculation 
of ΔH and ΔS per mole of ConA monomer yielded values very similar to those obtained 
for α-Me-Man, indicating that the presence of the PEG spacer does not affect 
recognition of the sugar moiety. Moreover, the results evidenced that grafting of 1a onto 
the fullerene core resulted in an approximate 20-fold enhancement in the binding 
affinity. 
Overall, ITC data fully supported the binding trends observed in the microarray 
competition experiments, with both mannofullerenes exhibiting a noticeably higher 
inhibitory activity compared to the free monosaccharide. Thus, having validated the 
microarray set-up for evaluation of the glycofullerenes as inhibitors of ConA, we were 
in a position to examine their inhibitory potential on E. coli binding to mannan 
microarrays.   
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Fig. 4.51 Calorimetric titration of ConA with α-Me-
Man and compound 1a. Con A (239 μM) was titrated 
with 15 mM α-Me-Man (■) or compound 1a (●) in 
HBS, pH 7.4 at 22 ºC. Continuous lines correspond to 
the fit to one-set-of-sites model.
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4.3.2.3 Testing of glycofullerenes as E. coli anti-adhesives 
The binding of live SYTO®62-stained UTI89, in exponential growth phase, to mannan 
printed on H-slides was examined in the absence and presence of increasing 
concentrations of glycofullerenes, this time including mannofullerenes 1, 2, and 3, 
together with the galactofullerene as control for specificity. 
As illustrated in Fig. 4.52 a, for mannofullerene 1, the binding was efficiently inhibited 
by mannofullerenes at concentrations as low as 0.3 μM. In comparison, the presence of 
0.3 μM α-Μe-Man produced no meaningful inhibition (Fig. 4.52 b), evidencing the 
increase in inhibitory activity resulting from the multivalent presentation of the sugar on 
the fullerene scaffold. In contrast, the galactofullerene did not show any inhibitory 
effect, in agreement with the specificity of FimH towards mannosides (Bouckaert et al., 
2005). Moreover, this result evidenced that neither the fullerene core nor the PEG 
spacer (the same as for mannolullerene 1), are involved in non-specific interactions that 
could affect FimH functionality. Thus, the inhibitory activity of the mannofullerenes 
can be confidently attributed to specific carbohydrate-mediated interactions.  
Inhibition curves were built by semi-logarithmic plotting of the percentage of inhibition 
of UTI89 binding to mannan printed at 6 mg/ml versus the concentration of  
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Fig. 4.52 Inhibition of the binding of FimH-expressing UTI89 by mannofullerenes. (a) The binding of live 
SYTO®62-stained bacteria in exponential growth phase to different concentrations of mannan–poly-L-lysine, 
printed as sextuplicates, was tested in the absence and presence of increasing concentrations of mannofullerene 1.  
(b) Fluorescence intensity of  bacteria bound to mannan,  printed at increasing concentrations, in the absence ( ) 
or presence of 0.3 μΜ of mannofullerenes 1 ( ), 2 ( ), and 3( ), and of  galactofullerene ( ). α-Μe-Man at 0.3 
μM ( ) or 10 mM ( ) was used as reference.
(a) (b)
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mannofullerene, and sigmoidal fit to 
the data (Fig. 4.53). IC50 values were 
estimated from these curves (Table 
4.17). The three mannofullerenes 
exhibited a clearly enhanced 
inhibitory activity compared to α-Me-
Man, with 5 to 18-fold higher relative 
potencies per mannose residue. 
Mannofullerene 3 was 2.6-3.6-fold 
less potent inhibitor than 
mannofullerenes 1 and 2, which 
contain flexible PEG spacers. 
Moreover, mannofullerene 2 was
slightly more efficient than 
mannofullerene 1, which bears a
shorter spacer, following the same trend than in the case of ConA. Thus, the results 
indicate that mannose grafting to the fullerene core through flexible and appropriately 
long spacers facilitates binding to FimH, a lectin that presents a deep binding pocket 
(Bouckaert et al., 2005; Durka et al., 2011).
Table 4.17 Inhibitory capacity of the compounds tested for UTI89 binding to immobilised 
mannan
Compound IC50 (M)
Relative inhibitory potential
Relative potencya Normalised potencyb
Mannofullerene 1 (1.99 ± 0.06) x 10-7 154 13
Mannofullerene 2 (1.42 ± 0.02) x 10-7 215 18
Mannofullerene 3 (5.2 ± 0.2) x 10-7 59 5
α-Me-Man (3.1 ± 0.2) x 10-5 1 1
a Relative potency calculated taking the IC50 value for α-Me-Man as unit. b The normalised potency 
corresponds to the relative potency divided by the number of sugar residues per fullerene molecule (12).
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Fig. 4.53 Inhibitory activity of mannofullerenes on 
UTI89 FimH-mediated binding to immobilised 
mannan–poly-L-lysine. Bacteria binding to the highest 
mannan concentration (6 mg/ml) was tested in the 
presence of  increasing concentrations of 
mannofullerene 1 ( ), 2 ( ), and 3( ). Data shown are 
the mean of at least four different experiments and error 
bars indicate its standard deviation. Solid lines  
correspond to a sigmoidal fit to experimental data.
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5.1 Pathogen-derived glycosylation patterns: typification and prospects for the 
establishment of virulence correlations 
Bacteria-based microarrays have proved to be an efficient high-throughput tool for 
screening glycosignatures of NTHi, a highly variable pathogen, lacking capsular 
polysaccharides and large O-antigen-containing LPSs, thereby expanding the 
applicability of an approach previously developed in our laboratory (Campanero-
Rhodes et al., 2015). Besides the semi-quantitative data derived from the microarray 
binding analysis as for binding avidity, detailed information on the affinity and kinetics 
of lectin binding to entire bacteria cells could be obtained using the tailored QCM 
bacteria chips and real-time binding assays with label-free lectins (Kalograiaki et al., 
2016). Evidently, the two methods benefitted from each other, the microarray screening 
pointing to relevant candidates for bacterial capture and kinetic analysis, and the QCM 
providing real-time insights into the interactions occurring at the native bacterial 
surface, thus closely reflecting the real lectin-bacteria interplay. 
Since bacterial virulence often correlates with the carbohydrate structures displayed and 
their recognition, or lack of recognition, by lectins of the innate immune system (Sahly
et al., 2008), the microarray approach proved to be a useful tool for exploring these 
features. In the case of NTHi, the extensive inter-strain heterogeneity in glycosylation 
patterns is likely to be strategic for its commensal behaviour, the comparison of 
concrete glycosignatures and their recognition by endogenous lectins aiming to aid in 
the establishment of functional and clinical correlations. In the microarrays the lectin-
binding fingerprint for the tested isolates and mutants revealed the presence of specific 
carbohydrate structures to be potentially recognised by lectins of the innate immune 
system with the appropriate carbohydrate-binding specificity. As significant example, 
recognition of NTHi clinical isolates by WGA followed a similar trend as Siglec-14 
(section 4.1.8) both reported to recognise Neu5Ac. A comparable correlation was 
observed for the Lac-specific RCA and the hGal-8 with the illustrative exception of 
NTHi1566. This event claims that the final presentation of glycans on the pathogen 
surface may count for the fine-tuning of endogenous lectin action as PRRs in the 
context of epitope clustering or, their protein or lipid scaffolding on the tissue or 
pathogen surface (Dam and Brewer, 2010). 
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In this context, the classification of galectins, long-established “self”-element binders, 
as PRRs may require additional considerations. Most metazoans are endowed with a 
complex galectin repertoire, members exhibiting multiple isoforms and subtle variations 
in carbohydrate specificity (Vasta et al., 2012), also being well accepted that their direct 
binding to glycoconjugates on the surface of bacteria results in either positive or 
negative regulation of the innate and adaptive immunity (Vasta, 2009). Then again the 
molecular basis of their binding to distinct self and non-self glycans via the same CRD
remains to be elucidated. In this regard, galectins with tandemly arrayed CRDs stand 
out as intriguing entities both in their binding properties and functional aspects, the 
most striking example being the recognition and killing of E. coli O86 displaying B-
blood group oligosaccharides (BGB+) by the hGal-4 and -8 (Stowell et al., 2010). The 
results obtained in the context of this Dissertation revealed that the C-ter. domain 
mediates recognition of NTHi375 by hGal-4, and that bacterial viability is not affected 
even when integrity of the full length galectin is guaranteed (section 4.1.10.3). Study of 
the role of the full-length hGal-4 in Pseudomonas aeruginosa (PAO1) susceptibility to 
antimicrobial peptides revealed increased cooperativity, despite its failure of direct 
killing (Buzamet, 2012). It is here suggested that the redox properties of the intracellular 
and extracellular environments may modulate the activity of lectin–ligand interactions, 
and the functional outcome. Most galectins are active in the intracellular, reducing 
environment, but once secreted they are susceptible to inactivation by oxidation of their 
free Cys residues present in the CRD (Stowell et al., 2009), compromising the 
oligomerisation of the galectin subunits. Intriguingly, we observed a striking increase in 
hGal-4 recognition and NTHi375 agglutination in absence of reducing agent, possibly 
underscoring the formation of higher-order structures (section 4.1.10.4).
Apart from the mechanistic viewpoint, ligand assignment for lectin binding to the 
bacterial surface is of particular interest also for establishing virulence correlations. The 
results exposed in section 4.1 support that the dissection of specific epitopes for lectins 
is greatly facilitated when isogenic mutants or relevant strains are available. A parallel 
comparison of lectin-binding profiles of wild type K. pneumoniae strain Kp52145 and a 
panel of isogenic mutants lacking different surface epitopes (i.e. the capsule, LPS O-
polysaccharide chain, or the major outer membrane protein OmpA), pointed to the O-
antigen as the primary epitope recognised by the Gal-specific lectins tested 
(Campanero-Rhodes et al., 2015). Consistently, hGal-3 is projected to recognise the 
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repetitive motif Galβ(1,3)Gal– on the O-antigen of purified Kp52145-LPS in a 
carbohydrate-specific manner, binding being completely abolished in presence of 10 
mM hapten inhibitor, Galβ(1,3)Gal–OMe, in LPS-based microarrays (not shown). The 
K. pneumoniae LPS was previously shown to be also a ligand for rat Gal-3 (Mey et al., 
1996), sharing high homology with the human protein. Accordingly, for NTHi375 the 
LOS ramification off Hep III behaved as ligand for hGal-8N and the full length-protein, 
a stronger binding to ΔlgtF over ΔompP5 LOS being observed and truncation of the 
LOS extension at Hep III in ΔlpsA dramatically reducing recognition (Fig. 4.32).
Similarly, the results derived from lectin screening of the NTHi375 mutant library 
bearing sequentially truncated LOS, pointed to its being a docking site for Gal- and 
manno-Hep-binding lectins (section 4.1.3). Consistently, direct VAA and ConA binding 
was confirmed upon isolation of the LOS molecule and development of LOS 
microarrays (section 4.1.5.2). In the illustrative case of ConA and SP-D presenting 
similar preference as for manno-Hep (Jaipuri et al., 2008; Wang et al., 2008), strong 
binding to deep LOS-truncated mutants (ΔlgtF, ΔlpsA and double mutant) and the 
isolated molecules, indicated a protected target for both lectins to lay in the LOS inner 
core structure (section 4.1.9). What is more, our results provided the first experimental 
evidence for direct binding of SP-D to the surface of NTHi and also advocated for the 
proximal manno-Hep moiety (Hep I) being preferentially recognised by the collectin.
The elucidation of the crystal structure of the complex of SP-D with the LOS derived 
from Haemophilus influenzae Eagan (Clark et al., 2016) was fully consistent with these
observations, suggesting the ramifications extension and complexity as key to 
efficiently disguise the vulnerable inner-core components of the LOS pattern.
On the other hand, besides its variable LOS, NTHi also presents a collection of adhesins 
and glycoproteins that constitute virulence factors of equal importance, and are 
associated to bacterial attachment and consequent invasiveness (Rao et al., 1999). In 
particular, the adhesins HMW (High Molecular Weight glycoproteins 1/2) are present in 
the NTHi375 surface and glycosylated by HMWC following an alternative cytoplasmic
pathway by adding mono- or di-Hex (mostly Glc- and Gal-) to certain Asn residues
(Gross et al., 2008; Grass et al., 2010; Gawthorne et al., 2014; Naegeli et al., 2014). 
Remarkably, a recent experimental study highlighted how the transfer of the hmw1 gene
from 86028-NP (invasive isolate) to Rd KW20 (considerably less adherent) can alter its 
phenotype and increase its colonisation potential (Mell et al., 2016). In our study we 
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used Rd strain and a mutant expressing HMW1 of NTHi12 and our lectin-screening 
results claimed that HMW112 does not constitute a ligand for RCA (section 4.1.6). Even 
though it is suspected that HMW1 does not present Gal in a favourable fashion for RCA 
recognition, such possibility should not be generally discarded. Indeed, HMW genes 
throughout the species share homology, but sequence alignments with Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/) revealed nine aminoacid substitutions for 
HMW1375 with respect to HMW112 knocking out reported glycosylation sites 
(Domenech et al., 2016), thus suggesting relevant heterogeneity among strains (see 
Annex VI). The binding of ConA was also significantly enhanced upon expression of 
the HMW112, a remark particularly expected since the presence of Glc and Glc-Glc 
units decorating the protein was formerly established (Grass et al., 2003). Although 
previous evidence of direct ConA binding to HMW is lacking, it has been suggested 
that differences observed in ConA-labelling of biofilms derived from NTHi strains 
carrying hmw genes, including NTHi375 (Domenech et al., 2016) could be furtherly 
attributed to variations in the expression of genes, known to be modulated by phase 
variation (Dawid et al., 1999).  
Membrane glycoproteins like HMW are actually hard to purify, thus limiting the study 
of molecular recognition reactions in solution. Entire bacteria microarrays proved out to 
be a powerful tool for the study of such systems, revealing that RCA and VAA despite 
being highly homologous and terminal Gal- specific, recognised different targets on the 
bacterial surface. Since the isolation of LOS was possible, STD-NMR experiments have 
served to furtherly define the LOS(s) epitopes recognised by these two lectins at the 
atomic level, supporting our previous findings. On the LOS derived from 
NTHi375ΔompP5, VAA clearly recognised terminal Gala, in line with previous 
microcalorimetric studies revealing 20-fold increased affinity values for Galα(1,4)Gal 
compared to lactose (Bharadwaj et al., 1999). Intriguingly, the same lectin 
predominantly bound Galβ on the Rd LOS, demonstrating a surprising deficiency
towards Gala-recognition. Noteworthy, the presence of Gala isoform in the Rd OS 
preparation was confirmed by heteronuclear correlation NMR experiments, 
corresponding to approximately 20% as previously reported (Risberg et al., 1999). 
Consistent with our observation on VAA incapacity of Gala-binding on the Rd LOS, 
this and other NTHi strains were negative for immunoblotting with the anti-globotriose 
monoclonal antibody 4C4 (High et al., 1993) evidently pointing to unfavourable ligand 
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presentation. Among the strains tested for 4C4-reactivity also stand NTHi358 and 1566 
(Martí-Lliteras et al., 2011), yielding weaker fluorescence intensities for VAA-binding 
than NTHi375 in the microarray set-up, accordingly (section 4.1.8). 
As galabiose recognition by VAA was feasible on the NTHi375-derived OS as shown 
by STD-NMR, a model structure was created using PyMOL (v. 1.6) and UCSF Chimera 
(v. 1.11) software, through manual superimposition. The aGal(1,4)βGal- disaccharide or 
the globotriose unit was superimposed onto the same atomic positions as for the Galp in 
the VAA crystal structure (Niwa et al., 2003),  Fig. 5.1, a, b. 
At protein concentration that low as 8 μM, VAA is still expected to form a dimer, and 
consequently spatial restrictions would apply to the accessibility of its Trp-binding site 
(1α, around Trp38) as previously demonstrated (Jiménez et al., 2005; Jiménez et al., 
2006). Thus, the 2γ domain engaged around Tyr249 is the central glycan-binding site 
under our working conditions. Qualitatively, the suggested binding mode is compatible 
with the STD-deduced epitope mapping (Fig. 4.17 and Table 4.6). Both galabiose and 
globotriose seem to perfectly fit in the shallow groove-shaped binding site of VAA, but 
contacts established solely seem to include the CH-π interaction of the terminal Gala
H1/H3/H5 with the Tyr aromatic ring and bidentate H-bonding (Fig. 4.18), as 
Fig. 5.1 Represantation of binding of Galα(1,4)Gal and globotriose moieties to the 2γ carbohydrate-
binding site of VAA. Representations of Galα(1,4)Gal (a) and globotriose (b) in the same binding 
groove, 2γ, suggest a possible interaction mode with VAA (PDB: 1OQL) and illustrate that stronger 
contacts are projected only for the terminal α-Galp moiety, furtherly supporting the acquired STD data
for VAA-OS from NTHi375ΔompP5. Aminoacid residues in (b) are coloured by element (red for 
oxygen and blue for nitrogen).
(a) (b)
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previously discussed. No direct contacts with Gal I seem to be possible, with the 
reducing end (Glc II) of the globotriose moiety, clearly staying outside the binding 
groove and heading towards the solvent, unable to establish contacts with the receptor 
(Fig. 5.1, b). 
5.2 Conserved glycosignature for THP-1-derived exosomes  
It is currently technically challenging to obtain pure EV fractions, free from non-
vesicular components for functional studies, what makes substantial the common 
demand for establishment of a minimal set of biochemical, biophysical and functional 
parameters of their characterization (Lötvall et al., 2014). In order to classify EVs 
according to particular glycosylation patterns they may carry, the prerequisite of 
previous physical characterisation was evident (Rupert et al., 2017). EV preparations 
derived from THP-1 cell culture were submitted to ultracentrifugation and filtration 
fractionation, resulting in discrete EV populations of standard protein-to-lipid ratio, as 
suggested (Osteikoetxea et al., 2015). Moreover, higher lipid order was evident for 
exosome preparations when compared to bigger-size elements, MVs, as function of the 
enrichment of exosomes in saturated phospholipids (Subra et al., 2007) and their 
relevant curvature (de Jesus et al., 2013; Kastelowitz and Yin, 2014). 
Requirement for validation of the arrays with anti-CD63 antibody or Annexin V in 
parallel to the lectin binding assays, not simultaneously using different laser channels as 
done for bacterial microarrays, brought out the need for discovery of probes and 
markers beyond the phosphatidylserine and caspase molecules. Noteworthy, concerns 
about universality of these markers have risen, given their detection in preparations of 
different origin in an inconsistent manner (Jimenez et al., 2003; Connor et al., 2010; 
Yoshioka et al., 2013).
Upon set-up of the EV-based microarrays, the study of glycosylation patterns of THP-1-
derived extracellular vesicles by means of microarrays and lectin screening revealed 
conserved profiles, rich in Man, GlcNAc and Gal for exosomes. Regarding relevant 
abundance of these residues’, our results for the THP-1-derived EV subpopulations 
were in line with previous observations for cancer cell-lines, including ovary 
(Escrevente et al., 2011) and another six solid and liquid tumours (Batista et al., 2011). 
Despite their diverse origin, exosomes isolated from healthy donors’ blood were also 
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recognised from different lectins, the snowdrop lectin (GNA) attracting again the 
attention. All evidence comprised, it is primarily suggested that exosomes are enriched 
for oligomannose structures on their surface glycoproteins and, GNA specifically binds 
them. Besides exosomes, virions of hepatitis C (Tullis et al., 2009) and HIV are also 
known to expose glycoproteins bearing high-mannose structures (Botos and Wlodawer, 
2005; Hu et al., 2007). In addition, previous work has provided strong evidence that 
HIV-1 and T-cell-derived EVs traffic out of host T-cells in a similar way, their 
glycosignatures being cell-line dependent yet sharing the same oligomannose epitope 
(Krishnamoorthy et al., 2009). These results argue for a common origin and support the 
so-called Trojan exosome hypothesis (Gould et al., 2003; Hirabayashi, 2009). In this 
context, antiviral lectins i.e. cyanovirin (Botos et al., 2002), binding both virus and EV 
particles raise concern about targeting these glycans for therapeutics as suggested (Hu et 
al., 2007), yet potentially explaining why eliciting a protective antiviral immune 
response is difficult.
In translational medicine a therapeutic hemofiltration approach emerged from the same 
observation, and was previously applied as adjuvant therapy permitting hepatitis C viral 
cargo reduction in dialysis patients, also having a remarkable impact in improving 
patient responses to the existent pharmaceutical remedies (Tullis et al., 2009). A similar 
approach was later suggested under the brandname Haemopurifier®, based on a GNA- 
affinity-based plasmapheresis cartridge for exosome depletion during hemodialysis 
(Marleau et al., 2012). Since the conserved oligomannose pattern is specifically 
recognised from GNA, its use as capturer guided the QCM sensors development for the 
study of exosomes. Indeed, GNA-derivatised chips were able to selectively capture 
exosomes contrary to MVs in flow, thus constituting a novel approach for efficient 
vesicle detection. The possibility of in-flow capture of exosomes even in body fluids 
paves the way for the establishment of novel, non-invasive biomarker detectors for 
clinical application, and is well inside the capacity of QCM instruments (Tombelli, 
2012). This trend could also be exploited for designing new isolation protocols based on 
lectin affinity chromatography, distinguishing among EV subpopulations.  
As for the kinetic analysis achieved directly on the surface of exosomes by QCM, 
further aspects of lectin domain organisation due to be considered. Even though data fit 
was proficient on the basis of a one-set-of-sites model for ConA and PNA, this was not 
the case for GNA. Usually, if a 1:1 model does not yield a proper fit, the existence of  
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 different docking sites for the lectin 
on the bacterial surface, or even 
ligand clustering, can be inferred. In 
this case however, the application of 
a 2:1 model was furtherly requested 
by the proper binding site 
arrangement in the lectin quaternary 
structure. Indeed, for this lectin not 
all sites are spaced at maximum 
distance, as occurs in the case of 
ConA. Instead, each monomer 
contains three subdomains, in close 
distance of the dimer interface as 
suggested by its crystallographic 
structure (Hester et al., 1995; Hester 
and Wright, 1996). We have 
furtherly confirmed these 
observations in solution by 
isothermal titration calorimetry of 
GNA with α-Me-diMan. The 
equilibrium association constant for 
ligand binding at site 1 is nearly an order of magnitude higher than at site 2 (Ka1 =8 
10-4 M-1; Ka2 = 6.9  10-3 M-1). Binding to site 2 had a 7-fold higher enthalpy variation. 
Noteworthy, GNA was reported to bind mono- and dimannosides at distinct sites
(Hester and Wright, 1996). Interestingly, cyanovirin-N also contains two sets of sites in 
solution, shown to be responsible for multivalent binding between the lectin and the 
high-mannose chains, each site targeting a different part of the epitope (Shenoy et al., 
2002). Altogether, the observations point to specific binding of GNA on the THP-1 
exosomes’ surface, resulting in tight association and affinities in the submicromolar 
range (section 4.2.5).
Fig. 5.2 Calorimetric titration of GNA with α-Me-
diMan (■) at 22 °C. GNA was loaded in the calorimeter 
cell at 300 μM in HBS, pH 7.4, and the ligand was 
injected in a stepwise fashion. Continuous lines 
correspond to data fit to a
two-set-of-sites model.
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5.3 Evaluation of glyconanoscaffolds of potential anti-adhesive application  
Evidently, the microarray set-up permitted the evaluation of potent multivalent 
inhibitors and even enabled the comparison of their capacity, in the submicromolar 
range. Sensible fluorescent detection added an important advantage and along with 
miniaturisation and low quantity requirement, the approach proved out to be a valuable 
alternative to more tedious, time- and sample-consuming protocols previously 
established (Köhn et al., 2004; Hartmann et al., 2012; Barras et al., 2013). Importantly, 
the approach also exhibited great reproducibility: control of bacterial viability and FimH 
stability is essential and clearly contributing to this direction. Previously reported 
repeatability deficits i.e. in the yeast aggregation assay (Firon et al., 1983) may be 
possibly attributed to uncontrolled bacterial growth conditions, hereby proved to 
detrimentally affect the outcome (section 4.3.1). 
Indeed, during the last couple of decades it has been considered that biofilm production, 
synthesis of capsular material and flagella motility is influenced by population density 
in several Gram-positive but also -negative bacteria, including E. coli (Miller and 
Bassler, 2001; Sperandio et al., 2002). These “quorum sensing” bacteria produce and 
release chemical signal molecules (auto-inducers) that increase in concentration as a 
function of cell density. The detection of a minimal threshold stimulatory concentration 
of an auto-inducer leads to an alteration in gene expression. Interestingly, an auto-
inducer called stationary phase-specific sigma factor (RpoS) was shown to have a 
negative regulatory role (probably indirect), at both the fimA and the fimB promoters, 
thus making a key contribution to the switching of cells between fimbriate and 
afimbriate states (Dove et al., 1997). Further complex regulatory mechanisms were 
established regarding bacterial fimbriation through evolution. As relevant example, a 
drop in the intracellular concentration of cAMP (3′,5′-cyclic adenosine monophosphate) 
due to altered physiological conditions (e.g. growth in presence of glucose) increases 
the percentage of fimbriated cells in the bacterial population (Müller et al., 2009). 
Accordingly, our rich, LB2YT medium used during E. coli UTI89 cultivation (section 
3.1), could be furtherly promoting fimbriation. 
As for the glycoside cluster effect as observed by ITC in the case of ConA and 
mannofullerenes (1) and (2) several observations may be done. Of note, the latter were 
found to be superior ConA inhibitors over silica nanoparticles, with almost two orders 
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of magnitude enhanced relative inhibitory potential per mannose residue. ITC results 
suggested binding of approximately 7 ConA monomer units per mannose-derivatised 
dodecafullerene (section 4.3.2.2.3). Calculation of the relative area corresponding to 
each mannose residue yielded ca. 38 nm2 – considering the glycofullerene as a sphere of 
radio r = 6 nm (mean value for fullerenes bearing 2-4 PEG repeats in linker) and total 
area A = 4  π  r2 = 452 nm2. This relative area per mannose corresponds to an 
imaginable sphere of ca. 2 nm radio surrounding each residue. At this point, if one 
considers the distance between two adjacent ConA sites in the tetramer to be of 6.5 nm 
(Derewenda et al., 1989), this would suggest a radio of 4.6 nm per tetramer and 1.15 nm 
ConA monomer. If all moieties are spherical, the accommodation of 12 monomers per 
fullerene seems rather impossible due to steric hindrance. What is more, the distance 
between vicinal ConA sites in the tetramer (6.5 nm) would not permit the establishment 
of contacts with adjacent mannose residues.
Thus, the importance of the linker length and flexibility in multivalent systems becomes 
evident. Most likely, the capacity of pegylated linkers to form a strong core resembling 
the SAMs (Harder et al., 1998) – when it is distance-permitted – conditions the final 
availability of grafted sugars and their correct presentation, along with the 
hydrodynamic properties of the fullerenes. In this context, computational studies on the 
valency and behaviour of different classes of nanoscaffolds in the solvated state will 
probably be enlightening.  
The high density of immobilised ConA on the chip could be responsible for a “bind and 
roll” effect (Munoz et al., 2009), of particular relevance in the reliable evaluation of 
binding efficiencies in surface-based multivalent carbohydrate recognition. Evidently, 
this effect should apply for both fullerenes since the same chip was used for assessment. 
However, the linker length and core packing still conditions the final availability of 
mannose-residues for recognition. Further SPR experiments using chips of ConA 
immobilisation minimum 10-fold lower could contribute in rejecting bind and roll 
effects. 
5.4 Perspectives 
Despite the common trends in carbohydrate composition and display on the surface of 
diverse bacterial strains (Herget et al., 2008; Sahly et al., 2008), precise availability of 
glycosylation patterns for recognition by a given lectin may substantially differ. 
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Undoubtedly, studies on isolated macromolecules alone lead to the acquisition of solid 
information describing carbohydrate-lectin interactions. For example, our STD-NMR 
results illustrate how this ligand-based approach may confidently reveal the epitope for 
lectins at atomic level. Nonetheless, in these approaches the natural presentation and 
accessibility of glycans along with possible cooperativity of neighbour molecules are 
not considered. This aspect is of crucial relevance in the case of intrinsically weak 
binders as the lectins, whose affinity is controlled in multiple levels and are prone to 
synergistic interactions with third-party elements. 
Thus, holistic methods that monitor the events directly at the surface may contribute to 
greater mechanistic understanding. In this direction, the developed bacteria-based 
microarrays served to gain information on the availability of certain motifs for 
endogenous lectin recognition and provided semi-quantitative data on binding avidity. 
These clues were validated and complemented by QCM kinetic analyses, providing the 
apparent affinity values and rate constants. Importantly, this combined approach 
operates directly at the surface thus closely mimicking the real bacteria–receptor 
interplay (Kalograiaki et al., 2016).  
Unravelling the binding patterns of lectins of the innate immune system by means of the 
newly developed platforms will serve as a starting point for further functional analyses 
regarding bacterial resistance and subversion of host lectins. Many bacteria bear 
extended LPS structures that are essential in shielding more vulnerable sites in the LPS 
inner core as suggested in this Dissertation and elsewhere (Matsuura, 2013; Clark et al., 
2016). Evidence points to mechanisms of these immunodominant molecules variation 
among others, in order to efficiently evade a first-line mucosal innate immune defense 
(Simon et al., 1980; Finlay and McFadden, 2006). Of note, besides nontypeable 
Haemophilus influenzae (Weiser et al., 1989) and Klebsiella pneumoniae here studied, 
several opportunistic respiratory pathogens such as Neisseria and Pseudomonas species, 
Bordetella pertussis and Moraxella catarrhalis are long used as models of antigenic 
variation (Henderson et al., 1999), using a multitude of controlling element concepts 
and emphasizing why a vaccine to these organisms has not been successful yet. It is 
anticipated that high-throughput typification of Gram-negative clinical isolates and 
comparison of their virulence phenotypes and inter-strain glycosignatures with their 
relevant recognition by endogenous lectins will aid in the establishment of clinical 
correlations. Typification of bacterial strains by lectin fingerprinting based on both 
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binding pattern and binding affinity, could thereby add a further level of discrimination 
between strains. Importantly, the method is not limited to Gram-negative bacteria but 
also to Gram-positive or other pathogens as yeast, since the identification of high-
affinity strain-selective binders may facilitate the development and optimization of 
lectin-based biosensors for their detection in clinical, environmental, and food samples. 
In sections 4.2.3-4, the availability of docking points for lectins on the EV surface was 
furtherly confirmed by the QCM vesicle-based chips, again allowing for the calculation 
of kinetic parameters in the glycans´ native milieu. Of note, GNA worked as a first-rate, 
selective capturer for exosomes also in the straight-forward in-flow capture approach, 
and was well recommended by the microarray-based lectin screening. Of general 
importance, the biosensor approach presented in this Dissertation could be tailored in 
order to address a variety of EV types and soluble molecules, e.g. aberrant 
glycoproteins, as potential biomarkers even directly in body fluids, diagnosis fully 
supported by the current state-of-the-art. In each case, previous glycophenotyping using 
the high-throughput microarray platforms may reveal other affinity agents of choice to 
better exploit the approach potential in diagnostics and clinical practice.  
Finally, with respect to the microarray-assisted screening of anti-adhesive compounds, 
the approach introduced herein represents a powerful alternative for compound 
evaluation, also addressing the multiple needs arising from the use of live bacteria. The 
potential of the selected glycan-presenting nanoscaffolds as adhesion inhibitors was 
analysed by non-linear regression of several valid data points, and noticeably exposed 
even slight differences in the inhibitory potential between glycofullerenes of similar 
features, well within the acceptable error limit of 10%. Essential discrepancies between 
the theoretical expectations and the actual “functional affinity” values obtained for the 
nanoscaffolds can be attributed to the multivalent effect, as previously discussed.  
Importantly, the original set-up here presented also proved out to permit differentiation 
between the fimbriate and afimbriate states of pathogenic bacteria, suggesting a full 
range of promising applications in microbiology. An additional approach of added value 
in which we are currently working, involves capture of tripsinised bladder epithelial 
cells in microarrays and further evaluation of anti-adhesive compounds as effective 
inhibitors of bacterial adhesion. In parallel, host and E. coli interplay could definitely be 
monitored in real-time by adapting the assay for QCM studies and directly growing the 
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host cells in COP-1 sensor chips, as previously reported (Pei et al., 2012; Peiris et al., 
2012). 
All things considered, the results presented in this Dissertation intended to respond to 
the constant need of novel high-throughput tools that permit quantitative glycan 
profiling and interaction monitoring with their host counterparts. Undoubtedly, a lot 
remains to be done in terms of application of these technologies in biomedicine and 
their integration in clinical diagnosis and therapy. 
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176
177
1. Bacteria-based microarrays have proved to be efficient for lectin typing of 
carbohydrate structures on the surface of bacteria lacking capsular polysaccharides and 
O-antigen-bearing lipopolysaccharides, thereby broadening the applicability of the 
initially established approach. Using non-typeable Haemophilus influenzae (NTHi) as 
model bacterium, strain- and lectin-specific binding patterns have been observed for a 
panel of NTHi375 mutants as well as for six different NTHi clinical isolates, also 
providing semi-quantitative data on binding avidity. The results have evidenced the 
availability of Man/Glc, sialic acid, and Gal residues on the bacterial surface for lectin 
recognition. 
2. New Quartz Crystal Microbalance (QCM) NTHi sensor chips have been 
developed and used for label-free kinetic analysis of bacteria−lectin interactions directly 
on the bacterial surface, yielding quantitative data on binding affinity and kinetic 
parameters. Data obtained for the binding of the Gal-specific Ricinus communis
agglutinin (RCA) revealed the formation of extremely stable complexes, while the 
binding profiles of wheat germ agglutinin and concanavalin A, which recognize sialic 
acid and Man/Glc residues, respectively, indicated the presence of more than one set of 
sites for these lectins, with noticeably faster dissociation rates compared to RCA. 
3. Bacteria- and lipooligosaccharide (LOS)-based microarrays have revealed that 
RCA and the highly homologous Gal-specific agglutinin from Viscum album (VAA) 
recognize different ligands on the NTHi surface. In addition, STD-NMR experiments 
have served to define the recognized LOS epitopes, which are lectin- and 
oligosaccharide-specific. Only VAA binds strongly to the α-Gal-terminated LOS of 
NTHi375, whereas RCA shows a remarkable preference for the β-Gal-terminated LOS 
of NTHi strain Rd.  
4. In line with the glycophenotyping results, binding to the NTHi arrays of three 
lectins of the innate immune system with Man/Glc-, sialic acid-, and Gal-binding 
specificity, i.e. SP-D, Siglec-14, and human galectin-8, has been observed, providing 
the first experimental evidence for direct binding of SP-D to NTHi. Moreover, 
comparison of the behaviour of selected galectins belonging to the three structural 
subgroups of this lectin family has unveiled striking differences in NTHi recognition, 
even when comparing the two carbohydrate-binding domains of tandem-repeat-type 
galectins. In particular, LOS truncation had detrimental effects on the binding to NTHi 
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of human galectins 4 and 8, pointing to LOS serving as ligand. The binding of galectin-
8 was found to be carbohydrate-mediated, while for galectin-4 ionic interactions 
apparently drive recognition, red-ox conditions also playing a noticeable role. 
5. Distinctive glycosylation profiles for EV subpopulations have been unveiled 
using novel EV microarrays and lectin screening. Pioneer vesicle-based QCM sensor 
chips have confirmed the binding trends observed for selected lectins in the microarray 
set-up and provided apparent affinity and kinetic parameters.  In addition, a straight-
forward approach for in-flow selective exosome detection has been developed, paving 
the way for non-invasive high-throughput screening of glycosignatures transported 
through biological fluids.  
6. A microarray set-up for assessment of the functionality of E. coli FimH adhesin 
has been successfully established. The approach, involving analysis of the binding of 
fluorescently-labelled bacteria to mannan-printed arrays, has been found to be efficient 
for discriminating between E. coli fimbriate (FimH-expressing) and afimbriate states. 
7. Using ConA as model lectin, the potential of designer microarrays for testing 
mannose-bearing silica nanoparticles and dodecafullerenes as inhibitors of lectin 
binding has been demonstrated, SPR and ITC analyses of ConA-inhibitor interactions 
serving to confirm the microarray-derived results. Mannofullerenes, found to be 
superior ConA inhibitors over silica nanoparticles, also proved to be efficient for 
preventing binding of FimH-expressing E. coli to mannan-printed arrays, with up to 18-
fold enhancement of the relative inhibitory potential per mannose residue. The precise 
structure and length of the spacer used for linking mannose to the fullerene core has a 
noticeable impact on compound activity. To the best of our knowledge, this is the first 
report on a microarray approach enabling the screening of anti-adhesive compounds 
using live bacteria. 
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aANNEXES
bAnnex I 
FT-IR spectra for SNP preparations 
Fig. A1. The azide absorption signal at 2134 cm–1 was clearly observed on the SNPs-PFPA, as well as the 
amide C═O absorption band at 1639 cm–1 indicating successful functionalization of the SNPs with PFPA-
silane. In the FT-IR spectrum of the final products the disappearance of the azide signal is characteristic 
as well as the appearance of triazole bands at 1697 and 1377 cm–1 for the sugar-derivatised GNPs (not 
shown due to spectra overlapping). 
Annex II 
Supplementary NMR spectra 
Fig. A2. 1H-spectra of 10 mM Neu5Ac, before (black) and after acid hydrolysis (blue), performed as 
described in section 3.8.1. Spectra were acquired in deuterated PBS in a Bruker Avance 500 MHz 
spectrometer at 310 K, applying a water suppression pulse sequence with gradients (zgesgp), then 
referenced to the residual water (HDO) signal.
cFig A3. Section of the TOCSY spectrum of core oligosaccharides derived from Hex3 and Hex4 OS 
glycoforms of NTHi375ΔompP5.  Mixing time was of 70 ms. The corresponding 1D 1H-spectrum was 
acquired applying a water suppression pulse sequence with gradients (zgesgp). Relevant correlation peaks 
are denoted in the zoomed section. All spectra were acquired at 310 K, in deuterated PBS in a Bruker 
Avance 600 MHz spectrometer equipped with a cryoprobe, then referenced to the residual water (HDO) 
signal, as described in the Materials and Methods (section 3.8). 
Fig A4. Section of a ROESY spectrum of core oligosaccharides of NTHi375ΔompP5. 
Spectrum was acquired with a 300 ms spin-lock mixing time.  In the inserted zoomed section of increased 
intensity, relevant intra- and inter-residual ROE contacts are denoted. Transglycosidic ROE cross-peaks 
between the proton pairs Hep III, H1/Hep II, H2 and Hep II, H1/Hep I, H3, established the sequence of 
the inner-core trisaccharide to be L-α-D-Hepp-(1,2)-L-α-D-Hepp-(1,3)-L-α-D-Hepp-(1→).
Table A1. 1H-13C NMR chemical shifts for core oligosaccharides derived from Hex3, Hex4 and Hex5 OS glycoforms of NTHi Rd
Isoform Residue Sugar unit 3JH,H H1
(C1)
H2
(C2)
H3
(C3)
H4
(C4)
H5
(C5)
H6A
(C6)
H6B H7A
(C7)
H7B
all Hep I 3,4)-l-α-D-Hepp-(1→ N/R 5.09-5.14
(99.7)
4.04
(69.1)
N/D 4.24*
(78.1)
N/D 4.14*
(64.5)
N/D N/D N/D
all Hep II 2)-l-α-D-Hepp-(1→ N/R 5.60-5.68
(99.2)
4.32
(78.8)
4.01
(87.8)
3.68
(72.8)
N/D N/D N/D 3.75
(65.0)
3.92
(61.2)
all Hep III 2)-l-α-D-Hepp-(1→ N/R 5.10-5.13
(99.7)
4.24
(78.1)
4.02
(84.3)
3.80
(75.4)
N/D N/D N/D N/D N/D
all Glc I β-D-Glcp-(1→ 8.2 4.52
(103.3)
3.38
(73.8)
3.48
(76.2)
3.55
(74.8)
3.61*
(74.8)
4.14
(64.5)
4.27
(64.5)
all Glc II 4)-β-D-Glcp-(1→ 7.5 4.67
(101.6)
3.38
(72.6)
3.69
(74.3)
3.69
(78.8)
3.69
(74.6)
3.85
(60.2)
3.99
(60.2)
Hex3 Gal I β-D-Galp-(1→ 7.7 4.47
(103.1)
3.55
(73.7)
3.68
(72.7)
3.94
(68.7)
3.74
(75.5)
3.78
(61.2)
N/D
Hex4 Gal I 4)-β-D-Galp-(1→ 7.5 4.52
(103.3)
3.60
(71.1)
3.76
(72.3)
4.05
(77.6)
3.79*
(75.5)
3.86
(60.5)
3.92
(60.5)
Hex4 Gal II α-D-Galp-(1→ 3.5 4.96
(100.4)
3.86
(68.7)
3.90
N/D
4.04
(69.1)
4.35*
(71.0)
3.71-2 
(60.7)
Hex5 Gal II 3)-l-α-D-Galp-(1→ 3.7 4.94
(100.6)
3.90
N/D
3.96
(78.9)
4.26
(69.0)
N/D N/D
Hex5 GalNAc β-D-GalΝΑcp-(1→ N/R 4.64
(100.2)
3.95
(68.7)
3.90
(69.3)
4.04
(69.2)
3.69*
(71.0)
all PEtn 4.16
(62.1)
3.22
(40.8)
all PCho 4.38
(59.6)
3.69
(66.2)
3JH,H values for anomeric 1H resonances (H1) are given. Except 
where indicated, chemical shifts are the same (± 0.02 ppm) for 
the conserved inner core residues, shared by both glycoforms. 
N/R: not resolved, N/D: not defined.
*Tentatively assigned from ROESY spectra. 
eFig. A5. Section of the multiplicity edited 1H-13C HSQC spectrum of core oligosaccharides derived from a 
mixture of OS glycoforms of the Rd strain. The inserted spectral zoom at δ ~ 3.5-4.5 ppm (1H, F2 axis) 
corresponds to a zone of special interest for galactose moieties, where several resonances were successfully 
assigned, and here denoted for relevant protons. Symbol S is used as for substituted glycans, given the coexistence 
of multiple glycoforms in the sample. Chemical shifts and coupling constants of the anomeric protons are reported 
in Table A1. For both spectra: CH2 are shown in petrol; CH and CH3 in black.
Fig A6. Section of a ROESY spectrum of core oligosaccharides of the Rd strain. 
Spectrum was acquired with a 300 ms spin-lock mixing time.  Relevant intra- and inter-residual ROE contacts are 
denoted. In the inserted zoomed section, symbol S stands for substituted residues. Substitution of the Gal II residue 
in position 3, provokes a small, yet perceptible shift for its H3 resonance.
fAnnex III 
Table A2. Confocal microscopy photos for different galectins (red) and NTHi375 (green)
Excitation at 488 nm Excitation at 561 nm Merge
hGal-1
hGal-3
hGal-4
hGal-4*
hGal-8
*Bacteria were incubated with hGal-4 in absence of dithiothreitol.
gAnnex IV 
Sequence alignments for galectins used in this Thesis 
As briefly described in the introduction of the section 4.10, human galectins were 
classified into three groups on the basis of their structure: proto-type, chimeric, and 
tandem-repeat. A galectin-CRD bears approximately 130 amino acids. Sequence 
alignments for hGal-1, -3, -4, -8 and -9 here shown, were acquired using Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/). For tandem-repeat galectins (-4, -8 and -9) 
several isoforms have been identified, bearing distinct length peptide-linker, which is 
prone to peptidase cleavage. Residues that are highly conserved between galectins and 
those that are known to make contacts with carbohydrate ligands are indicated by 
arrows. Binding domains for tandem-repeat galectins are in boxes. 
hAnnex V 
Calculation of the dissociation constants for GNPs 
Calculation of the dissociation constants for the ConA-GNPs (α-Me-Man- and α-Me-
diMan-NPs) interaction  took place as follows, based on a comparable set-up previously 
established (Rivera-Sagredo et al., 1991).
Here, [A] corresponds to MAF285 (biotinylated heptylmannoside) and [B] to the GNPs 
concentration, KA to the dissociation constant for MAF285 and KB to that of GNPs. 
Assuming that the association constant, Ka, of MAF285 for ConA is comparable to that 
measured for α-Me-Man by ITC, (8.77 ± 0.09) × 103 (Table 4.13), it corresponds to 
1/KA. Thus, KA=1.14 × 10-4.
If Mtotal stands for the total amount of ConA in the incubation mixture, Mo the amount 
of free ConA, and MA, MB the amount of ConA-sites captured by A and B respectively, 
then Mtotal = [Mo] + [MA] + [MB] (eq. 1). 
iEq. 1 can be substituted in terms of the dissociation constants KA and KB of the 
complexes of ConA with A and B respectively, referred to as [MA] and [MB]: 
K  =                 K =A B
[Μ] [Α]×
[ΜΑ]
[Μ] [Β]×
[ΜΒ]
rearranged to: 
[Μ ] [Μο  =                  =B]KA× M[ Α]o[Α]o
[Μ] [Β]o×
KB
For the binding experiment of A to ConA we have:
M  = M + M =total o o [ Α] KA× M[ Α]o[Α]o + [MA] 1+o o= [ΜΑ]
KΑ[Α]
[ Α]M o total= M 1+ KΑ[Α]
Thus, eq. 1 is rearranged to: 
M  =                    total
KA× M[ Α][Α]
[Μ] [Β]o×
KB
+  + [ΜΑ]
M  =                    total
KA× M[ Α][Α]
[Β]
KB
+  + [ΜΑ] × KA× M[ Α][Α]
M  =  [ ]total ΜΑ 1+ KΑ[Α] 1+
[Β]
KB
 [ ] =  MΜΑ total 1+ KΑ[Α] 1+
[Β]
KB
[ΜΑ]
[ΜΑ]ο = 50 % =
1+
KΑ[Α] 1+
[Β]50%
KB
Mtotal
1+
KΑ
[Α]Mtotal
=
1+
KΑ[Α]
1+
KΑ[Α] 1+
[Β]50%
KB
j0.5 + 0.5        + 0.5 = 1 +           × × ×
KΑ[Α]
KΑ[Α]
[Β]50%
KB
KΑ[Α]
0.5 = 0.5 + 0.5 × × ×
KΑ[Α]
KΑ[Α]
[Β]50%
KB
× = 1 +           
KΑ[Α]
KΑ[Α]
[Β]50%
KB
= 1 +           
[Α]
KΑ
[Β]50%
KB
KB =            [Α]
KΑ
1 +
[Β]50%
The concentration of free ligands [A] and [B] can be considered equal to the total 
amount present in the incubation mixture, since their concentrations are, in all cases, 
much larger than the concentration of ConA. Therefore, a plot of the reciprocal of the 
ConA fraction bound to A versus the B should give a straight line since [B] is a fixed 
value, being KB = (intercept-l)/slope. 
Annex VI 
Localization of N-glycosylated Asn residues in three HMW1 adhesins of NTHi 
The Asn residues of HMW1 of strain 12 are shown in comparison with those from 
86028-NP and NTHi375. Conservative and non-conservative amino acid substitutions 
are shown in a grey and black background respectively (Domenech et al., 2016). 
kMultiple partial alignment of the HMW1 adhesins of strains 12 (AAA20527), 86-
028NP (AAX88733) and 375 (AIT67726). The locations of N-glycosylated Asn 
residues were previously reported (Gross et al., 2008), and here the conserved (black 
triangles) and not conserved ones (red triangles) are highlighted for the three aligned 
proteins (Domenech et al., 2016).
.
